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Summary 
 
 
Several viral envelope glycoprotein oligomers assembled into a viral fusion 
machine, form a molecular scaffold that brings the viral and target cell membranes into 
close apposition and allow the subsequent fusion events. The fusion pore formation and its 
sequential expansion are orchestrated by viral and cellular lipids and proteins. The HIV 
entry process is understood in some detail at the molecular level. It is coordinated by the 
HIV envelope glycoprotein complex, a trimer of three gp120 surface glycoproteins, each 
noncovalently attached to three gp41 ransmembrane glycoprotein subunits. 
It is know that changes in GSLs expression in target membranes can modulate viral 
fusion and entry. These studies on structure–function relationship of target membrane 
GSLs, the gp120-gp41 and the viral receptors suggest that plasma membrane GSLs support 
HIV-1 entry by stabilizing the intermediate steps in the fusion cascade. These observations, 
led it to hypothesize that upregulation of GSLs metabolites (such as ceramide) and/or 
modulation of GSLs, which preferentially partition in the plasma membrane microdomains, 
could have a significant influence on HIV-1 entry.  
Based on these findings, in this work has been developed a strategy to synthesize 
glycodentritic polymers that bind HIV rgp120 and inhibit HIV-1 entry. To reach this goal, 
first it was carried out the total synthesis of D-erytrho-sphingosine with high 
enantioselectivity and diasteroselectivity. Then, an efficient protocol of glycosylation of 
ceramides employing stannyl derivatives as strategy was developed. Finally, water-soluble 
hyperbranched glycodendritic polymers for the study of carbohydrate interactions were 
synthesized. These glycoconjugate consists of Boltorn H30 hyperbranched polymers, based 
on the monomer 2,2-bis(hydroxymethyl)propionic acid, functionalized with naturally 
occurring β-Galceramide. The click chemistry permits functional group tolerance during 
the derivatization of Boltorn H30. Their ability to bind HIV-1 rgp 120 was demonstrated 
using surface plasmon resonance (SPR). 
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BCD    β-cyclodextrin 
BINAP  2,2’-bis-(diphenylphosphino)-1-1’-binaphthyl 
Bn    Benzyl 
Boc   tert-Butyloxycarbonyl 
t-Bu   tert-Butyl 
t-BuLi   tert-Butyllithium 
Bz   Benzoyl 
Cbz   Benzyloxycarbonyl 
CDI    Carbonyldimidazol 
Cer    Ceramide 
CM    Cross-metathesis reaction 
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HIV-1    Human immunodeficiency virus 
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Lys   Lysine 
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TBDMSCl  tert-Butyldimethylsilyl chloride 
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1.1. Chemistry and Biology of Glycosphingolipids  
 
In the fluid mosaic model of biological membranes, lipids form a homogeneous 
two-dimensional solvent phase for membrane proteins. Yet membrane lipids comprise 
several hundreds of distinct molecules that exist in different physical states controlled 
by several physicochemical parameters such as the temperature, presence of cholesterol 
and chemical nature of the hydrocarbon chains. Biological membranes (Figure 1) are 
thus better described as a ‘mosaic of lipid domains’ rather than a homogeneous fluid 
mosaic. Membrane cholesterol, for instance, is unevenly distributed into cholesterol-
rich and cholesterol-poor domains, consistent with the notion that specialized lipid 
domains with specific biochemical composition and physicochemical properties do exist 
in membranes. 1  
 
 
 
Figure 1. Schematic representation of the bilayer fluid mosaic model of the cell memebrane. 
 
Among these domains, those containing sphingolipids and cholesterol, referred 
to as lipid rafts or caveolae (when associated with the integral membrane protein 
caveolin), have been extensively studied.2 For cell biologists, lipid rafts are chiefly 
involved in cellular trafficking and signalling functions.3 For pathologists, these 
membrane areas are preferential sites for host–pathogen/toxin interactions4 and for the 
generation of pathological/infectious forms of proteins associated with Alzheimer’s and 
                                                 
1
 Taïeb, N.; Yahi, N.; Fantini,  Adv. Drug Deliv. Rev. 2004, 56, 779−794. 
2
 Simona, K.; Ikolen, E. Nature 1997, 387, 569−572. 
3
 (a) Sprong, H.; van der Sluijs, P.; van Meer, G. Nat. Rev. 2001, 2, 504−513. (b) Kasahara, K.; Sanai, Y. 
Glycoconj. J. 2000, 17, 153−162. 
4
 Duncan, M. J.; Shin, J.- S.; Abraham, S. N. Cell. Microbiol. 2002, 4, 783−791. 
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prion diseases.5 As a matter of fact, both the physiological and pathological aspects of 
lipid raft functions have been the subject of excellent recent reviews.6  
Glycosphingolipids7 (GSLs) are characteristic membrane components of eukaryotic 
cells where they are found in the carbohydrate-rich glycocalix, which consists of 
glycoproteins and glycosaminoglycans in addition to GSLs.8 Minor sites of location are 
the subcellular organelles where glycosphingolipid metabolism occurs, or the vesicles, 
or other transport structures, involved in glycosphingolipid intracellular traffic. 
Gangliosides are major components of neuronal membranes, where they constitute 10-
12% of the total lipid content (20-25% in the outer membrane layer). Details regarding 
glycosphingolipids, particularly gangliosides, structure and cellular location can be 
found in classical reviews.9 Each GSL carries a hydrophobic ceramide (Cer) moiety and 
a hydrophilic extracellular oligosaccharide chain which protrudes from the membrane 
surface (Figure 2). 
 
 
Figure 2. Structure of a glycosphingolipid 
 
Ceramide is constituted by a long amino alcohol chain (sphingoid base) linked to a 
fatty acid, most commonly with a long chain of carbons atoms (18-20), sometimes 
hydroxylated. The most frequently occurring long chain bases contain a C4-C5 double 
bound in the trans-D-erythro configuration, and are C18 and C20 sphingosines. Less 
frequent are sphinganines, that lack the double bond, and phytosphingosine that carries 
a hydroxyl group on C4. The saccharide moiety is represented by a single saccharide 
                                                 
5
 Mahfoud, R.; Garmy, N.; Maresca, M.; Yahi, N.; Puigserver, A.; Fantini, J. J. Biol. Chem. 2002, 277, 
11292−11296. 
6
 (a) Smart, E. J.; Graf, G. A.; McNiven, M. A.; Sessa, W. C.; Engelman, J. A.; Scherer, P. E.; Okamoto, 
T.; Lisanti, M. P. Mol. Cell. Biol. 1999, 19, 7289−7304. (b) Hakomori, S.-I. Glycoconj. J. 2000, 17, 
143−151. (c) Norkin, L. C. Adv. Drug Deliv. Rev. 2001, 49, 301−315. 
7
 (a) Vankar, Y. D.; Schmidt, R. R. Chem. Soc. Rev. 2000, 29, 201−216. (b) Miller-Pedraza, H. Chem. 
Rev. 2000, 100, 4663−4682. 
8
 Sweely, C. c. Biochemistry of Lipids, Lipoproteins and Membranes, (Eds.: Vance, D. E. and Vance, J. 
E.) Benjamin/Elsevier, Amsterdam, 1991. 
9
 (a) Huwiler, A.; Kolter, T.; Pfeilschifter, J.; Sandhhoff, K. Biochim. Biophys. Acta, 2000, 1485, 63−69. 
(b) Shayman, J. A. Kidney Inter. 2000, 58, 11−26. 
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unit, as in the case of cerebrosides (β-Galcer 1, Figure 3); sulphated mono- or di-
saccharides, as in the case of sulphatides (Sulfatide β-Galcer 2, Figure 3); and as linear 
or branched oligosaccharide chain (iGB3 3 or GM3 4, Figure 3). The saccharide units 
present in glycosphingolipids are glucose, galactose, N-acetylglucosamine, N-
acetylgalactosamine, fucose, sialic acid and glucuronic acid. The mono- or multi-
sialosylated glycosphingolipids are named gangliosides that, together with sulphatides, 
constitute the group of acidic glycosphingolipids. The remainder glycosphingolipids are 
neutral glycosphingolipids. Thus, GSLs are generally classified as follows: 
(i) Cerebrosides, which contain one sugar residue (β-Galcer 1)  
(ii) Sulfatides whose structure contain one sugar residue with a sulphate group 
(Sulfatide β-Galcer 2 ) 
(iii) Neutral Glycosphingolipids (iGB3 3) 
(iv) Gangliosides (GM3 4) 
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Figure 3. Naturally occurring glycosphingolipids 
 
The formation of ceramide is catalysed by membrane bound enzymes on the 
cytosolic leaflet of the endoplasmic reticulum (ER).10 Starting from the amino acid L-
serine 5 and two molecules of the palmitoyl-coenzyme A 6, dihydroceramide 9 is 
formed in three steps (Scheme 1). This N-acyl-2-aminoalkyl-1,3-diol (N-
acylsphinganine) is dehydrogenated to ceramide 10 with a 4,5-trans-double bond by a 
dihydroceramide desaturase. At the membranes of the Golgi apparatus, hydrophilic head 
groups are attached to ceramide leading to sphingomyelin, galactosylceramide, 
glucosylceramide, and higher glycosphingolipids, which are synthesised by the stepwise 
                                                 
10
 Merrill Jr., A. H. J. Biol. Chem. 2002, 277, 25843−25846. 
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addition of monosaccharides to glucosylceramide. Their biosynthesis is coupled to 
exocytotic vesicle flow to the plasma membrane (Figure 4). 
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Scheme1. Biosynthesis of ceramide 10 
 
The constitutive degradation of sphingolipids occurs in both the endosomes and the 
lysosomes.11 Parts of the plasma membrane are endocytosed and transported via the 
endosomal to the lysosomal compartment. Hydrolytic enzymes cleave the carbohydrate 
residues of glycolipids sequentially. Many glycosphingolipids, and also ceramide, 
require the additional presence of activator proteins and negatively charged lysosomal 
lipids for degradation.12 In humans, inherited defects of glycosphingolipid and 
sphingolipid catabolism give rise to lysosomal storage diseases, the sphingolipidoses.13 
 
 
 
Figure 4. Localization and topology of ceramide-metabolizing enzymes 
                                                 
11
 (a) Kolter, T.; Sandhoff, K. Angew. Chem. 1999, 111, 1633−1670. (b) Kolter, T.; Sandhoff, K. Angew. 
Chem. Int. Ed. 1999, 38, 2532−1568. (c) Kolter, T.; Sandhoff, K. Trens Cell Biol. 1996, 6, 98−103. 
12
 Kolter, T.; Sandhoff, K. Phil. Trans. R. Soc. London B 2003, 358, 847−861. 
13
 Kolter, T.; Sandhoff, K. Brain Pathology 1998, 8, 79−100. 
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Several external proteins that are specifically associated with lipid rafts are bound to 
the membrane by a glycosylphosphatidylinositol (GPI) anchor consisting of two 
saturated chains (1-alkyl-2-acyl-glycerol) that can tightly pack with raft lipids.14 
Although sphingolipids are usually not found in the cytoplasmic leaflet of the plasma 
membrane, specific glycerophospholipids such as phosphatidylserine (PS) with 
saturated or monounsaturated chains may form liquid-ordered domains through 
interaction with long sphingolipid acyl chains of the outer monolayer.15 On the other 
side of the membrane, acylated proteins anchored in the internal leaflet with two or 
more saturated acyl chains (generally myristyl and palmityl) are constitutively 
associated with lipid rafts. It is likely that these proteins may significantly contribute to 
the formation of a Lo phase in the inner leaflet of lipid rafts.16  
The situation is even more complex for transmembrane proteins, which have three 
main distinct possibilities of interaction with the specific lipid components of the rafts: 
(i) the extracellular domain, which interacts with the polar head of glycosphingolipids 
(ii) the cytoplasmic juxtamembrane domain, which faces anionic glycerophospholipids 
such as PS, and (iii) the transmembrane (TM) domain (Figure 5). Since lipid rafts are 
enriched in cholesterol, it can be predicted that the TM domain contains amino acid side 
chains particularly suited for interacting with this sterol. Although the relative affinity 
of the 20 amino side chains for cholesterol is not know, it can be anticipated from the 
chemical structure that Phe and Ile residues would ideally fit with the aliphatic cycles 
and the isooctyl tail of the lipid (Figure 5). In support of this hypothesis, it has been 
shown that replacement of the TM domain of CD40, a raftassociated protein, by the one 
of CD45, a non-raft protein, resulted in the exclusion of CD40 from lipid rafts.17 The 
TM domains of CD40 and CD45 are both composed of 22 amino acids, but CD40 has 6 
Ile and 3 Phe residues, whereas CD45 has only 4 Ile and 2 Phe residues. Basically, a 
TM domain is an α-helix buried in the hydrophobic region of the membrane. The 
assembly of cholesterol molecules around a TM domain enriched in Ile and Phe 
residues may contribute to stabilize the interaction of the a-helix with the Lo phase of 
lipid rafts. Mutating these residues in the TM domain of CD40 and other raft-associated 
proteins will help to validate this hypothesis. 
 
                                                 
14
 Benting, J. FEBS Lett. 2003, 462, 47−50. 
15
 Pike, L. J.; Han, X.; Chung, K.-N.; Gross, R. W. Biochemistry 2002, 41, 2075−2088.  
16
 Edidin, M. Annu. Rev. Biophys. Biomol. Struct. 2003, 32, 257−283. 
17
 Bock, J.; Gulbins, E. FEBS Lett. 2003, 534, 169−174. 
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Figure 5. Interaction of membrane proteins with lipid rafts 
 
A polybasic motif enriched in Arg or, to a lesser extent, Lys residues is often 
found in the juxtamembrane cytoplasmic domain of raft-associated proteins (e.g. human 
CD4, EGF and PDGF receptors). The positive charge of these basic amino acids may 
interact with the net negative charge of PS through electrostatic interactions. Finally, the 
extracellular domain of raft-associated proteins faces sphingomyelin, which carries one 
positive and one negative charge, and GSLs which may be either neutral or negatively 
charged in the case of gangliosides. Ideally, a sphingolipid-binding domain (SBD) 
should be composed of a charged residue (preferentially basic) for interacting with the 
polar head of sphingomyelin and gangliosides. Moreover, the SBD should also contain 
a solvent-exposed aromatic side chain conveniently oriented to stack against the sugar 
rings of GSLs. In any case, the three modes of interaction of transmembrane proteins 
with lipid rafts (i.e. SBD, TM domain and polybasic motif) may allow the assembly of a 
lipid shell around the protein.18 According to this model, lipid shells have a preferential 
affinity for lipid rafts, so that they are assumed to target the protein they encase to these 
microdomains. 
Since bacterial adhesins and toxins may interact first (if not exclusively) with the 
extracellular side of lipid rafts, they can be considered as foreign competitors for host 
membrane proteins associated with lipid rafts. On this basis, it could be anticipated that 
bacterial adhesins and toxins could present in their three-dimensional structure a SBD 
                                                 
18
 Anderson, R. G. W.; Jacobson, K. Science 2002, 296, 1821−1825. 
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domain similar to the one found in the raft proteins of the host. The first identification 
of a microbial SBD came from the study of HIV-1 surface envelope glycoprotein gp120 
and its GSL intestinal receptor GalCer.5 The region of gp120 responsible for GalCer 
recognition is a disulfide-linked domain referred to as the V3 loop.19 Searches for 
structure similarities revealed the presence of a V3-like SBD in various sphingolipid-
binding proteins including cellular proteins such as the prion protein isoform PrPc or the 
Alzheimer β-amyloid peptide5 and bacterial toxins.20  
The GSLs are used as cellular binding sites for a wide variety of pathogens, 
including viruses, bacteria, fungi and parasites.21 The oligosaccharide residues of GSLs 
protrude into the extracellular space, providing a considerable number of carbohydrate-
binding sites for microbial adhesions. However, specificity of a carbohydrate sequence 
is not the unique parameter controlling pathogen binding, and density levels of GSLs on 
the host cell surface may also be critical. Indeed, a threshold level of GSLs is often 
required to ensure microbial adhesion, suggesting that those GSLs are active only when 
concentrated in a lipid raft to form an operational attachment platform. Thus, although 
individual GSLs–protein interactions may be weak, the resulting avidity of the pathogen 
for the raft may be very high. To complicate further the story, the same pathogen (e.g. 
HIV-1) may use either high or low affinity GSLs binding sites to infect various cellular 
targets. Moreover, the binding of a pathogen on the cell surface may also require, in 
addition to the GSLs, a second component, generally a protein which can be either GPI-
anchored or an integral transmembrane protein. In this case, the lipid and the protein 
cooperate and the binding reaction proceeds in three steps. First, the pathogen selects a 
raft with appropriate GSLs binding sites. Once stabilized on this attachment platform, 
the raft float on the cell surface, allowing the pathogen to ‘browse’ over the cell surface, 
looking for a high affinity receptor. Third, a ternary ‘GSL-pathogen-receptor’ complex 
is formed within the raft area. It should also be noted that the role of GSLs in this 
process has been remarkably anticipated to viruses22 and bacterial neurotoxins,23 several 
years before the elaboration of the raft concept. Basically, this mechanism can be 
viewed as a pathological exploitation of the coalescence model (Figure 6). 
 
                                                 
19
 Cook, D. G.; Fantini, J.; Spitalnik, S. L.; Gonzales-Scarano, F. Virology, 1994, 201, 206−214. 
20
 Fantini, J. Cell. Mol. Life Sci. 2003, 60, 1027−1032. 
21
 Van der Goot, F. G. Semen. Immunol. 2001, 13, 89−97. 
22
 Haywood, A. J. Virol. 1994, 68, 1−5. 
23
 Montecucco, C. Trens Biochem. Sci. 1986, 11, 314−317. 
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In the coalescence model, the IgE 
receptor FcεRI is a multichain immune 
recognition receptor which is not 
constitutively associated with raft 
microdomains. Upon crosslinking with their 
physiological ligand (i.e. the IgEantigen 
complex), FcεRI receptors are rapidly 
recruited in raft areas.24 The co-
compartmentation of FcεRI receptors with the 
raft-associated tyrosine kinase Lyn provides 
an adequate spatial proximity allowing the 
phosphorylation of FcεRI on tyrosinebased 
activation motifs (ITAMs). This membrane 
coordinated signal triggers the intracellular 
cascade that leads to release of mediators of 
the allergic response. Finally, it is important to mention that some signal transduction 
units may pre-assembled in lipid rafts of quiescent cells, allowing rapid and efficient 
signal initiation upon activation.25 As show in Figure 6 (A) in quiescent mast cells, the 
IgE receptor (FcεRI) is localized outside membrane rafts, so that it cannot interact with 
Lyn, a kinase of the src family anchored to the inner leaflet of the plasma membrane 
with acyl chains. (B) Upon binding of the antigen (Ag)-IgE complex to FcεRI, Lyn and 
FcεRI are recruited in rafts. (C) The coalescence of rafts induced by the multivalent 
antigen allows the interaction between FcεRI and Lyn, resulting in phosphorylation of 
FcεRI and activation of the signal transduction pathway. 
 In the other hand, it has long been recognized that the aglycone, hydrophobic 
part of GSLs has a major impact on the conformation of their glycone moiety and thus 
on GSLs receptor function.26 Moreover, it has been demonstrated that cholesterol, 
which functions as ‘molecular spacer’ in lipid rafts,2 may have a critical effect on the 
conformation and thus on the binding properties of raft GSLs. This is the case for Gb3, 
                                                 
24
 Prieschl, E. L.; Baumruker, T. Immunol. Today, 2000, 21, 555−560. 
25
 Drevot, P.; Langlet, C.; Guo, X. J.; Bernard, A. M.; Colard, O.; Chauvin, J. P.; Lasserre, R.; He, H. T. 
EMBO J. 2000, 15, 1899−1908. 
26
 Kiarash, A.; Boyd, B.; Lingwood, C. A. J. Biol. Chem. 1994, 269, 11138−11146. 
 
 
Figure 6. Signal transduction pathway 
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which requires cholesterol to interact optimally with the SBD of HIV-1 gp12027 and for 
cholera toxin, which binds to GM1 only when presented as condensed complexes in 
artificial cholesterol/phospholipid membranes.28 Therefore, although cholesterol has 
been described as a specific binding site for a number of bacterial pore-forming toxins 
(the so-called cholesterol-dependent cytolysins),29 it may also act as a fine regulator of 
most GSLs–pathogen interactions.  
Yet in some 
instances, cholesterol has an 
inhibitory rather than a 
stimulatory effect on GSLs–
pathogen interactions. This is 
the case for GalCer, a major 
GSLs of the apical brush 
border of enterocytes.30 Due 
to the relatively small size of 
its polar head (only one sugar 
ring), GalCer can form a 
tightly packed platform in 
absence of cholesterol 
(Figure 7A). In contrast, Gb3 
with three sugar rings may 
require cholesterol to form a condensed complex on the cell surface,27 as proposed in 
Figure 7B. This is consistent with the body of data suggesting that different types of 
lipid rafts, with and without cholesterol, exist in the apical brush border.31 In particular, 
a high concentration of cholesterol may suppress the formation of membrane domains 
by impairing the tight packing of GalCer, a major GSLs of brush border membranes. 
                                                 
27
 Mahfoud, R.; Mylvaganam, M.; Lingwood, C. A.; Fantini, J. J. Lipid Res. 2002, 43, 1670−1679. 
28
 Radhakrishnan, A.; Anderson, T. G.; McConnell, H. M. Proc. Natl. Acad. Sci. U.S.A. 2000, 97, 
12422−12427. 
29
 Alouf, J. E.; Int. J. Med. Microbiol. 2000, 290, 351−356. 
30
 Hammache, d.; Piéroni, G.; Maresca, M.; Ivaldi, S.; Yahi, N.; Fantini, J. Methods Enzymol. 2000, 312, 
495−506. 
31
 (a) Corbeil, D.; Röper, K.; Fargeas, C. A.; Joester, A.; Hunttner, W. B. Traffic, 2001, 2, 82−91. (b) 
Milhiet, P. E.; Giocondi, M.-C.; Le Grimellec, C. J. Biol. Chem. 2002, 277, 875−878. (c) Braccia, A.; 
Villani, M.; Immerdal, L.; Niels-Christiansen L.-L.; Nystrom, B. T.; Hansen, G. H.; Danielsen, E. M. J. 
Biol. Chem. 2003, 278, 15679−15684. 
 
 
Figure 7. Influence of the hydrophopic moiety of GSLs on the 
orientation of the glycone polar head 
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This may explain the opposite effects of cholesterol on GalCer and Gb3 receptor 
functions.27  
The potential absence of cholesterol in GalCer enriched intestinal rafts does not 
mean that the aglycone part of this GSLs does not influence the orientation of the 
galactose ring. The presence of an α-OH group in the acyl chain of the ceramide 
backbone of GalCer allows the formation of a H-bond which orientates the galactose 
ring of GalCer so that the molecule adopts a typical L-shape structure32 (Figure 7A). In 
contrast, the galactose ring of GalCer containing a non hydroxylated acyl chain 
protrudes at 180° with respect to the plane of the membrane (Figure 7A). As a result, 
vicinal sugar units share a stacking interaction and are thus not available for pathogens. 
For these reasons, many microbial adhesins and toxins specifically recognize alpha-
hydroxylated vs. nonhydroxylated galactose-containing GSLs.33 In this respect, it is 
interesting to note that the α-OH group of the fatty acid chain and cholesterol have a 
comparable conformational effect on GSLs, allowing in both cases an orientation of the 
sugar head compatible with the establishment of CH–π stacking interactions with 
aromatic amino acid side chains of the SBD. 
 
1.2. Cluster effect 
Although protein-carbohydrate 
interactions (Figure 8) are essential to 
many biological processes, individual 
interactions usually exhibit weak 
binding34 affinities (Kd values in the 
mM to µM range) as well as apparently 
relatively low selectivities between 
similar carbohydrate ligands. These 
characteristics and properties are at 
odds with the observed biological 
activities which demand interactions 
                                                 
32
 Nylhom, P. G.; Pasher, I.; Sundell, S. Chem. Phys. Lipids 1990, 52, 1−10. 
33
 (a) Tang, W.; Seino, K.; Ito, M.; Konishi, T.; Senda, H.; Makuuchi, M.; Kojima, N.; Mizuochi, T. 
FEBS Lett. 2001, 504, 31−35. (b) Fantini, J.; Maresca, M.; Hammache, D.; Yahi, N.; Delézay, O. 
Glycoconj. J. 2000, 17, 173−179. (c) Fantini, J.; Cook, D. G.; Nathanson, N.; Spitalnik, S. L.; 
Gonzalez-Scarano, F. Proc. Natl. Acad. Sci. U.S.A. 1993, 90, 2700−2704. (d) Karlsson, K. K. Ann. Rev. 
Biochem. 1989, 58, 309−350.  
34
 Lee, R. T.; Lee, Y. C. Acc. Chem. Res. 1995, 321−327. 
 
 
Figure 8. A graphical representation of cell surface 
protein-carbohydrate interactions 
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that are both extremely selective and of high affinity. Nature’s answer to this problem is 
to use multivalency.35 Thus, multiple copies of the carbohydrate ligands are arranged on 
glycoprotein scaffolds or in patches of glycolipids on the surface of one cell, and 
multiple copies of lectins (or lectins each with multiple binding sites) are displayed at 
the surface of another cell. When these two surfaces come together, the individual 
interactions reinforce one another to give overall a high avidity, not unlike molecular 
scale Velcro. 
 
 
 
Figure 9. The glycoside cluster effect 
 
The glycoside cluster effect was defined initially36 as the ‘binding affinity 
enhancement exhibited by a multivalent carbohydrate ligand over and beyond that 
expected from the concentration increase resulting from its multivalency’. This 
enhancement in binding affinity can be the consequence of two different mechanisms37 
at the molecular level: 1) a statistical effect in which the multivalent compound gives 
rise (Figure 9a) to a highly localized concentration of the ligand at the receptor binding 
site; and 2) a chelate effect in which the multivalent ligand cross-links binding sites 
either in adjacent receptors (Figure 9b) or in a single multivalent receptor (Figure 2c and 
2d). It has been observed that,37 in those cases where cross-linking lectin binding sites 
with a multivalent ligand (chelation) are not possible, a small increase (five-fold to 10-
fold) in binding affinity still occurs as a consequence of the statistical effect. By 
contrast, however, exponential increases in binding affinities are possible in situations 
that favor the chelation mechanism. Furthermore, just as the multivalent display of 
                                                 
35
 Mammen, M.; Choi, S.-K.; Whitesides, G. M. Angew. Chem. Int. Ed. 1998, 37, 2754−2794. 
36
 Lee, R. T.; Lee, Y. C. Neoglycoconjugates: Preparation and Applications, 1994, Academic Press, San 
Diego, 23−50. 
37
 Pohl, N. L.; Kiessling, L. L. Synthesis 1999, 1515−1519. 
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ligands can occur on different scales (multivalent glycans attached to multivalent 
proteins clustered in a multivalent fashion at a cell surface) the glycoside cluster effect 
can operate at different levels of complexity. This phenomenon has been described36-38 
in terms of the so-called minicluster (Figure 9b) and maxicluster (Figure 9c) effects, 
which can express themselves separately or in unison.  
Although the observation that multivalency is important in protein-carbohydrate 
interactions formed the original rationalization for developing a whole range of 
synthetically engineered glycoconjugate systems the pioneering work in the field by 
Lee39 has also contributed to understanding of multivalency. An important aspect of 
multivalency that has been observed, in addition to high affinity, is the enhancement of 
the selectivity of a particular interaction. Small differences in the intrinsic binding 
affinity (monovalent binding affinity) can be ‘amplified’ greatly on displaying the 
ligands in a multivalent fashion.40 
 
1.3. Human Immunodeficiency Virus 
 
The human immunodeficiency virus (HIV) has proven to be a difficult pathogen 
to overcome; there are currently no effective vaccines that provide specific and long-
lasting immunity to the virus. Moreover, there are only a few currently FDA-approved 
drugs that target HIV proteins such as reverse transcriptase, protease, and the surface 
envelope protein. Although these drug combination therapies provide effective 
suppression of HIV virions in individuals, the cost, toxicity, and drug resistance remain 
common concerns. Until recently, with the FDA approval of Fuzeon® (enfuvirtide), 
there were no drugs on the market that specifically target and prevent the entry of HIV 
into human cells. Inhibitors of reverse transcriptase and protease are designed to work 
only after viral contents have entered into cells, whereas enfuvirtide works by binding 
to the HIV transmembrane envelope subunit gp41 and preventing the fusion of the viral 
membrane with the host membrane.41 Other fusion inhibitors involving the blocking of 
                                                 
38
 Yi, D.; Lee, R. T.; Longo, P.; Borger,E. T.; Lee, Y. C.; Petri, W. A.; Jr. Schnaar, R. L. Glycobiology, 
1998, 8, 1037−1043. 
39
 Lee, Y. C. Carbohydr. Res. 1978, 67, 509−514. 
40
 (a) Pieters, R. J. Med. Res. Rev. 2007, 27, 796−816. (b) Schengrund, C.-L. Biochem. Phar. 2003, 65, 
699−707. (c) Bezouška, K. Rev. Mol. Biotech. 2002, 90, 269−290. (c) Turnbull, W. B.; Stoddart, J. F. 
Rev. Mol. Biotech. 2002, 90, 231−255. (d) Ortiz-Mellet, C.; Defaye, J.; García-Fernández, J. M. Chem. 
Eur. J. 2002, 8, 1982−1990. (e) Lee, R. T.; Lee, V. C. Glycoconj. J. 2000, 17, 543−551. 
41
 Kilby, J. M.; Hopkins, S.; Venetta, T. M.; DiMassimo, B.; Cloud, G. A.; Lee, J. Y.; Alldredge, L.; 
Hunter, E.; Lambert, D.; Bolognesi, D.; Matthews, T.; Johnson, M. R.; Nowak, M. A.; Shaw, G. M.; 
Saag, M. S. Nat. Med. 1998, 4, 1302−1307. 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 15
host chemokine receptors are currently being investigated in preclinical models and 
clinical trials.42 Despite the development of such potential therapeutics, the spread of 
HIV worldwide continues unabated with no promising cure in sight. Further pursuit of 
its understanding of HIV will lead to new possibilities for preventing HIV infection that 
can be effective and affordable. 
The HIV fusion and 
infection involves a step-wise 
process that includes a number of 
host cell proteins and lipids.43 
First, the HIV envelope protein 
gp120 binds to CD4 on target 
cells. Many other accessory 
proteins have also been implicated 
in mediating HIV binding to host 
cells as well, including DC-
specific intercellular adhesion 
molecule-3 (ICAM-3)-grabbing nonintegrin (DC-SIGN), macrophage mannose 
receptor, lymphocyte functionassociated antigen–1 (LFA-1), intercellular adhesion 
molecule–1 (ICAM-1), and glycosaminoglycans. 44 Subsequent to the initial binding to 
CD4, a conformational change in gp120 allows it to bind to chemokine receptors, 
generally, either CCR5 or CXCR4, although a number of other chemokine receptors 
may serve as HIV coreceptors (Figure 10). This binding then triggers a conformational 
change that exposes a previously buried portion of the transmembrane glycoprotein, 
gp41, resulting in its insertion into the host cell membrane. The host and viral 
membranes then fuse, permitting the contents of the virus to enter the cell cytoplasm. 
Lipid rafts, which are cholesterol- and sphingolipid-enriched membrane 
domains, appear to be involved in HIV fusion and infection.45 The formation of lipid 
                                                 
42
 Shaheen, F.; Collman, R. G. Curr. Opin. Infect. Dis. 2004, 17, 7−16. 
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Su, S. V.; Gurney, K. B.; Lee, B. Curr. HIV Res. 2003, 1, 87−99. 
45
 (a) Viard, M; Parolini, I.; Sargiacomo, M.; Fecchi, K.; Ramoni, C.; Ablan, S.; Ruscetti, F. W.; Wang, J. 
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Figure 10. Binding of HIV to cell 
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rafts arises from the tight packing of cholesterol with saturated sphingolipid chains that 
allows for increased order in the membrane and resistance to non-ionic detergents at 
4°C.46 Studies using β-cyclodextrin (BCD) to remove cholesterol from target cell 
membranes have demonstrated significant inhibition of HIV infection. Similarly, 
chemical inhibition of glycosphingolipid production also resulted in the inhibition of 
HIV infection.47 Thus, perturbation of lipid raft–specific lipids in the target cell 
membrane can influence the cell’s ability to be infected. A supposed minor alteration in 
the cholesterol molecule by oxidation of carbon-3 (to form 4-cholesten- 3-one) also 
results in significant inhibition of HIV infection.48 Although it was initially thought that 
cholesterol is simply required for membrane mixing, studies have demonstrated that the 
HIV inhibitory effects of treating cells with BCD can be overcome by over-expressing 
chemokine receptors.  
The CD4 molecule is predominantly localized in lipid rafts under normal 
physiological conditions; however, the requirement for the interaction of CD4 and lipid 
rafts in HIV infection is currently being debated: some researchers have demonstrated 
the interaction to be essential for infection,49 whereas others have found it to be non-
essential.50 An additional point of interest regarding cholesterol is that statin drugs, 
originally identified as cholesterol-lowering agents, inhibit HIV infection both by 
blocking the interaction of ICAM-1 with LFA-1 and by inhibiting Rho GTPase 
activity.51 Because lipid-altering drugs can influence a number of cell signaling 
pathways and cell responsiveness, the question: “Is the effect a pure membrane 
inhibitory effect or is it inhibiting cell signaling pathways that may be required for 
productive infection?” remains to be determined.  
Cholesterol in the HIV membrane is also essential for infectivity. As viruses bud 
from infected cells they do so at cholesterol-rich lipid rafts, resulting in the enrichment 
                                                                                                                                               
Z.; Cimakasky, L. M.; Hampton, R.; Nguyen, D. H.; Hildreth, J. E. AIDS Res. Hum. Retroviruses 2001, 
17, 1009−1019. 
46
 Brown, D. A.; London, E. Annu. Rev. Cell. Cev. Biol. 1998, 14, 111−136 
47
 (a) Manes, S.; del Real, G.; Lacalle, R. A. EMBO Rep. 2000, 1, 190−196. (b) Nguyen, D. H.; Taub, D. 
J. Immunol. 2002, 168, 4121−4126. (c) Popik, W.; Alce, T. M.; Au, W. C. J. Virol. 2002, 76, 
4709−4722. 
48
 Nguyen, D. H.; Taub, D. D. Exp. Cell. Res. 2003, 291, 36−45. 
49
 del Real, G.; Jimenez-Baranda, S.; Lacalle, R. A.; Mira, E.; Lucas, P.; Gomez-Mouton, C.; Carrera, A. 
C.; Martinez, A. C.; Manes, S. J. Exp. Med. 2002, 196, 293−301. 
50
 (a) Kozak, S. L.; Heard, J. M.; Kabat, D. J. Virol. 2002, 76, 1802−1815. (b) Percherancier, Y.; Lagane, 
B.; Planchenault, T.; Staropoli, I.; Altemeyer, R.; Virelizier, J. L.; Arenzana-Seidedos, F.; Hossli, D.; 
Bachelerie, F. J. Biol. Chem. 2003, 278, 3153−3161. 
51
 (a) Giguere, J. F.; Tremblay, M. J. J. Virol. 2004, 78, 12062−12065. (b) del Real, G.; Jimenez-Barada, 
S.; Mira, E.; Lacalle, R. A.; Lucas, P.; Gómez-Moutón, C.; Alegret, M.; Peña, J. M.; Rodríguez-Zapata, 
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of cholesterol in viral membranes as compared to the levels of cholesterol found on host 
cells.52 Hildreth and colleagues have proposed the use of BCD in topical formulations, 
which would remove cholesterol from free virions, in order to prevent HIV infection.53 
Preclinical studies using such topical compounds are currently underway. Moreover, the 
HIV Gag protein, which is the major viral structural protein, is modified by the addition 
of a saturated myristoyl tail promoting its incorporation into lipid rafts. This finding has 
led others to demonstrate that the addition of unsaturated fatty acids to HIV producing 
cells can inhibit the production of virions, most likely by covalent modification of Gag, 
resulting in non-raft protein localization.54  
Although the common approach to manipulating lipid rafts is to target 
cholesterol into the cell membrane, another approach is to alter raft-associated 
sphingolipids. In a recent publication, Blumenthal and colleagues have demonstrated 
that increasing cellular ceramide can inhibit HIV infection.55 The addition of a 
phosphocholine group produces sphingomyelin, a known raft-associated lipid. In their 
study, the retinoic acid derivative 4-HPR (fenretinide) was utilized to increase cellular 
ceramide levels in HeLa cells, peripheral blood activated T cells, and monocyte-derived 
macrophages (MDMs). Such treatment resulted in a significant decrease in the HIV 
infectivity of the three cell models and with all of the viral strains tested. Some viral 
strains demonstrated nearly complete inhibition of infection at concentrations of <5 mM 
4-HPR, but there was significant variability in the IC50 values and maximal inhibition 
among the different strains. This HIV inhibition was a ceramide-specific effect, as 
evidenced through the use of sphingomyelinase, which cleaves sphingomyelin to create 
ceramide, and by the addition of exogenous ceramide. Unlike BCD, which removes 
cholesterol from cell membranes, 4-HPR did not affect chemokine receptor function. 
The increase in cellular ceramide levels inhibited cell-cell fusion, leading to the 
hypothesis that increasing ceramide affects membrane lipid-raft organization and 
structure. Based on these data, the authors propose that 4-HPR could potentially be used 
as an anti-HIV drug in combination with current therapies, based on its low toxicity. 
The potential for targeting ceramide raises some interesting aspects regarding HIV 
therapy. Further studies will need to be done in order to fully characterize how 
                                                 
52
 (a) Nguyen, D. H.; Hildreth, J. E. J. Virol. 2000, 74, 3264−3272. (b) Ono, A.; Freed, E. O. Proc. Nalt. 
Acad. Sci. U.S.A. 2001, 98, 13925−13930. 
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 Khanna, K. V.; Whaley, K. J.; Zeitlin, L. J. Clin. Invest. 2002, 109, 205−211. 
54
 Lindwasser, O. W.; Resh, M. D. Proc. Nalt. Acad. Sci. U.S.A. 2002, 99, 13037−13042. 
55
 Finnegan, C. M.; Rawat, S. S.; Puri, A.; Wang, J. M.; Ruscetti, F. W.; Blumenthal, R. Proc. Nalt. Acad. 
Sci. U.S.A. 2004, 1001, 15452−15457. 
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increased ceramide levels may influence the cell membrane. How does 4-HPR and 
ceramide impact the formation, integrity, and structure of lipid rafts, including 
signalling protein association and CD4 association? 
It should be noted that Blumenthal and coworkers also reported that this 
ceramide-mediated inhibition of HIV infectivity was not observed using VSV-gene-
containing pseudotyped or surrogate virions. Given that VSV-pseudotyped viruses do 
not depend on lipid rafts for entry into cells, these data strongly support a lipid raft–
specific but not a whole-membrane effect. Another recent study has demonstrated that 
ceramide also efficiently displaces cholesterol from lipid rafts,56 thus potentially 
explaining the raft-specific effect without interfering with CXCR4 cholesterol 
interactions. Can ceramide somehow prevent the ability to cluster CD4 and chemokine 
receptors into microdomains that may be required for infection? As there is no known 
physiologic reason that CD4 would need to interact with chemokine receptors, 
inhibiting such clustering could potentially be quite specific for HIV infection (Figure 
11). On T cells, the HIV receptor CD4 is constitutively associated with lipid rafts at the 
cell surface, whereas chemokine receptors such as CXCR4 are normally excluded. 
Upon HIV binding and cell signaling, CXCR4 is recruited to rafts where they can 
interact with gp120, resulting in viral fusion to the cell membrane (bottom left). 
Treatment with BCD or statins 
to remove membrane cholesterol 
disrupts lipid rafts and cell signaling, 
resulting in an inhibition of HIV 
infection and a loss of chemokine 
receptor function (bottom center). 
Increasing membrane ceramide levels 
also alter the properties of lipid rafts 
(bottom right), possibly by displacing 
cholesterol from lipid rafts, which 
results in the inhibition of HIV 
infection. In contrast to treatment with BCD, increased ceramide in the cell membrane 
does not result in the loss of chemokine receptor function (Figure 11). 
                                                 
56
 London, M.; London, E. J. Biol. Chem. 2004, 279, 9997−10004. 
 
 
 
Figure 11. Model for inhibit HIV infection 
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For now, as we expect HIV infected patients to be treated with anti-retrovirals 
for the rest of their lives, thus, the use of lipid concentration-altering drugs could elicit 
serious long-term effects, especially in cells such as neurons that are rich in 
gangliosides and sphingolipids. Do these drugs have immune inhibitory effects, such as 
with T cell activation? As HIV patients already have suppressed immune systems with 
decreased CD4 T cell counts, any additional suppression may prove dangerous. The 
path to inhibiting HIV infection remains elusive, in which, we will require the 
development of new approaches to achieve success. Targeting lipid rafts could possibly 
provide such a means to inhibiting viral infection. Whether BCD formulations in topical 
microbiocides or 4-HPR will be clinically effective at slowing or stopping HIV 
infection remains to be demonstrated. At least we can begin to broaden the scope of 
HIV therapy by understanding how host cell lipids contribute to HIV infection. In 
addition, the targeting of non-HIV proteins may provide the path of least resistance to 
achieving effective HIV therapy. 
Studies described above illustrate that glycosphingolipids, ceramide, and their 
metabolites play a direct and/or auxiliary role during HIV-1 infection. Although the 
exact mechanisms by which these lipids modulate HIV-infection warrant further 
investigation, it is certain that the site of action of these lipids at the virus-cell 
membrane fusion level. Therefore, a number of strategies have been developed to 
design GSL/glycoconjugate based molecules to inhibit HIV-1 fusion reaction.  
In this context, a series of β-GalCer and β-SGalCer-derivatized dendrimers 
(multivalent neoglycoconjugates) were synthesized to enhance binding affinity with 
HIV-1 gp120 (Figure 12).57,58 The glycodendrimers were evaluated for binding to 
rgp120 using surface plasmon resonance (SPR). All of the GalCer analogues, when 
appended to Dab-Am generations 3-5 (with 16, 32, and 64 amino end groups, 
respectively), gave equilibrium dissociation constants (KD) on the order of 10-9 M. The 
binding affinities for the GalCer glycodendrimers were roughly 2 orders of magnitude 
                                                 
57
 Kensinger, R. D., Yowler, B. C., Benesi, A. J., and Schengrund, C. L. Bioconjug. Chem. 2004, 15, 349–
358. 
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 Kensinger, R. D.; Catalone, B. J.; Krebs, F. C.; Wigdahl, B.; Schengrund, C. L. Antimicrob. Agents 
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lower than that observed for the known standard, DS (2.29 X 10-11 M). SPR also 
indicated that the binding of both the GalCer glycodendrimers and DS was 1:1 with 
respect to rgp120. In addition to evaluate the binding affinities of the GalCer 
glycodendrimers, the ability of the glycodendrimers to inhibit HIV infection of U373-
MAGI-CCR5 cells by HIV-1 Ba-L was tested, again utilizing DS as a standard. These 
cells express CD4 and included either cloned CCR5 or CXCR4 coreceptor genes. It was 
determined that none of the nonsulfated GalCer glycodendrimers were able to inhibit 
HIV infection in Vitro. However, one of the sulfated derivatives, when attached to the 
higher order dendrimers (generations 3-5), gave EC50 values of approximately 90, 70, 
and 20 µM, respectively. Dextran sulfate was found to be a superior inhibitor with a 
measured EC50 value of less than 1 µM.  
 
 
 
Figure 12. Schematic representation of the glycodendrimers 
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Multivalent interactions of Au glyconanoparticles containing galactosyl and 
glucosyl headgroups with recombinant gp120 were recently reported.59 The gold 
nanoparticles were prepared from disulfides containing C-glycosides linked to 
triethylene glycol via an amide bond (Figure 13). Results from high-resolution 
transmission electron microscopy (HR-TEM), atomic force microscopy (AFM), UV/Vis 
absorption spectroscopy, HR-TEM, and elemental analysis data indicated that the 
nanoparticles averaged 2 nm in diameter and contained approximately 120 carbohydrate 
head groups per particle. The BNAA was used to evaluate the ability of the Au 
glyconanopraticles to displace rgp120 from plate-bound GalCer. The results showed 
divalent disulfides were <10% as active as biotinylated GalCer; however, when these 
same carbohydrates were presented in a polyvalent display, they were greater than 350 
X times more active than the disulfides and at least 20 X more active than biotinylated 
GalCer. 
 
 
Figure 13. Synthesis of glyconanoparticles 
                                                 
59
 Yu, J.-J.; Nolting, B.; Tan, Y. H.; Li, X.; Gervay-Hague, J.; Liu, G.-Y. NanoBiotechnology 2005, 1, 
201-210. 
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 With this background, the objective of this work is the synthesis of novel 
hyperbranched glycodentritic polymer that bind HIV-1 gp 120. To reach this goal, it 
glimpses a strategy that involves the next steps: 
 
i) Synthesis of D-erytrho-sphingosine with high enantioselectivity and 
diasteroselctivity (Figure 14). 
 
OH
NH2
OH
 
Figure 14 
 
ii) Glycosilation of ceramides employing stannyl derivatives as strategy (Figure 
15). 
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Figure 15 
 
iii) Synthesis of glycodendritic polymer based on Boltorn H30 as a dendritic 
support and β-Galcer as external group. Click chemistry will be the key 
reaction to explore (Figure 16). 
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iv) Finally, evaluate the interaction between this glycoconjugate with HIV-1 gp 
120 (Figure 17). 
 
 
Figure 17 
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3.1. Synthesis of D-erythro-sphingosine 
 
 
 
 
     D/L-erythro-sphingosine and D-erythro-sphingosine were efficiently synthesized 
with 33% overall yield in 8 steps and 60% overall yield in 5 steps, respectively. A key 
transformation in the synthesis of D/L-erythro-sphingosine is the tethered 
aminohydroxylation (TA) to introduce the required stereochemistry. 
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     A crucial step in the synthesis of D-erythro-sphingosine comprises an asymmetric 
sulfur ylide reaction between the bromide of dodecane and the appropriate aldehyde in 
presencia the EtP2. 
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3.1.1. Chemistry and biology of sphingosine 
 
In 1881, when Johann Thudichum 
first described the compound that would 
later be fully characterized as sphingosine, 
he named it after the Greek mythological 
character, the Sphinx, “in commemoration of 
the many enigmas which it has presented to 
the inquirer”.60 Sphingolipids (Figure 18) 
have emerged over the last several decades 
as a family of key signalling molecules 
including ceramide 10, sphingosine 19 and 
sphingosine-1-phosphate 20.61 These 
compounds together with 
glycerophospholipids and cholesterol are building blocks62 that play essential roles as 
structural cell membrane components63 and participant in higher order physiological 
processes including inflammation64 and vasculogenesis.65 Recent studies implicate 
sphingolipid involvement in many of the most common human diseases including 
infection by microoorganisms,66 diabetes,67 a range of cancers,68 Alzheimer´s,69 and 
many others.70  
The basic structure of a sphingolipids consists of a long-chain sphingoid base 
backbone linked to a fatty acid via an amide bond with the 2-amino group and to a polar 
head group at the C-1 position via an ester bond (Figure 18). There are four sphingosine 
stereoisomers with a wide range of biological activities.71 The isomer D-erythro is the 
most common metabolite and has been meticulous studied. Since, sphingosine and its 
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derivatives are available a limited amount from natural sources, there is a continuing 
interest in developing efficient methods for their synthesis. There are many methods for 
synthesizing sphingosine reported in the literature72 and they can be classified into four 
categories: i) In the first, carbohydrates are used as the source of chirality, ii) the 
Sharpless asymmetric epoxidation to generate the asymmetric centres, iii) the third 
relies on the aldol reaction with a chiral auxiliary and finally iv) the use of amino acid 
serine as the source of chirality. However, most of the methods require multistep 
reactions that resulted in low total yields. The key to cost-effective and efficient 
synthesis is the choice of a proper starting material that requires minimal protection-
deprotection steps. 
 
3.1.2. Recent contributions in the synthesis of sphingosine reported in the 
literature (1998-2008) 
 
3.1.2.1. Carbohydrate approach 
 
The total synthesis of sphingosine 19 was performed via the azidosphingosine 
intermediate 24 starting from D-galactose 21 (Scheme 2). 73 Thus, D-Galactose 21 was 
converted to 4,6-benzylidene-D-galactose as a mixture of α and β anomers (85:15), then 
it was oxidated with NaIO4 to give 22, which was employed in the next reaction without 
column chromatographic purification. The olefination reaction and protection of alcohol 
group afforded 23 in a 44% yield over two steps, results that agreed with the original 
report.74 Synthesis of azide proceeded via mesylate 23 with inversion of configuration 
employing NaN3 in DMSO at 95ºC to afford the product 24 with a lower yield (21%). 
Finally, the bezylidene group was removed by acid-catalyzed and the azide reduced 
with H2S to give pure D-erythro-sphingosine 19 (Scheme 2). In this work, apparent 
discrepancies in literature procedures and characterization have been resolved. 
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 For reviews, see: (a) Merrill, A. H., Jr.; Hannun, Y. A. Methods Enzymol. 2000, 311, 91–479; (b) 
Koskinen, P. M.; Koskinen, A. M. P. Synthesis 1998, 1075–1091. (c) Liao, J.; Tao, J.; Lin, G.; Liu, D. 
Tetrahedron 2005, 61, 4715–4733. 
73
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Scheme 2 
 
To the synthesis of sulfatides like 2, which are an antigen presented by CD1a 
proteins,75,76,77 3-O-benzoylazidosphingosine78 29 was stereoselectively preparing 
through a CuCN-catalyzed allylic alkylation of a hexenitol dimesylate 27. Thus, D-
xylose 25 (Scheme 3) was converted into the 3,5-O-isopropylidene derivative 26 and 
subsequently a Peterson olefination by condensation between 26 and a Grignard reagent 
gave the β-silylalcohol. Finally the treatment of the alcohol with potassium hydride and 
reaction with MsCl afforded the dimesylate 27 (41% overall yield). Allylic 
displacement of the mesylate group in position 3 was effected with n-
dodecylmagnesium bromide in the presence of catalytic copper cyanide to give 28. This 
compound was treated with tetrabutylammonium azide in toluene, and then acetonide 
was removed in acid medium. The obtained product was transformed into the desired 3-
O-benzoylazidosphingosine 29 through standard protection-deprotection reactions.79 
Alternatively, D-xylose 25 was transformed into the dithioethyl derivative, which 
without purification was converted to the di-acetonide 30 (Scheme 3). A Wittig reaction 
and a series deprotection and protection steps allowed to obtain compound 31.80 In the 
last stage of synthesis, 31 was treated with NaN3 and a solution of HCl to afford 3-O-
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 Nazi, K.; Chiu, M.; Mendoza, R.; Degano, M.; Khurana, S.; Moody, D.; Melian, A.; Wilson, I.; 
Kronenberg, M.; Porcelli, S.; Modlin, R. J. Immunol. 2001, 166, 2562−2570. 
76
 Melian, A.; Watts, G. F.; Shamshiev, A.; De Libero, G.; Clatworthy, A.; Vincent, M.; Brenner, M. B.; 
Behar, S.; Niazi, K.; Modlin, R. L.; Almo, S.; Ostrov, D.; Nathenson, S. G.; Porcelli, S. A. J. Immunol. 
2000, 165, 4494–4504. 
77
 Shamshiev, A.; Donda, A.; Prigozy, T. I.; Mori, L.; Chigorno, V.; Benedict, C. A.; Kappos, L.; 
Sonnino, S.; Kronenberg, M.; De Libero, G. Immunity 2000, 13, 255–264. 
78
 Compostella, F.; Franchini, L.; De Libero, G.; Palmisano, G.; Ronchetti, F.; Panza, L. Tetrahedon 
2002, 58, 8703−8708. 
79
 Zimmermann, P.; Schmidt, R. R. Liebigs Ann. Chem. 1988, 663−667. 
80
 Kumar, P.; Schimidt, R. R. Synthesis 1998, 33−35. 
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benzoylazidosphingosine 29 in good yield. This synthesis it is reproducible up to at 
least a 20 g scale (Scheme 3). 
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OO
C13H27
OMs
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1. Me3SiCH2MgCl, THF, 70ºC
2. KH, THF, 50 ºC
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3. MsCl, DMAP, collidine,
    0ºC rt., 74 %
 n-C12H25MgBr, CuCN,
    THF, 0 ºC, 41 %
C13H27
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2. HCl, THF/H2O
         80%
HO
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2829
OH
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1. HCl, EtSH
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 pTsOH, 
    acetone-H2O, 80 %
OO
O O
CH(Et)2
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1. NaN3, 16-crown-6,
DMF, 95ºC
72 %
2. 1% aq HCl, EtOH,
73%
OH
OH
OH
O
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2530
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Scheme 3 
 
Ceramide 10 was prepared from the 1-thio-β-D-xylopyranoside 32, through a 
Cu(I)-mediated 1,2-metallate rearrangement as key step (Scheme 4).81 The synthesis of 
the crucial α-lithiated glycal 35 began with the oxidation of 32 to the corresponding 
sulfone. Subsequent β-elimination using MeLi as base afforded the α-phenylsulfonyl 
glycal derivative 33 in 72% yield. A Ni(0)-catalyzed82 coupling of 
tributylstannylmagnesium bromide converted the sulfone to the corresponding stannane 
34 in 82% yield. Transmetallation with BuLi gave 35. Alternatively, 32 can be 
converted into the sulfoxide with hydrogen peroxide catalyzed by ammonium 
molybdate and subsequent treatment with LDA gives the β-elimination of t-
BuMe2SiOLi affording the α-phenylsulfiny glycal 36 in 69% yield. Reaction of 
sulfoxide with t-BuLi at -78ºC gave the α-lithiated glycal 35 (Scheme 4). In the second 
stage of synthesis, 35 was reacted with n-tridecyllithium in the presence of CuBr·SMe2 
to generate the alkenylsilane 37 in 68% overall yield. The obtention of this product can 
be explained by the formation of the higher order cuprate and its rearrangement with 
inversion of configuration at the alkenylmetal centre and the subsequent selective 
intramolecular O→C silyl transfer of the C3O-silyl group.83 To complete the synthesis, 
37 was protected as its bezylidene acetal and then treated with TBAF to give 38. The C-
TBS group was transferred back to oxygen by a Brook rearrengement84 employing 
sodium hydride and 15-crown-5. TBAF was used to obtain the alcohol 39. A Mitsunobu 
                                                 
81
 Milne, J. E.; Jarowicki, K.; Kocienski, P. J.; Alonso, J. Chem. Comm. 2002, 426−427. 
82
 Gunn, A.; Jarowicki, K.; Kocienski, P.; Lockhart, S. Synthesis, 2001, 331−338 
83
 Kocienski, P.; Wadman, S.; Cooper, K. J. Am. Chem. Soc. 1989, 111, 2363−2365. 
84
 Lutens, M.; Delanghe, P. H. M.; Goh, J. B.; Zhang, C. H. J. Org. Chem. 1995, 60, 4213−4227. 
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reaction was used to introduce the azide group and the benzylidene group was removed 
under acid conditions to afford azido-sphingosine 40. Finally, the reduction of azide 
with Zn and acylation of the amine afforded the ceramide 10 (Scheme 4).  
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Scheme 4 
 
The cross-metathesis (CM) reaction was explored as the key step in the synthesis 
of D-eythro and D-threo-sphingosine because the compatibility of Grubb’s catalyst 
(second generation) with sugar azide, and the high E-selectivity and functional group 
tolerance (Scheme 5).85 Thus, the required 3-azido-3,5,6-trideoxy-1,2-O-
isopropylidene-α-D-ribo-hexofuran-5-ene 41 was obtained from D-glucose,86,87 while 3-
azido-3,5,6-trideoxy-1,2-O-isopropylidene-α-D-xylo-hexofuran-5-ene 42 was derived 
from D-allose88,89,90 following the same reaction sequence. The use of first generation 
Grubb’s catalyst in the individual reactions of both starting materials with 1-nonene did 
not provide cross-coupling products, while the second generation catalyst afforded the 
cross-coupling product in good yield in the same conditions. Consequently, the second 
                                                 
85
 Chaudhari, V. D.; Kumar, K. S. A.; Dhavale, D. Org. Lett. 2005, 7, 5805−5807. 
86
 Gruner, S. A. W.; Keri, G.; Schwab, R.; Venetianer, A.; Kessler,H. Org. Lett. 2001, 3, 3723−3725. 
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 Gurjar, M. K.; Patil, V. J.; Pawar, S. M. Indian J. Chem. 1987, 26B, 1115−1120. 
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 Fernandez, J. M.G.; Mellet, C. O.; Blanco, J. L. J.; Fuentes, J. J. Org. Chem. 1994, 59, 5565−5572. 
89
 Calvo-Flores, F. G.; Garcia-Mendoza, P.; Hernandez, F.; Isac-Garcia, J.; Santoyo-Gonzalez, F. J. Org. 
Chem. 1997, 62, 3944−3961. 
90
 Santoyo-Gonzalez, F.; Garcia-Calvo-Flores, F.; Garcia-Mendoza, P.; Hernandez-Mateo, F.; Isac-
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generation Grubb’s was employed in the reaction with 1-pentadecene to afford the 
cross-coupling alkenes 43 and 44 with good yields and excellent stereoselectivities. 
Finally, 43 and 44 were treated with TFA-water to afford an anomeric mixture of 
hemiacetals that were treated with sodium periodate the resulted aldehyde was 
subsequently reduced with LiAlH4 furnishing D-erythro-sphingosine 19 and D-threo-
sphingosine 45, respectively, in three steps (Scheme 5). 
 
 
41 R1= N3, R2 = H
42 R1= H,  R2 = N3
1. TFA:H2O, 0 ºC
2. NaIO4, acetone-H2O, 
0 ºC to 30 ºC
3. LiAlH4, THF, 
   0ºC to 30ºC
79% three steps.
O
C13H27
CH2Cl2, 30 ºC,
       87%
N N
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Cl
Cl
O
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R2 R1
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O
O
O
R2 R1
C13H27
C13H27
OH
HO
R1 R2
43 R1= N3, R2 = H
44 R1= H,  R2 = N3
19 R1= H, R2 = NH2
45 R1= NH2,  R2 = H
A
 
 
Scheme 5 
 
Glyceraldehyde is also a suitable starting material for the synthesis of 
sphingosines.91 Thus, 2,3-O-benzylidene-D-glyceralehyde92 46 (Scheme 6) was 
generated by periodate cleavage of 1,2:5,6-di-O-cyclohexylidene-D-manitol, and the 
subsequent treatment with 1-pentadecinylmagenium bromide afforded a 
diastereoisomeric mixture of propargylic alcohols in a syn/anti ratio of 4:6. This mixture 
of alcohols was resolved with Candida antarctiva (LCA) lipase and vinyl acetate to 
furnish the anti acetyl derivative 48, while the syn alcohol 47 was recovered unchanged. 
The undesired anti acetyl derivative 48 was hydrolyzed in Zemplen conditions and the 
configuration was inverted by reaction with acetic acid in Mitsunobu conditions to 
provide the acetyl derivative 49. The trans allylic alcohol was obtained in quantitative 
yield from 47 or 49 by reaction with LiAlH4, and it was used in the next reaction with 
benzoyl chloride without purification to give the compound 50. Cleavage of the 
cyclohexylidene acetal and 1-O-sylilation furnished the 51. Hydroxyl group at position 
                                                 
91
 Compostella, F.; Franchini, L.; Giovenzana, G. B.; Panza, L.; Prosperi, D.; Ronchetti, F. Tetrahedron 
Asymmetry 2002, 13, 867−872. 
92
 Chattopadhyay, A. J. Org. Chem. 1996, 61, 6104−6107. 
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2 was activated as mesylate for nucleophilic displacement by azide affording the fully 
protected azidosphingosine, which was treated with HF to give 3-O-benzoyl 
azidosphingosine 29 (Scheme 6). 
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       72% two steps.
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Scheme 6 
 
 3.1.2.2. From Serine and Garner’s aldehyde 
 
L-Serine has a hydroxyamino function with the appropariate configuration that 
makes this compound especially suitable for synthesising sphingosine derivatives. In 
this context, recently a highly efficient and versatile method for synthesising 
sphingosine 19 was established by olefin cross metathesis reaction between 1-
pentadecene and amino alcohol 55, which was derived starting from L-serine 52 
(Scheme 7).93 The synthesis started with protection of L-serine 52 afforded 53, followed 
by the formation of Weinreb amide and the protection of the primary hydroxyl group to 
give 54 in excellent yield in three steps without column chromatography. The reaction 
of 54 with vinylmagnesium bromide and reduction of the resulting ketone with tri-tert-
butoxyaluminohydride94,95 provided the allylic alcohol 55 with excellent yield and as a 
                                                 
93
 Yamamoto, T.; Hasegawa, H.; Hakogi, T.; Katsumura, S. Org. Lett. 2006, 8, 5569−5572. 
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 Hakogi, T.; Fujii, S.; Morita, M.; Ikeda, K.; Katsumura, S. Bioorg. Med. Chem. Lett. 2005, 15, 
2141−2144. 
95
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sole diastereomer. Then 55 was treated with pentadecene in presence of second 
generation Grubb’s catalyst to afford 56 in 75% yield. Reaction of 56 with 
trifluoroacetic acid furnoshed unprotected sphingosine 19 (Scheme 7).  
The L-serine derivatives were used in an alternative synthesis of sphingosine 
whose key step relies on the palladium catalyzed cross-coupling between an alkenyl 
boronic acid and a thiol ester.96 Initially, the cross-coupling of a series of N-protected 
serine thiophenyl esters and trans-1-pentadecyl boronic acid97 were studied. From 
protective groups studied (i.e. Cbz, Trityl, Fmoc), the ter-butyloxycarbonyl (Boc) gave 
the highest yield of ketone. 
Thus, the synthesis started from commercially available N-Boc-L-serine 53, 
which was converted into the corresponding thiophenyl ester 57 using typical 
dehydration condition (DCC/HOBT), and silyl protection of alcohol group with 
TBSCl/NMM/DMAP in DMF (Scheme 7).98 The subsequent cross-coupling of thiol 
ester 57 and the appropriate boronic acid afforded ketone 58 in high yield (94%). 
Lithium tri-tert-butoxyaluminohydride in ethanol was used for a highly 
diastereoselective reduction of ketone and, finally, removal of protecting groups in acid 
medium provided D-erythro-sphingosine 19 (Scheme 7). 
The syntheses of all four diastereomers of sphingosine from L-serine have been 
also achieved through highly diasteroselective reduction of the N-trityl protected α-
amino enone derivative.99,100 The synthetic route started with the fully protected serine 
methyl ester 59 (Scheme 7), which was readily obtained from commercially available 
L-serine derivative 52. The protected serine ester was reacted with lithium dimethyl 
methylphosphonate yielding quantitatively yielding the keto-phosphonate which was 
treated tetradecyl aldehyde in a Horner-Wadsworth-Emmons olefination reaction to 
provide the corresponding enone 60 in good yield. Removal of protecting groups with 
2N HCl in MeOH-THF and diastereselective reduction with zinc borohydride afforded 
D-erythro-sphingosine 19 in 90% d.e.; presumably via a cyclic Felkin-Anh transition 
state, and probably due to the high chelating ability of the zinc ion. When enone 60 was 
reduced via non-chelation control using NaBH4 in presence of CeCl3·7H2O the N,O-
diprotected L-threo-sphingosine 61 in 92 % d.e. was obtained (Scheme 7). By 
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 Yang, H.; Li, H.; Wittenberg, R.; Egi, M.; Huang, W.; Liebeskind, L. S. J. Am. Chem. Soc. 2007, 129, 
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employing the same procedures on D-serine esters, L-erythro and D-threo-sphingosines 
were also synthesized. 
1. PhSH, HOBT, DCC
    EtOAc, rt., 89 %
2. TBSCl, NMM, DMAP, DMF 100%
 Pd2(dba)3, P(OEt)3, CuTC,
   THF, rt., 94 %
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    EtOH, -78 ºC, 
96 %
2. HCl, MeOH-H2O,
 99%
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Scheme 7 
 
An L-serine derivative was also the starting material for a synthesis of 
sphingosine relying on the synthesis of an amino-enone by reaction of a serine ester 
with a sulfur estabilized carbanion followed by elimination (Scheme 7).101 The 
synthesis began with the reaction of L-serine derived N-Boc-oxazoline methyl ester 
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62102 with an alkyl phenyl sulfoxide to give a sulfoxide intermediate which was not 
isolated and that afforded the enone 63 upon heating in CCl4 overnight. The synthesis of 
D-erythro-spingosine 19 was completed in two steps, first the diasteroselective 
reduction with NaBH4 and CeCl3 in methanol to provide the alcohol and finally the 
hydrolysis with HCl (1M) in dioxane furnished D-erythro-sphingosine 19 (Scheme 7). 
Garner’s aldehyde is also an L-serine derivative that is commercially available 
and that has been widely used as starting material for synthesis of enantiomerically pure 
compounds. With the objective of preparing of 13C- and 14C-labelled 
glucosphingolipids,103 Garner’s 
aldehyde104 64 was reacted with 
pentadec-1-ynyllithium to give the 
acetylenic alcohol 65 in a moderate 
diastereomeric excess. The removal 
of acetonide in 65 afforded 66, 
which was reacted with Red-Al105 
to stereoselectively reduce the 
alkyne with concomitant 
deprotection of amine group. 
Removal of silyl protecting group 
afforded D-erythro-sphingosine 19 
(Scheme 8). This preparative 
approach was employing in the 
synthesis of a series of 3-C-
methylceramede derivatives106 and 
sphingosine 1-phosphate.107 
6-Hydroxy-4E-sphingosine108,109,110 70 was synthesized from Garner’s aldehyde 
following a similar procedure (Scheme 8). Thus, the alkyne 67 was lithiated using n-
                                                 
102
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1, 2000, 2237−2242.  
104
 Garner, P.; Park, J. M.; Malecki, E.; J. Org. Chem. 1988, 53, 4395−4398. 
105
 Herold, P. Helv. Chim. Acta 1988, 71, 354−363. 
106
 Sawatzki, P.; Kolter, T. Eur. J. Org. Chem. 2004, 3693−3700. 
107
 Blot,V.; Jacquemard, U.; Reissig, H-U.; Kleuser, B. Synthesis, 2009, 759−766. 
108
 Yadav, J. S.; Geetha, V.; Krishnam Raju, A.; Gnaneshwar, D.; Chandrasekhar, S. Tetrahedron Lett. 
2003, 44, 2983−2985. 
109
 Mori, K:, Masuda, Y. Tetrahedron Lett. 2003, 44, 9197−9200. 
110
 Masuda, Y; Mori, K. Eur. J. Org. Chem. 2005, 4789−4800. 
 
64
65
66
67
68
O
NBoc
OH
C13H27
O
NBoc
OH
HO
NH2
OH
HO
NH2
OH
C12H25
n-BuLi
THF, HMPT, -78 ºC,
87 %
C12H25
C12H25
1N HCl/THF,
reflux, 66 %
LiAlH4,THF, rt
  61%
 Amberlyst 15
   MeOH, 75 %
1. Red-Al, Et2O, 90 %
2. HCl, MeOH, 89%
H
NBoc
O
O
HO
NHBoc
OH
C13H27
Li C13H27
THF 71%
C12H25
OTBS OTBS
OH
OH
69
70
HO
NH2
OH
C13H27
19
 
 
Scheme 8 
 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 41
BuLi and reacted with 64 in HMPT at -78ºC to give the alcohol 68. Removal of 
protecting groups in acid medium provided 69 which was treated with LiAlH4 to yield 
6-hydroxy-4E-sphingosine 70, which have been found in human skin.111,112,113 
 
3.1.2.3. From tartaric acid  
 
The use of tartaric acid and its derivatives as synthons in the synthesis of natural 
products is amply described in the literature.114,115,116,117 In this context, recently D-
tartaric acid has been used as chiral starting material118 in the synthesis of D-erythro-
sphingosine 6. (Scheme 9). The synthesis started with the transformation of D-tartaric 
acid 71 into the alcohol 72,119 which was oxidized with PCC to afford the aldehyde 73. 
The olefination of 73 was achieved by reaction with diidopropyl 
(ethoxycarbonylmethyl)phosphonate in the presence of lithium bromide and 
triethylamine, to obtain the ester 74 in good yield. Reduction of the ester with DIBAL 
and acylation of the resulting alcohol provided the allyl acetate 75. Chain elongation 
was carried out by reacting acetate 75 with C12H25MgBr in the presence of catalytic 
Li2CuCl4. Subsequent acetal  deprotection and introduction of azide group by a 
Mitsunobu reaction furnished the azido sphingosine 76. Then, the azide was reduced to 
amine group by means of the Staudinger reaction and the benzyl group was removed by 
Birch reduction to give D-erythro-Sphingosine 19 (Scheme 9). 
 In the same context, D-Threose 73 was obtained from tartaric acid and was as 
starting material to synthesize the ceramide analogue 79,120 which was evaluated as 
inhibitor of growth mouse embryonic fibroblast cells. Thus, aldehyde 73, reacted with 
tetradecylmagnesium bromide to give a diastereomeric mixture of alcohols, which was 
oxidized to ketone with the Dess-Martin reagent. Methyllenation reaction was carried 
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out with (C5H5)2TiCH2ClAl(CH3)2 (Tebbe reagent)121 to give the alkene 77. Then, 
deprotection of diol with 5% H2SO4 and introduction of azide group furnished the 
analogue of azidosphingosine 78. Reduction of the azido group with PPh3, followed by 
amide formation and elimination of benzyl group furnished compound 79 (Scheme 9). 
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Scheme 9 
 
The known alcohol 80122 derived from D-tartaric acid 71 was chosen as starting 
material in the formal synthesis of 3-O-(4-methoxybenzyl)-azidosphingosine.123 This 
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synthetic route is an example of the versatility of the Kocienski124 modification of the 
Julia olefination.125 Thus, alcohol 80 was first converted into the 1-phenyl-1H-tetrazole-
5-yl thiother under Mitsunobu conditions, and then it was oxidized to 81. A solution of 
sulfone 81 in DME was treated with KHMDS, followed by the addition of tetradecanal 
to give the compound 82, which was transformed into the target 3-O-(4-
methoxybenzyl)-azidosphingosine (Scheme 9).122 
Other important route synthetic from D-tartaric acid 71 employing a highly 
stereoselective olefin cross methathesis reaction has been recently described.126 In this 
case, the D-tartrate was converted into the know azidotriol 83 in three steps.127,128,129 
Selective benzoylation of 83 was accomplished via the stannylene ketal intermediate. 
Sylilation of he remaining primary alcohol followed by installation of the p-
methoxybenxyl ether afforded the differentially protected intermediate 84. Deacylation 
followed by oxidation with the Dess-Martin reagent proceeded smoothly to provide the 
corresponding aldehyde, which was converted into 85 via Wittig methylenation. This 
building block presented low reactivity in cross metathesis reaction, and in order to 
increase the yield of the metathesis step, the azide was reduced to the amine and 
protected as the Fmoc carbamate 86. Reaction of 86 with pentadecene provided 87 in 
good yield (Scheme 9). 
 
3.1.2.4. Synthesis from phytosphingosine 
 
The synthesis of D-erythro-sphingosine 19 and D-erythro-azidosphingosine 40 
were achieved from commercially available D-ribo-phytospingosine 88 (Scheme 10).130 
Their synthesis began with the conversion of the amino function into azide and the 
protection of primary hydroxyl group of phytosphingosine 88 to give the diol 89. 
Conversion of 3,4-vicinal diol 89 to its cyclic sulphite with thionyl chloride followed by 
oxidation with RuCl3/NaIO4 provided cyclic sulphate 90 in high yield (90 %). Then, it 
was explored the base-mediated direct transformation of cyclic sulphate 90 into allylic 
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 Baudin, J. B.; Hareau, G.; Julia, S. A.; Ruel, O. Tetrahedron Lett. 1991, 32, 1175−1178. 
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alcohol 40 by the regioselective abstraction of a β-hydrogen. Thus, 90 was treated with 
DBU in refluxing toluene to give, after hydrolysis in acid medium an removal of silyl 
group, compound 40 in low yield (39%). The yield increase notably (87%) when the 
reaction was carried out in the presence of TBAI.131 No cis olefin was detected by 1H 
NMR of the reaction crude. Azide group in 40 was reduced with NaBH4 to give D-
erythro-sphingosine 19 (Scheme 10). The sulfate intermediate has been also used in an 
elegant synthesis of the sphingosine analogue Pachastrissamine.132 
Similarly, D-ribo-phytosphingosine 88 was transformed into D-erythro-
sphingosine 19 in high yield,133 by means of a regio- and stereoselective oxiran opening 
reaction as key step (Scheme 9). Protection of 1,2-aminoalcohol function in one step 
and selective tosylation of hydroxyl group in position 4 afforded 91. The synthesis of 
key intermediate 92 was achieved by treatment of 91 with potassium tert-butoxide. 
Treatment of oxirane 92 with TMSI/DBN134 led to the exclusive isolation of E-allyl 
silyl ether 93. Finally, removal of trimethylsilyl, and phenyloxazoline protecting groups 
of 93 furnished D-erythro-sphingosine 19 (Scheme 10).  
 Other important contribution to synthesis of D-erythro-sphingosine 19 pursuing 
the same idea of transforming D-ribo-phytospingosine 88 into D-erythro-sphingosine 19 
was carried out by a regiospecific and steroselective reduction of a Z-enol triflate 
(Scheme 10).135 To achieve this goal, D-ribo-phytospingosine 88 was treated with 
Boc2O and di-tert-butylsilyl ditriflate to afford the silylene derivative 94. Oxidation of 
the 4-hydroxyl group with acetic anhydride in DMSO, followed by treatment with 
potassium bis(trimethylsilyl)amide and sulfonylation of the in situ formed enolate 
furnished E-enol triflate 95. Reaction of enol triflate function with formic acid136 in the 
presence of Pd(OAc)2(PPh3)2 allowed to obtain compound 96. Finally, desilyation with 
TBAF and acidolysis of the N-Boc protecting group furnished D-erythro-sphingosine 19 
(Scheme 10). The same authors obtained D-erythro-sphingosine 19 from D-ribo-
phytospingosine 88 following the Smith137 procedure. Thus, 88 was subjected to diazo 
transfer and regioselective protection of the 1,3-diol to give 97 (Scheme 10). Triflation 
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of 97 with Tf2O in presence of pyridine afforded the E-olefin 98. In the last stage of the 
synthesis, the reduction of azide and elimination of the protective groups furnished D-
erythro-sphingosine 19 (Scheme 10). 
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3.1.2.5. Using chiral reagents and auxiliaries 
 
Starting from a glycine-derived silicon enolate the main functionalities present 
in sphingosine could be also prepared by a zirconium-catalyzed asymmetric aldol 
reaction (Scheme 11).138 This procedure was illustrated in the synthesis of L-erythro-
sphingosine 19 in 7-steps. Thus, the aldol reaction of 99 with aldehyde 110 was 
performed in the presence of the chiral zirconium complex 101, prepared from 
zirconium alkoxide and BINOL,139 affording the desired anti-aldol adduct 102 with 
high stereoselectivity and enantioselectivity (anti/syn=80/20, anti=97% ee). Reduction 
of 102, followed by protection of the resulting 1,3-diol as its p-methoxybenzylidene 
acetal furnished 103. Then, the t-butyldiphenylsilyl ether was converted to the 
corresponding acetate, which was treated with C12H25MgBr in presence of a catalytic 
amount of Li2CuCl4 to afford 104. Finally, deprotection of 2-amino-1,3-diol gave L-
erythro-sphingosine 19 (Scheme 11). 
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Scheme 11 
 
With the idea of synthesizing asymmetric vicinal amino alcohols, a highly 
diasteroselective anti-aminohydroxylation of α,β-unsaturated esters, via conjugate 
addition of lithium (S)-N-benzyl-N-(α-methylbenzyl)amide and subsequent in situ 
enolate oxidation with (+)-(camphorsulfonyl)oxaziridine (+)-CSO, has been used as the 
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key step in the synthesis of triacetyl D-erythro-Sphingosine140 111 (Scheme 12). Thus, 
γ-silyoxy-α,β-unsatured ester 106 was prepared from cis-but-2-ene-1,4-diol 105. Then, 
the conjugate addition of lithium (S)-N-benzyl-N-(α-methylbenzyl)amide and 
subsequent enolate oxidation with (+)-(camphorsulfonyl)oxaziridine (+)-CSO allowed 
obtain the (2S, 3S, αS)-α-hydroxy-β-amino-γ-silyloxy ester 107 with 98% de. 
Subsequent hydrogenolysis and in situ amino protection, followed by N,O-acetal 
formation afforded the oxazolidine ester 108. Reduction of oxazolidine esters 108 with 
DIBAL-H and oxidation of alcohol in presence of IBX furnished the aldehyde 109. In 
an attempt to reduce the ester with LiAlH4, resulted in reduction of the ester and 
desilylation, giving the corresponding diol. Schlosser modification141,142 of the Wittig 
olefination was used to obtain the (E)-alkene 110. Finally, hydrolysis of the protecting 
groups and acetylation gave 111 (Scheme 12). 
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Scheme 13 
 
The α-amino-β-hydroxy acid units can be derived from the corresponding 
aziridine derivatives.143 This strategy was applied in the synthesis of D-erythro-
sphingosine 19, using the addition reaction of chiral guanidinium ylides to aldehydes 
(Scheme 13).144 Thus, reaction of (R,R)-guanidinium ylide 112 with aldehyde 113 
followed by treatment with silica gel to give the cis- and trans-3-[(E)-pentadec-1-
anyl]aziridines 114 and 115 with a poor stereoselectivity (cis/trans=53/47). The 
aziridine ring-opening reactions with TsOH allowed directly to introduce a hydroxyl 
function into the skeleton affording the esters 116 and 117. Alternatively, the reaction of 
aziridines with acetic acid afforded the acetoxy derivatives 118 and 119, which could be 
hydrolyzed to the α-amino-β-hydroxy esters 116 and 117 by methanolysis (KOH, 
THF/MeOH). The configuration of the alcohol at C3 in the trans isomer can be inverted 
by protection of the amino group (Boc), formation of the mathanesulfonate and 
intramolecular cyclization to provide the cis-oxazolidine 120. This oxazoline can be 
also obtained by reaction of the α-amino-β-hydroxy ester 117 with Im2CO. The ester 
function was reduced with lithium boronhydride to afford the corresponding alcohol, 
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and then protecting-desprotecting protocol allowed to obtain D-erythro-sphingosine 19 
(Scheme 13). 
Stereoselective nucleophilic additions of enolates to imines and related 
compounds were used for the asymmetric synthesis of β-amino carbonyl derivatives. 
This reaction, as well called Mannich-type reaction, can be stereocontrolled to provide 
efficient routes to enentiomerically pure polyhydroxy-β-amino acids, which have been 
apply in the enentiodivergent synthesis of L- and D-erythro-sphingosine145 (Scheme 
14). Focusing in this idea, it was studied the reaction between the chiral nitrone 121 
(derived from glyceraldehyde) and silyl ketene acetal 122 in the presence of Lewis acid. 
The 2S,3S,4S isomer 123 being the major product (89%) when Zn(OTf)2 was employed 
as Lewis acid (anti/syn=97/3). If the Lewis acid used is SnCl4 the major product is 
2S,3R,4S, isomer 124 (84%) (anti/syn=92/8). Compound 123 was transformed into β-
amino-α-hydroxy ester 125 by catalytic hydrogenation in the presence of Boc2O. The 
ester 125 was reduced to the corresponding aldehyde, followed of a Schlosser 
modification of the Wittig condensation with phosphorane to generate the alkene 126. 
The dioxolane ring was converted into a hydroxymethyl group to give the orthogonally 
protected D-erythro-sphingosine 127. Finally, elimination of protecting groups allowed 
obtained D-erythro-sphingosine 19. The same methodology applied to compound 123 
was applied to compound 122 to give L-erythro-sphingosine 128 (Scheme 14). 
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 3.1.2.6. Enantioselective catalytic procedures 
 
D-erythro-sphingosine 19 was enantioselectively synthesized146 by a tin(II)-
catalyzed asymmetric aldol reaction (Scheme 15). Thus, when trimethylsilylpropynal 
129 was reacted with the silylenol ether 130 in the presence of  20 % of tin(II) triflate 
and the chiral diamine 131, compound 132 was obtained in high diastereo- and 
enantioselectivity (syn/anti=97/3, 91% ee for syn). The phenyl ester 132 was then 
reduced with DIBAL to the corresponding diol, which was protected as its acetonide. 
Finally the desilylation with tetrabutylammonium fluoride gave the desired intermediate 
133. The lipidic chain was introduced by alkylation of the acetylene-lithium derivative.  
The installation of the amino functionality at position 2 was carried out by removal of 
benzyl group under Birch conditions, triflation of the resulting alcohol and reaction with 
NaN3 to give 134 through an SN2 process. The synthesis of sphingosine 19 was 
completed by deprotection of acetonide, reduction of the azide under Staundinger 
conditions and of the acetylene using Red-Al (Scheme 15). 
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Scheme 15 
 
Sharpless asymmetric dihydroxylation was also used as key step in the synthesis 
of D-erythro-sphingosine 19 (Scheme 16). 147 The synthesis is really short and efficient 
and starts by formylation of lithium 1-pentadecyne 135 with 1-formylpiperidine to give 
                                                 
146
 Kobayashi, S.; Furuta, T. Tetrahedron 1998, 54, 10275−10294. 
147
 He, L.; Byun, H.S.; Bittman, R. J. Org. Chem. 2000, 65, 7627−7633. 
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the hexadec-1-ynal, which was reacted with diisopropyl(ethoxycarbonylmethyl) 
phosphonate (Horner-Wadsworth-Emmons reaction) to give the unsaturated ester 136. 
Then, asymmetric dihydroxylation of enyne ester 136 with AD-mix-β provided the diol 
137 in high yield and 98% ee. Reaction of 137 with thiophosgene quantitatively 
afforded to the corresponding cyclic thionocarbonate, which was subject to a ring-
opening reaction with NaN3. The reaction proceeded with the exclusive attack to the 
azido group to the α position to yield compound 138. In the last stage of synthesis, the 
triple bond, the azido and ester functional groups in 138 were reduced simultaneously 
by LiAlH4 in THF to furnish the D-erythro-sphingosine 19 (Scheme 16). 
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Scheme 16 
 
A divergent synthesis148 of D-erythro-Sphingosine 19 focused on the 
enantioselective epoxidation of diene 139 (Scheme 17). Thus, the benzylated diene 139 
was reacted under the under Shi’s asymmetric epoxidation conditions to afford the vinyl 
epoxide 140 in escellent yield and enantioselectivity (95% ee). Diastereospecific and 
regioselective opening in the allylic position, of vinyl epoxide 140 was carried out with 
ammonium hydroxide149 furnishing the anti-amino alcohol 141. In order to install the 
amino and the hydroxyl functionalities in the correct positions, compound 141 was 
reacted under Mitsunobu conditions150 to give the vinylaziridine which was opened in 
presence of trifluoroacetic acid to generate the anti-amino alcohol 142. Finally, the 
synthesis was completed by removal of the benzyl group under Birch conditions 
(Scheme 17). 
                                                 
148
 Olofson, B.; Somfai, P. J. Org. Chem. 2003, 68, 2514−2517. 
149
 Olofson, B.; Somfai, P. J. Org. Chem. 2002, 67, 8574−8583. 
150
 Olofson, B.; Wijtmans, R.; Somfai, P. Tetrahedron 2002, 58, 5979−5982. 
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Scheme 17 
 
 Asymmetric Sharpless epoxidation was also used as key step in the synthesis of 
sphingosine (Scheme 18).151 The synthesis starts with Sharpless epoxidation152 of 143, 
to give the alcohol 144, followed by base induced Payne rearrangement generated the 
corresponding epoxide 145, which was treated with benzyl isocyanate and Et3N to 
provide the benzyl carbamate 146. The subsequent intramolecular ring-opening using 
NaHMDS afforded the oxazolidinone 147. The use of Grubbs’ phosphine free catalyst 
149 in the E-selective cross-methathesis allowed to obtain the intermediate 148. 
Removal of the benzyl group with sodium in liquid ammonia, and hydrolysis with KOH 
generated 19 in a quantitative yield (Scheme 18). 
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Scheme 18 
 
                                                 
151
 Torsell, S.; Somfai, P. Org. Biomol. Chem. 2004, 2, 1643−1646. 
152
 Romero, A.; Wong, C-H. J. Org. Chem. 2000, 65, 8264−8268. 
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3.1.3. Results 
 
3.1.3.1 Synthesis of D/L-erythro-sphingosine using a tethered 
aminohydroxylation (TA) as key step 
 
With the aim to contribute to enrich this diversity of strategies in sphingosine 
synthesis, in this work we report an efficient method for synthesising of D/L-erytro-
sphingosine 19 employing the aminohydroxylation reaction as the key step. 
Unfortunately, this reaction is not 
compatible with the use of 
cinchona alkaloid-derived chiral 
ligands, which therefore precludes 
an enantioselective version. Our 
choice of starting material was 
dictated by the type of reaction that 
we planned employed to generate 
the asymmetric centres. Thus, the 
amino-hydroxylic functions were 
introduced in the last step by an 
aminohydroxylation of diene 150, which has the proper E,Z configuration in the 
aminohydroxylation reaction. This diene can be prepared by reduction of 151, which in 
turn can be obtained from aldehydes 152 by a Wittig reaction (Scheme 19). 
The synthesis of diene 150 starts from acetylenic alcohol 154 which under 
oxidation conditions with BaMnO4 gave aldehyde 155. Then, the reaction of 155 with 
the phosphonium salt 153 afforded the E-enyne 151. The desired E,Z-diene 150 was 
obtained in 80% yield by Lindlar reduction of 151, followed of deprotection of 
hydroxyl group in acid medium (Scheme 20). The Sharpless asymmetric 
aminohydroxylation153 (AA) and tethered aminohydroxylation154 (TA) allows the 
catalytic and diasteroselective synthesis of aminoalcohols. However, in AA persist the 
drawbacks of regioselectivity during the oxidation of unsymmetrical alkenes. This 
                                                 
153
 (a) Li, G.; Chang, H.-T.; Sharpless, K. B. Angew. Chem. Int. Ed. Engl. 1996, 35, 451. For review, see: 
(b) Bodkin, J. A.; McLeod, M. D. J. Chem. Soc. Perkin Trans. 1 2002, 2733–2746. 
154
 (a) Donohoe, T. J.; Helliwell, M.; Johnson, P. D.; Keenan, M. Chem. Commun. 2001, 2078–2079. (b) 
Donohoe, T. J.; Cowley, A.; Johnson, P. D.; Keenan, M. J. Am. Chem. Soc. 2002, 124, 12934–12935. 
(c) Donohoe, T. J.; Johnson, P. D.; Pye, R. J. Org. Biomol. Chem. 2003, 1, 2025–2028. (d) Donohoe, T. 
J.; Johnson, P. D.; Keenan, M.; Pye, R. J. Org. Lett. 2004, 6, 2583–2585. (e) Donohoe, T. J.; Chughtai, 
M. J.; Klauber, D. J.; Griffin, D.; Campbell, A. D. J. Am. Chem. Soc. 2006, 128, 2514–2515. 
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Scheme 19. Retrosynthetic analysis of DL-erythro-
sphingosine 19 
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inconvenient can be avoided through the use of TA. At this point of the synthesis, we 
were interested in extending the TA methodology155 as a general strategy in order to 
aminohydroxylate the double bond. Thus, the E,Z-diene 150 was reacted with 
carbonyldimidazol (CDI) in the presence of pyridine, followed by the addition of 
hydroxylamine hydrochloride, to give the hydroxycarbamate 156. The latter was treated 
with O-pentafluorobenzoyl choride (C6F5COCl), to yield the hydroxycarbamate 157, 
which was then reacted under aminohydroxylation conditions (TA), to give 
oxazolidinone 148 in 85% yield with complete regio- and stereoselectivity. Alkaline 
hydrolysis of 148 afforded racemic sphingosine 19 in quantitative yield (Scheme 20). 
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Scheme 20. Synthesis of sphingosine 19 using a tethered aminohydroxylation reaction as key step 
 
In terms of mechanism, it has suggest that the carbamate 157 (a nitrene 
equivalent), combines with potassium osmate (OsVI) to form the active osmium species 
I, which then adds to the alkene to form the azaglycolate species II. The osmium is first 
reoxidised through the addition of a second nitrene equivalent 157 to form a second 
glycolate species III. The hydrolysis of the glycolate species III releases the 
hydroxyamination product 148 and regenerates the initial active osmium species I, so 
completing the catalytic cycle (Scheme 21). 
 
                                                 
155
 Donohoe, T. J.; Bataille, C. J. R; Gattrell, W.; Kloesges, J.; Rossignol, E. Org. Lett. 2007, 9, 1725–
1728. 
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Scheme 21. Proposed mechanism for the TA reaction 
 
To rationalize the key step in the intramolecular addition, the model A (Figure 
19) which supports the syn selectivity observed during the reaction, is proposed. By X-
ray crystallography it has been shown that related transition-metal complexes form 
linear metal-nitrogen-carbon arrangements 
(with the metal forming a double bond to an 
acyl-substituted nitrogen).156 Thus, such a 
linear arrangement is present during the TA 
reaction (Figure 19). The nitrogen and oxygen 
then overlap with the pi-orbitals of the alkene, 
with deformation of the linear (C=N=Os) 
arrangement occurring as the reaction proceeds 
                                                 
156
 Thomas, S.; Lim, P. J.; Gable, R. W.; Young, C. G. Inorg. Chem. 1998, 37, 590−593. 
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 Figure 19. Transition states to rationalize 
the syn selectivity observed during the TA 
reaction 
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to furnish an azaglycolate osmate ester. A consequence of starting with a linear 
osmium-nitrogen-carbon bond is that the initial dihedral angle φ required to give good 
orbital overlap between the oxidant and alkene must be large. Therefore, only one 
reactive conformation need be considered, which lead to the syn product (Figure 19). 
 
3.1.3.2 Synthesis of D-erythro-sphingosine employing an asymmetric sulfur 
ylide reaction as key step 
 
In the present study, we report a convenient and concise route for the synthesis 
of D-erythro-spingosisne 19. Based on the retrosynthetic analysis depicted in Scheme 
21, compound 19 could be generated from the corresponding epoxide 158 via an 
intramolecular ring-opening to introduce the amino functionality at C-2. The selectivity 
of the intermolecular opening is controlled by the double bond and affords the 3-amino 
derivative. For synthesising epoxide 158 we envisaged an asymmetric reaction between 
a chiral sulfur ylide obtained from bromide 160 and aldehyde 159, which can 
incorporate the nucleophile (X) for epoxide opening in its structure. The aldehyde 159 
is readily prepared from the alcohol 161. Lipophilic chain part 160 should be available 
from alkenes 162 and allyl bromide 163 by means of cross-metathesis (CM) reaction in 
order to introduce the required E-olefin moiety (Scheme 22). 
 
 
OH
NH2
OH
Br
X
O
H
O
HO
H
O
Br
Asymmetric sulfur
   ylide reaction
CM
Protection of
    alcohol
19
163
158
159
161
OOX
Intramolecular
ring-opening of  epoxide
162 160
 
 
 
Scheme 22. Retrosynthetic analysis of D-erythro-sphingosine 19 
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As shown in Scheme 23, the synthesis started with the protection of 
hydroxyaldehyde 161 as a carbamate, since it is appropriate for opening the epoxide in a 
subsequent step. Thus, aldehyde 164 for 
asymmetric sulfur ylide reaction was 
obtained in excellent yield by reaction of 
hydroxylaldehyde 161 and benzyl 
isocyanate (1.5 equiv) in presence of 
Et3N, employing Et2O as solvent. 
 
In the other hand, the high E-selctivity and the funtional tolerance are attractive 
features of cross-metathesis olefination in the synthesis of natural products.157 In recent 
synthesis of sphingosines and phytosphingosines, CM has been used as carbon chain 
elongation strategy.158 Therefore, we reasoned that a cross metathesis reaction of alkene 
162 and allyl bromide 163 and in presence of 
Grubbs’159 catalyst will provide the 
intermediate 160 with the correct 
configuration. Thus, substrate 163 was stirred 
with 4 equiv of olefin 162 and 0.02 equiv of 
second generation Grubbs’ B in CH2Cl2 for 8 
h at reflux. The reaction proceeded smoothly, 
and desired coupling product 160 was 
obtained in 97% yield with an E:Z selectivity 
of 52:1. The homocoupling product of 163 
was not observed in its 1H NMR. In this case 
the use of Ti(OiPr)4 or other additive was not necessary to obtain excellent results. A 
decrease in the selectivity (E:Z 11:1) and the yield (78%) was observed when the first 
generation Grubbs’ catalyst A was employed under similar conditions (Scheme 24). 
                                                 
157
 For review, see: (a) Franck, R. W.; Tsuji, M. Acc. Chem. Res. 2006, 39, 692–701. (b) Prunet, J. Curr. 
Top. Med. Chem. 2005, 5, 1559–1577. (c) Cannon S. J.; Blechert, S. Angew. Chem Int. Ed. 2003, 42, 
1900–1923. 
158
 (a) Yamamoto, T.; Hasegawa, H.; Hakogi T.; Katsumura, S. Org. Lett. 2006, 8, 5569–5572. (b) 
Lombardo, M.; Capdevila, M. G.; Pasi F.; Tombini, C. Org. Lett. 2006, 8, 3303–3305. (c) Chaudhari, 
V. D.; Kumar K. S. A.; Dhavale, D. D. Org. Lett. 2005, 7, 5805–5807. (d) Torssell S.; Somfai, P. Org. 
Biomol. Chem. 2004, 2, 1643–1646. (e) Rai A. N.; Basu, A. Org. Lett. 2004, 6, 2861–2863. (f) Singh, 
O. V.; Kampf D. J.; Han, H. Tetraheron Lett., 2004, 45, 7239–7242. 
159
 Trnka T. M.; Grubbs, R. H. Acc. Chem. Res. 2001, 34, 18–29. 
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Scheme 23. Synthesis of carbamate 164 
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Scheme 24. Synthesis of allyl bromide  
160 by cross-metathesis 
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The key step is the synthesis of the epoxide 167 with control of the configuration 
of the stereogenic centers at C-2 and C-3 by using the stoichiometric sulphur ylide 
reaction, which is the particular interest because of the valuable synthetic intermediate 
that have been generated using this reaction.160 The sequence developed to prepare 
epoxide 167 is summarized in scheme 25. Sulfide 165 was selected as chiral auxiliary161 
in order to prepare the corresponding chiral sulphur ylide. Reaction of sulfide 165 (1 
equiv) with allyl bromide 160 (1.2 equiv) in CH2Cl2 and in the presence of AgBF4 (4 
equiv) afforded the required sulfonium salt 166 in 80% yield. 162 Subsequent treatment 
of the salt 166 with EtP2 base (1.1 equiv) and the aldehyde 164 (1.1 equiv) furnished the 
desired epoxide 167 in 60% yield. Crucial to the success of the reaction were conditions 
that favoured the formation of stabilized ylide 168 employing the EtP2 base at -78 °C in 
CH2Cl2 (Squeme 25).  
To complete the synthesis (Scheme 25), a highly regioselective intramolecular 
ring-opening of epoxide 167 was carried out under basic conditions. A complementary 
chemoselectivity occurred with the internal delivery of a nitrogen nucleophile to the 
epoxide α-position. Thus, the intermediate 167 was converted to oxazolidinone 148 by 
first treatment with NaHMDS (1.5 equi) at -20 °C in THF.163 Then, elimination of the 
benzyl group employing Li (excess) and EtNH2/t-BuOH at -78 °C gave 148 in 90% 
yield over two steps. Finally, alkaline hydrolysis of oxazolidinone 148 with KOH at 
reflux for 2.5 h, allow to obtain D-erythro-sphingosine 19 in quantitative yield. 
Synthetic 19 gave mp 72-74 °C (lit158d mp 72-75 °C), [α]D = −1.6.0 (lit158d [α]D = −1.6) 
400 MHz 1H and 125 MHz 13C NMR spectroscopic data were consistent with data 
report for the natural product. The match of optical rotation values indicates that the 
formation of the epoxide 167 was completely stereoselective. 
 
                                                 
160
 For a general review about asymetric sulfur ylide reaction see: (a) McGarrigle, E. M.; Myers, E. L.; 
Illa, O.; Shaw, M. A.; Riches S. L.; Aggarwal, V. K. Chem. Rev. 2007, 107, 5841–5883. (b) Fulton, J. 
R.; Aggarwal V. K.; de Vicente, J. Eur. J. Org. Chem. 2005, 1479–1492. (c) Aggarwal V. K.; Winn, C. 
L. Acc. Chem. Res. 2004, 37, 611–620. (d) Aggarwal V. K.; Richarson, J. Chem. Commun. 2003, 2644–
2651. (e) Li, A.-H.; Dai L.-X.; Aggarwal, V. K. Chem. Rev. 1997, 97, 2341–2372. 
161
 Aggarwal, V. K.; Fang, G.; Kokotos, C. G.; Richardson J.; Unthank, M. G. Tetrahedron 2006, 62, 
11297–11303. 
162
 Aggarwal, V. K.; Bae, I.; Lee, H.-Y.; Richardson J.; Williams, D. T. Angew. Chem. Int. Ed. 2003, 42, 
3274–3278 
163
 (a) Bew, S. P.; Bull, S. D.; Davies, S. G.; Savory E. D.; Waltkin, D. J. Tetrahedron, 2002, 58, 9387–
9401. (b) Roush W. R.; Adam, M. A. J. Org. Chem., 1985, 50, 3752–3757. (c) Bernet B.; Vasella, A. 
Tetrahedron Lett. 1983, 24, 5491–5494. (c) Julina, R.; Herzig, T.; Bernet B.; Vasella, A. Helv. Chim. 
Acta, 1986, 69, 368–373 
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Scheme 25. Synthesis of sphingosine 19 
 
The mechanism of epoxidation involves three distinct steps: i) formation of the 
betaine with charges adjacent to each other, ii) followed by bond rotation to the trans- 
conformation, and finally iii) ring closure (Scheme 26). The high enantioselectivity 
observed is a consequence of ylide conformer II being strongly favoured over 
conformer I owing to 1,4-steric interactions and essentially complete preference for Si-
face attack, as the Re face of the ylide is hindered by the bulky camphor moiety. The 
diastereoselectivity obtained in depend on the degree of reversibility of the formation of 
the betaine intermediates arising from the attack of the sulphur ylide on the carbonyl 
group of the aldehyde. The addition of the ylide to the aldehyde occurs in a “cisoid” 
manner, which is preferred due to favourable Coulombic interactions, and two rotamers 
of the anti- and syn-betaines could be formed (III y IV Scheme 26). The high trans 
selectivity observed is a consequence of nonreversible formation of the anti betaine III 
and the unproductive, reversible formation of syn betaine IV. Finally, C-C bond rotation 
to lead to rotamer V, followed to the ring-closure step from the anti-periplanar rotamers 
furnished the trans-epoxide (Scheme 26). 
 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 60
RS
O
H
HS
O
R HHHH
S
O
HH
R'
O HH
R
S
O
HH
H
O R'H
R
S
O
HH
H
R' OH
R
S
O
HH
R'
H OH
R
O
R' R
O
R' R
Anty Betaine
Syn Betaine
Gauche Conformation Trans Conformation
Epoxide R,R
Epoxide R,S
Epoxide S,S
I II
III
IV
V
VI
 
 
Scheme 26. Proposed mechanism for the asymmetric sulfur ylide reaction 
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3.1.4 Experimental Part 
 
 
General methods 
 
All reactions were conducted under a dried argon stream. Solvents (CH2Cl2 
99.9%, toluene 99.9%) were purchased in capped Pure Solv System-4® bottles and used 
without further purification and stored under argon. Yields refer to the 
chromatographically and spectroscopically (1H and 13C) homogeneous materials, unless 
otherwise stated. All other solvents and reagents were used without further purification. 
All glassware utilized was flame-dried before use. Reactions were monitored by TLC 
carried out on 0.25 mm E. Merck silica gel plates. Developed TLC plates were 
visualized under a short-wave UV lamp and by heating plates that were dipped in 
ethanol/H2SO4 (15:1). Flash column chromatography (FCC) was performed using flash 
silica gel (32–63 µm) and employed a solvent polarity correlated with TLC mobility. 
Melting points, determined with Reichert apparatus, are uncorrected. Optical rotations 
were measured at 598 nm on a Jasco DIP-370 digital polarimeter using a 100 mm cell. 
NMR experiments were conducted on a Varian 400 MHz instrument using CDCl3 
(99.9% D) as the solvent, with chemical shifts (δ) reference to internal standards CDCl3 
(7.26 ppm 1H, 77.23 ppm 13C) or Me4Si as an internal reference (0.00 ppm) Chemical 
shifts are relative to the deuterated solvent peak and are in parts per million (ppm). 
 
Experimental Procedures 
 
4-[(l,l-Dimethylethyl)dimethylsilyloxy]but-2-yn-l-al 155. To a 
solution of alcohol 154 (1.50 g, 7.48 mmol) in dry CH2Cl2 (100 
mL) was added barium manganate (9.00 g, 37.4 mmol), and the 
mixture was stirred at room temperature for 3.5 h. Filtration of the 
mixture through a pad of Celite and evaporation of the filtrate in vacuo gave aldehyde 
155 (1.40 g, 95%) as an oil. The unstable aldehyde was used in the next step without 
purification: 1H NMR (400, MHz, CDCl3): δ 9.6 (1H, s), 4.4 (2H, s), 0.8 (9H, s), 0.1 
(6H, s). 
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Tetradecyltriphenylphosphonium bromide 153. A mixture of 
triphenylphosphine (8.51 g, 0.032 mmol) and 1-bromotetradecane 
(10.00 g, 0.036 mL) was heated at 140 °C for 7 h. The reaction 
mixture was cooled, and tetradecyltriphenylphosphonium bromide 
153 was crystallized from acetone/ether (17.00 g, 92%), mp 96-98 °C. 1H NMR (400 
MHz, CDCl3): δ: 7.29-7.91 (15H, m), 3.77 (2H, m), 1.62 (2H, m), 1.23 (11H, s), 1.19 
(11H, s), 0.87 (3H, t, J=6.7 Hz). Anal. Calcd for C32H44BrP: C, 71.23; H, 8.21. Found: 
C, 71.54; H, 8.11. 
 
Octadeca-4(E)-en-2-yn-l-ol 151. To a solution of 
tetradecyltriphenylphosphonium bromide 153 (3.90 g, 7.21 
mmol) in anhydrous THF (25 mL) at -78 °C was added 1.55 M 
n-butyllithium in hexane (5.1 mL, 7.95 mmol). The mixture was stirred for 1.5 h at -30 
°C. The orange-red reaction mixture was cooled to -78 °C, and aldehyde 155 (1.1g, 5.54 
mmol) in anhydrous THF (25 mL) was added. The mixture was stirred for 2 h at -78 °C, 
and 1.55 M n-butyllithium in hexane (5.1 mL, 7.95 mmol) was added. The resulting 
dark red solution was stirred at -30 °C for 1 hand was diluted with ether (10 mL) and 
methanol (3 mL). The resulting solution was stirred for 3 h at room temperature. Then, 
3.5 N HCl was added until pH 4 was reached, and the mixture was stirred for 22 h. The 
reaction mixture was diluted with water and extracted with ether (3 x 40 mL). The 
organic phase was dried and concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel using hexane-AcOEt-MeOH (80:20) as the eluent 
to give 154 mg of pure alcohol 151 (75 %). TLC (Hexane-AcOEt 60:40) Rf 0.60; m.p. 
104–106 °C; 1H NMR (400 MHz, CDCl3): δ 6.17 (1H, dd, J=15.8, 7.0, Hz), 5.49 (1H, 
dd, J=15.0, 1.7 Hz, Hz), 4 .38 (2H, dd, J=5.9, 1.6, Hz), 1.54 (2H, q, J=6.0 Hz), 1.37(2H, 
m), 1.26 (18H, m), 0.89 (3H, t, J=6.9 Hz); 13C NMR (100.6 MHz, CDCl3): δ 145.8, 
108.7, 85.5, 84.6, 51.6, 33, 31.9, 29.6, 29.5, 29.4, 29.3, 29, 28.6, 22.6, 14. Anal. Calcd 
for C18H32O: C, 81.55; H, 12.19. Found: C, 81.75; H, 12.03. 
 
Octadeca-2(Z),4(E)-dien-l-ol 150. A mixture of propargyl alcohol 
151 (0.850 g, 3.21 mmol), dry toluene (25 mL), and Lindlar 
catalyst (0.100 g) was stirred at room temperature under an 
atmosphere of hydrogen until TLC indicated the disappearance of 
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the starting material (-3 h). The reaction mixture was filtered through a Celite pad, and 
the filtrate was concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel using hexane-AcOEt (80:20) as the eluent to give 684 mg 
of pure alcohol 150 (80 %) as a colorless oil. TLC (Hexane-AcOEt 60:40) Rf 0.50; 1H 
NMR (400 MHz, CDCl3): δ 6.38 (1H, m), 6.31 (1H, m) 6.24 (1H, m), 5.58 (1H, m), 
4.31 (2H, d, J=6.8 Hz), 2.09 (2H, m), 1.26 (22H, m), 0.88 (3H, t, J=6.7 Hz,); 13C NMR 
(100.6 MHz, CDCl3): δ 137.6, 131.3, 127, 124.7, 58.8, 32.8, 31.9. Calcd for C18H34O: 
C, 81.13; H, 12.86. Found: C, 81.19; H, 12.01. 
 
Carbamate 157. N,N-Carbonyldiimidazole (182 mg, 1.12 
mmol) was added to alcohol 150 (200 mg, 0.75 mmol) in 
pyridine (20 mL) at 40 °C. When adduct between the alcohol 
and the N,N-carbonyldiimidazole was totally formed, 
hydroxylamine hydrochloride (130 mg, 1.87 mmol) was 
added. The resulting reaction mixture was stirred for 24 h at 40 °C, it was quenched 
with hydrochloric acid (1M, 10 mL), and finally AcOEt (10 mL) was added. After 
separation of organic phase, the aqueous phase was extracted with AcOEt (2 x 10 mL). 
The combined organic layers were then washed sequentially with water (10 mL) and 
brine (3 x 10 mL) dried (NaSO4), filtered and the solvent was azeotropically removed 
with toluene. The crude product was purified by flash column chromatography on silica 
gel using hexane/AcOEt (85:15) as the eluent to give 156, which was used directly into 
next step.  
A solution of 156 (243 mg, 0.75 mmol), and Et3N (83 mg, 0.82 mmol) in 20 mL 
of dry Et2O was cooled to 0 °C.  The acid chloride O-PFB-COCl (172 mg, 0.75 mmol) 
in 10 mL of dry Et2O was added drop wise over 1 h at 0°C, and then the reaction was 
stirred under argon for 12 h at room temperature. The reaction was quenched with HCl 
(1M aq. sol., 10 mL) and the aqueous layer was extracted with Et2O (3 x 10 mL). The 
combined organic layers were washed sequentially with HCl (10 % aqueous, 1 x 10 
mL), NaHCO3 (7 % aqueous, 1 x 10 mL), and brine (3 x 10 mL). The organic layer was 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel using hexane/AcOEt (85:15) as the eluent to give 270 mg 
of 157 (70 %) as a clear oil. 1H NMR (400, MHz, CDCl3): δ 8.36 (1H, s), 6.3 (1H, dd, 
J=13.8, 11.1 Hz), 6.15 (1H, dd, J=11.1, 10.6, Hz), 5.8 (1H, dq, J=13.8, 6.6 Hz), 5.4 (1H, 
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dt, J=10.6, 7.1 Hz), 4.73 (2H, d, J=7.1 Hz), 2.12 (2H, q, J=7.0 Hz), 1.37-1.2 (22H, m), 
0.85 (3H, t, J=6 Hz); 13C NMR (100.6 MHz, CDCl3): δ 158.5, 155.7, 148.9, 147.2, 
145.6, 143.0, 138.4, 133.1, 124.5, 121.9, 61.1, 32.8, 31.9, 29.6, 29.5, 29.4, 29.3, 29.2, 
29.1, 22.6, 14.0. Anal. Calcd. For C26H34F5NO4: C, 60.11; H, 6.60; F, 18.28; N, 2.70; O, 
12.32. Found: C, 60.13; H, 6.59; N, 2.72. 
 
Oxazolidinone 148. To a solution of 157 (250 mg, 0.48 mmol) in 
a mixture t-butanol/water (3:1, 10 mL/mmol) was added dropwise 
a solution of potassium osmate dihydrate (1.8 mg, 1 mol%) in 
water (0.25 mL). After, the resulting reaction mixture was stirred 
for 12 h at room temperature. The reaction was quenched by addition of sodium sulphite 
(100 mg, mmol), allowed to stir for 30 minutes and then, the solvent azeotropically 
removed with toluene. The crude product was purified by flash column chromatography 
on silica gel using hexane/AcOEt (85:15) as the eluent to give 132 mg of 148 (85 %) as 
a white solid. 1H NMR (400, MHz, CDCl3): δ 6.10 (1H, s), 5.83 (1H, ddt, J = 15.4, 6.8, 
0.8 Hz), 5.37 (1H, ddt, J=15.4, 6.8, 1.2 Hz), 4.39 (1H, dd, J=8.8, 8.5 Hz), 4.33 (1H, dd, 
J=8.8, 5.2 Hz), 4.12 (1H, m), 3.86 (1H, m), 2.92 (1H, br s), 2.04 (2H, q, J=7.0 Hz), 
1.37-1.2 (22H, m), 0.81 (3H, t, J=6.8 Hz); 13C NMR (100.6 MHz, CDCl3): δ 160.5, 
136.6, 126.6, 73.3, 66.4, 56.4, 32.5, 32.1, 29.81, 29.79, 29.74, 29.6, 29.5, 29.4, 29.1, 
22.8, 14.2. Anal. Calcd. For C19H35NO3: C, 70.11; H, 10.84; N, 4.30; O, 14.75. Found: 
C, 70.19; H, 10.80; N, 4.32. 
 
Sphingosine 19. Oxazolidone 148 (100 mg, 0.30 mmol) in 1 M 
KOH (5 mL, H2O:EtOH 1:1) was heated to reflux for 2.5 h, cooled 
to room temperature and then 2 M HCl (2.5 mL) was added. The 
mixture was extracted with EtOAc (3 x 10 mL) and the combined 
organic layers were dried over MgSO4 and concentrated in vacou giving 19 (89 mg, 100 
%) as a white solid. TLC (Hexane-AcOEt-MeOH 60:30:10) Rf 0.70; m.p. 104–106 °C; 
1H NMR (400, MHz, CDCl3): δ 5.76 (dt, 1H, J=15.4, 6.7 Hz), 5.47 (dd, 1H, J=15.4, 7 
Hz), 4.11 (m, 1H), 3.70 (dd, 1H, J=11, 3 Hz), 3.65 (dd, 1H, J=11, 5.8 Hz), 2.92 (m, 1H), 
2.05 (dt, 2H, J=6.7, 7.3 Hz,), 1.37 (m, 2H), 1.20–1.40 (m, 20H), 0.88 (t, 3H, J=6.9 Hz); 
13C NMR (100.6 MHz, CDCl3): δ 134.7, 128.8, 74.7, 63.3, 56.3, 32.5, 31.9, 29.7–29.2, 
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22.7, 14.1. Anal. Calcd. For C18H37NO2: C, 72.19; H, 12.45; N, 4.68; O, 10.68. Found: 
C, 72.21; H, 12.41; N, 4.70. 
 
Formylmethyl phenylcarbamate 164. To a solution of 2-
hydroxyacetaldehyde 161 (184 mg, 3.06 mmol) in 15 mL of dry 
Et2O was added freshly distilled Et3N (10.16 mmol) followed by 
BnNCO (647 mg. 4.8 mmol). The resultant mixture was heated to 
60 °C in a sealed tube for 17 h, cooled to room temperature and quenched with saturate 
NH4Cl (10 mL). The phases were separated and the aqueous layer was extracted with 
CH2Cl2 (2 x 10 mL). The organic layer was dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash column chromatography on silica gel using 
hexane-AcOEt (85:15) as the eluent to give 580 mg of pure formylmethyl 
phenylcarbamate 164 (98 %) as an oil. TLC (Hexane-AcOEt 80:10) Rf 0.70; 1H NMR 
(400 MHz, CDCl3): δ 9.67 (1H, t, J=0.7 Hz),   7.35-7.21 (5H, m), 5.08 (1H, br s) 4.89 
(2H, d, J=0.7 Hz) 4.4 (2H, d, J=5.5); 13C NMR (100.6 MHz, CDCl3): δ 194.2, 153.6, 
136.9, 128.5, 124.4, 121.6, 69.5. Anal. Calcd. For C10H11NO3: C, 62.17; H, 5.74; N, 
7.25. Found: C, 62.15; H, 5.75; N, 7.26. 
 
(E)-1-bromohexadec-2-ene 160. To a solution of 
allyl bromide 163 (240 mg, 0.15 mmol) in 40 mL 
of dry CH2Cl2 was added pentadec-1-ene 162 (1.68 
g, 8 mmol). A mixture of catalyst B (8 mg, 2%) and 20 mL of CH2Cl2 was added, with 
stirring, at a rate sufficient to reach and maintain refluxing. After the addition was 
completed, the reaction mixture was kept boiling for 6 h and then cooled to room 
temperature and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel using hexane-AcOEt (98:2) as the eluent to give 590 mg 
of pure (E)-1-bromohexadec-2-ene 160 (97 %). as colourless oil and with E:Z 
selectivity of 52:1. TLC (Hexane) Rf 0.60; 1H NMR (400 MHz, CDCl3): δ 5.78 (1H, dt, 
J=14.8, 7.6 Hz), 5.68 (1H, dt, J=14.8, 7.2 Hz), 3.96 (2H, d, J=7.6 Hz), 2.03 (2H, q, 
J=7.2, Hz), 1.34-1.20 (22H, m), 0.86 (3H, t, J=6.9 Hz); 13C NMR (100.6 MHz, CDCl3): 
δ 137, 126.3, 34, 32.3, 32.1, 29.8, 29.6, 29.5, 29.3, 29, 22.9, 14.3. Anal. Calcd. for 
C16H31Br: C, 63.36; H, 10.30. Found: C, 63.34; H, 10.31. 
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Sulfonium salt 166. To a rapidly stirred 
solution of chiral sulfide 165 (82 mg, 0.33 
mmol) and (E)-1-bromohexadec-2-ene 160 
(100 mg, 0.33 mmol) in 10 mL CH2Cl2 was 
added silver tetrafluoroborate (194 mg, 0.99 mmol) in the dark under an argon 
atmosphere at room temperature. The reaction stirred for 48 h and 10 mL of CH2Cl2 
was added. Silver bromide precipitate was filtered and the filtrate was concentrated in 
vacuo. The residual brown oil was recrystallized from CH2Cl2 and Et2O to give 
sulfonium salt 166 as a white precipitate which was used directly into next step.  
 
((2R,3R)-3-((E)-pentadec-1-enyl)oxiran-
2-yl)methyl benzylcarbamate 167. To a 
stirred solution of sulfonium salt 166 (465 
mg, 0.83 mmol) in 5 mL of CH2Cl2 was 
added N,N,N´,N´´,-tetramethyl-N´´-[tris(dimethylamino)phos-phoralidene]phosphoric 
triamide ethylimine (415 mg, 1.22 mmol) at -78 °C under argon. After 45 min, a 
mixture of 20 mL of CH2Cl2 and formylmethyl phenylcarbamate 164 (240 mg, 1.25 
mmol) was added to the solution. After 2 h stirring, the mixture was warmed up to room 
temperature and then saturated NaCl solution (10 mL) was added. The phases were 
separated and the aqueous layer was extracted with AcOEt (2 x 10 mL). The organic 
layer was dried over MgSO4 and concentrated in vacuo. The residue was purified by 
flash column chromatography on silica gel using hexane-AcOEt (85:15) as the eluent to 
give 192 mg of pure epoxide 167 (60 %). Compound 165 (180 mg, 87%9 was also 
recovered. TLC (Hexane-AcOEt 70:30) Rf 0.60; [α]D +15.0 (c 0.5 in CHCl3); 1H NMR 
(400 MHz, CDCl3): δ 7.37-7.26 (5H, m), 5.73 (1H, dt, J=14.8, 6.5 Hz), 5.10 (1H, dd, 
J=14.8, 9.1 Hz), 5.01 (1H, br s), 4.47 (1H, dd, J=12.2, 3.1 Hz), 4.39 (2H, d, J=6), 4.05 
(1H, dd, J=12.2, 6.3 Hz), 3.30 (1H,dd, J=9.1, 2.4), 3.15 (1H, ddd, J=6.3, 3.1, 2.4 Hz), 
2.03 (2H, q, J=6.5 Hz), 1.37-1.20 (22H, m), 0.81 (3H, t, J=6.8 Hz); 13C NMR (100.6 
MHz, CDCl3): δ 156.0, 138.4, 134.6, 128.8, 127.7, 127.6, 120.3, 64.9, 57.6, 56.5, 45.2, 
32.5, 32.1, 29.8, 29.6, 29.5, 29.4, 29.3, 22.8, 14.3. Anal. Calcd. for C26H41NO3: C, 
75.14; H, 9.94; N, 3.37. Found: C, 75.12; H, 9.95, N, 3.36. 
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(S)-4-((R,E)-1-hydroxyhexadec-2-
enyl)oxazolidin-2-one 148. To a stirred solution 
of epoxide 167 (220 mg, 0.57 mmol) in 15 mL of 
THF at -15 °C was added dropwise NaHMDS 
(0.57 mmol, 1 M in THF). The resultant mixture was slowly allowed to reach 0 °C (5 h) 
and then quenched by addition of saturate NH4Cl (10 mL). The phases were separated 
and the aqueous layer was extracted with AcOEt (2 X 10 mL). The organic layer was 
dried over MgSO4 and concentrated in vacuo. The residue was used directly into next 
step. Thus, to a stirred mixture of Li (excess) and freshly EtNH2 (45 mL) under argon at 
-78 °C was added a solution of first residue in dry 10 mL of Et2O via syringe. 
solutionthis residue. The reaction mixture was stirred at -78 °C for 4 h and then 
carefully quenched with saturate NHCl4. The phases were separated and the aqueous 
layer was extracted with AcOEt (2 X 10 mL). The organic layer was dried over MgSO4 
and concentrated in vacuo. The residue was purified by flash column chromatography 
on silica gel using hexane-AcOEt-MeOH (85:10:5) as the eluent to give 154 mg of pure 
oxazolidinone 148 (82 %). TLC (Hexane-AcOEt-MeOH 60:30:10) Rf 0.70; m.p. 104–
106 °C; 1H NMR (400, MHz, CDCl3): δ 6.10 (1H, s), 5.83 (1H, ddt, J=15.4, 6.8, 0.8 
Hz), 5.37 (1H, ddt, J=15.4, 6.8, 1.2 Hz), 4.39 (1H, dd, J=8.8, 8.5 Hz), 4.33 (1H, dd, 
J=8.8, 5.2 Hz), 4.12 (1H, m), 3.86 (1H, m), 2.92 (1H, br s), 2.04 (2H, q, J=7.0 Hz), 
1.37-1.2 (22H, m), 0.81 (3H, t, J=6.8 Hz); 13C NMR (100.6 MHz, CDCl3): δ 160.5, 
136.6, 126.6, 73.3, 66.4, 56.4, 32.5, 32.1, 29.81, 29.79, 29.74, 29.6, 29.5, 29.4, 29.1, 
22.8, 14.2. Anal. Calcd. For C19H35NO3: C, 70.11; H, 10.84; N, 4.30; O, 14.75. 
Found: C, 70.19; H, 10.80; N, 4.32. 
 
D-erythro-sphingosine 19. The mixture of 
oxazolidinone 148 (32 mg, 1.31 mmol) and 1 M 
KOH (20 mL, H2O:EtOH 1:1) was heated to 
reflux for 2.5 h, cooled to room temperature and 
then 2 M HCl (10 mL) was added. The mixture was extracted with EtOAc (3 X 20 mL) 
and the combined organic layers were dried over MgSO4 and concentrated in vacuo 
giving 30 mg of pure D-erythro-sphingosine 19 (100 %). TLC (Hexane-AcOEt-MeOH 
60:30:10) Rf 0.70; m.p. 104–106 °C; 1H NMR (400, MHz, CDCl3): δ 5.76 (dt, 1H, 
J=15.4, 6.7 Hz), 5.47 (dd, 1H, J=15.4, 7 Hz), 4.11 (m, 1H), 3.70 (dd, 1H, J=11, 3 Hz), 
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3.65 (dd, 1H, J=11, 5.8 Hz), 2.92 (m, 1H), 2.05 (dt, 2H, J=6.7, 7.3 Hz,), 1.37 (m, 2H), 
1.20–1.40 (m, 20H), 0.88 (t, 3H, J=6.9 Hz); 13C NMR (100.6 MHz, CDCl3): δ 134.7, 
128.8, 74.7, 63.3, 56.3, 32.5, 31.9, 29.7–29.2, 22.7, 14.1. Anal. Calcd. For C18H37NO2: 
C, 72.19; H, 12.45; N, 4.68; O, 10.68. Found: C, 72.21; H, 12.41; N, 4.70. 
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3.2. Glycosilation of ceramides 
 
 
 
 
 
 
 
 
     β-Galactosyl ceramides have been obtained in excellent yields and 
stereoselectivities by reacting disarmed glycosyl donors with stannyl ethers. The broad 
compatibility of stannyl ethers with various leaving groups has been demonstrated 
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3.2.1. Strategy of glycosylation 
 
With a stimulating biological background and the complicated availability of 
GSL’s from natural sources,164 many organic chemists have focused on developing 
methods for synthesizing GSLs.165 The retrosynthetic analysis and the disassembly at 
the strategic glycosidic, amide and ester bonds reveal three important steps in the 
syntheses of β-GalCer: (i) attachment of the sphingosine moiety, (ii) N-acylation with 
the fatty acid and finally (iii) elimination of the protecting groups (Figure 20). 
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Figure 20. Retrosynthetic analysis of β-galactosylceramide 
 
One of the main synthetic problems in the synthesis of glycosphingolipids is the 
glycosylation reaction,166 which gives low yields when ceramides like 172 are directly 
used in the reaction. That has been attributed to the low nucleophilicity of ceramides,167 
which are extremely order as a result of the headgroup hydrogen bonding. This driving 
force for molecular self-assembly in ceramides allow have hexagonal and orthorhombic 
phases, structural organization similar in crystalline and hydrated states, with high 
stability.168 This problem is usually circumvented by using azido-sphingosine 170, but 
that requires further reduction of the azido group and acylation (Scheme 27).169 The 
most classical and efficient glycosylation procedures that have been used in the GSLs 
synthesis include glycosyl trichloroacetamidates and fluorides.170,166 In these cases the 
stereochemistry of the reaction is determined by the participation of the neighbouring 
groups, solvent, and the kind of promoter.166  
                                                 
164 Schengrund, C.-L.; Ringler, N. J. J. Biol. Chem. 1989, 264, 13233–13237. 165
 (a) Howell, A. R.; So, R. C.; Richardson, S. K. Tetrahedron 2004, 60, 11327–11347. (b) Brodesser, S.; 
Sawatzki, P.; Kolter, T. Eur. J. Org. Chem. 2003, 2021–2034. (c) Duclos, Jr. R. I. Chem. Phys. Lipids, 
2002, 111, 111–138. 166
 For a review about the O-glycosylation of sphingosines and ceramides see: Morales-Serna, J. A.; 
Boutureira, O.; Díaz, Y.; Matheu M. I.; Castillón, S. Carbohydr. Res. 2007, 342, 1595–1612. 167
 (a) Polt, R.; Szabo, L.; Treiberg, J.; Li Y.; Hruby, V. J. J. Am. Chem. Soc. 1992, 114, 10249–10258. (b) Schmidt R. R.; Zimmermann, P. Angew. Chem. Int. Ed. Engl. 1986, 25, 725–726. 168
 Rerek, M. E.; Chen, H.-C.; Markovic, B.; Van Wyck, D.; Gardiel, P.; Mendelsohn, R.; Moore, D. J. J. 
Phys. Chem. B, 2001, 105, 9335–9362. 169
 Schmidt, R. R.; Zimmermann, P. Tetrahedron Lett. 1986, 27, 481-484. 170
 (a) Pellissier, H. Tetrahedron 2005, 61, 2947–2993. (b) Toshima, K.; Tatsuta, K. Chem. Rev. 1993. 93, 
1503–1531. 
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Scheme 27. Strategy of glycosilation 
 
 
3.2.2. Recent contributions in the synthesis of α-glycosyl sphingosines and 
ceramides report in the literature (2000-2007) 
 
3.2.2.1. Glycosylation of azido-sphingosines 
 
As mentioned before, interest in α-glycosylceramides derives from the relevant 
biological properties of these products and particularly of those having 
phytosphingosine as a part of the ceramide moiety (α-GalCer).  Consequently, most 
works are related with the synthesis of this compound and analogues. While formation 
of 1,2-trans glycosides can be easily achieved by taking advantage of neighbouring 
group assistance, such as O-acetyl or O-benzoyl at C-2, the stereospecific construction 
of 1,2-cis galactopyranosyl linkages has been one of the greatest challenges of glycoside 
synthesis. α-Gal-type linkages can be formed by working under thermodinamic 
conditions (anomeric effect), in appropriate solvents (ethereal solvent effect), and by 
using nonparticipating protecting groups at the C2 hydroxyl, typically benzyl groups. 
Glycosyl thichloroacetimidates are the most popular glycosyl donors for glycosylation 
of azidosphingosine, although SPh, OAc, and other leaving groups have also been used. 
In Table 1 are collected several examples of glycosylation of galactose derivatives with 
azidosphingosines. 
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Table 1. Synthesis of α-galactosyl-azido-sphingosines 182-186 
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174 Y= OH
175 Y= STol
176 Y=OC(NH)Cl3
182 R1= (E)-CH2-CH=CH-C11H23
183 R1= C14H29
184 R1= C5H11
177
186
179   R1= Bn,R2= (E)-CH2-CH=CH-C11H23
180a R1=Bn, R2= C14H29
180b R1=H, R2=C14H29
181   R1= C5H11
178
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Entry 
 
 
Acceptor 
 
Donor 
 
Promoter 
 
Solvent 
 
Product 
 
Yield 
(%) 
 
Ratio 
(α/β) 
 
Ref 
 
1 
 
179 
 
175 
 
DMTST 
 
CH2Cl2 
 
182 
 
39 
 
1:0 
 
171 
 
2 
 
179 
 
176 
 
BF3·OEt2 
 
THF/Et2O 
 
182 
 
50 
 
2.9:1 
 
171 
 
3 
 
179 
 
178 
 
BF3·OEt2 
 
THF/Et2O 
 
185 
 
68 
 
1:0 
 
171, 
173 
 
4 
 
180a 
 
175 
 
NIS/TfOH 
 
CH2Cl2 
 
183 
 
93 
 
1:1 
 
174 
 
5 
 
180a 
 
174 
 
Me2S, 
2-Cl-Py,Tf2O 
 
CH2Cl2 
 
183 
 
83 
 
3:1 
 
174 
 
6 
 
181 
 
174 
 
Me2S, 
2-Cl-Py,Tf2O 
 
CH2Cl2 
 
184 
 
nr 
 
3:1 
 
174 
 
7 
 
180b 
 
177 
 
Me2S, 
2-Cl-Py,Tf2O 
 
CH2Cl2 
 
186 
 
nr 
 
3:1 
 
174 
 
In the context of synthesis of α-galactosylceramide, azido-sphingosine 179, that 
was obtained in nine steps from 2-deoxygalactose in an overall yield of 36%, was 
reacted with perbenzylated S-galactoside (1-thio-galactose) 175 using 
dimethyl(methylthio)sulfonium triflate (DMTST) as promoter affording the galactosyl 
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ceramide 182 in 39% yield as a pure α-isomer (entry 1, Table 1).171 The use of the 
promoter system NIS/TfOH gave complex mixtures as consequence of the addition of 
the electrophile to the double bond. The use of the trichloroacetimidate 176 and 
BF3·Et2O as promoter allowed improving the yield to 50% but at the cost of decreasing 
the stereoselectivity (α/β=2.9:1) (entry 2, Table 1). Schmidt172 had previoulsy 
demonstrated that 4,6-benzylidene-galactosyl trichloroacetimidate 178 reacts with 
unprotected azido-phytosphingosine 180b to give the α-glycosylated product in 49% 
yield.  Interestingly, when the 2-O-Ms precursor of 180b was used in the glycosylation 
the yield improved up to 73%, and no competition of secondary alcohols in 
glycosylation was observed. Thus, when the trichloroacetimidate 178 was reacted with 
the azido-phytosphingosine 179 using BF3·OEt2 as a promoter, galactosyl ceramide 185 
was cleanly delivered in 68-70% yield.171,173 Hydroxyl groups were deprotected and 
double bond reduced by treating 185 under hydrogenolitic conditions providing α-
galactosylceramide. 
Coupling phytosphingosine 180a with the galactosyl donor 175 by using NIS-
TfOH as promoter system afforded 183 in 93 % yield, albeit as a 1:1 α/β mixture (entry 
4, Table 1).174 When a dehydrative glycosylation procedure175 was used in the coupling 
of tetrabenzyl galactose 174 with the acceptor 180a, compound 183 was obtained in 
83% yield and improved stereoselectivity (α/β=3:1) (entry 5, Table 1). α-
Galactosylsphingosine 184 and α-fucosylsphingosine 186 were also synthesised in a 3:1 
α/β ratio by dehydrative glycosylation of phytosphingosines 181 and 180b, with the 
glycosyl donors 174 and 177 (entries 6, 7, Table 1). These compounds were 
transformed into the final galatosylceramides by azide reduction, amide formation, and 
debenzylation. 
The 3-O-sulfo-α-galactosylceramide 189, a stimulator of human NKT cells to 
secrete IL-4 and IFN-γ,176 was prepared from 4,6-O-benzyliden-glycosyl 
trichloroacetimidate 187, which has positions 2 and 3 differentially protected to 
facilitate selective deprotection and sulfation (Scheme 28). Donor 187 was coupled with 
                                                 
171
 Plettenburg,O.; Bodmer-Narkevitch, V.; Wong, Ch-H. J. Org. Chem. 2002, 67, 4559–4564. 172
 Figueroa-Pérez, S.; Schmidt, R. R. Carbohydr. Res. 2000, 328, 95–102. 173
 Risseeuw, M.D.P.; Berkers, C.R.; Ploegh, H.L.; Ovaa, H. Tetrahedron Lett. 2006, 47, 3677–3679. 174
 Fan, G-T.; Pan, Y-S.; Lu, -C.; Cheng, Y-P.; Lin, W-C.; Lin S.; Lin, C-H.; Wong, C-H.; Fang, J-M.; 
Lin C-C. Tetrahedron 2005, 61, 1855–1862. 175
 Nguyen, H. M.; Chen, Y.; Duron, S. G.; Gin, D. Y. J. Am. Chem. Soc. 2001, 123, 8766–8772. 176
 Xing, G.-W.; Wu, D.; Poles, M.A:; Horowitz, A.; Tsuji, M.; Ho, D.D.; Wong, C.-H. Biorg. Med. 
Chem. 2005, 13, 2907–2916. 
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the azidosphingosine 179, with a donor/acceptor ratio D/A=1.5:1, in the presence of 
TMSOTf to give 188 in 46% yield, exclusively as the α-anomer.  
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Scheme 28 
 
Some years ago, in the course of a study concerning the immunostimulatory 
activity of several natural α-Gal-GSLs, it was found that the glycosylation of 2-OH 
group of galactose resulted in a complete loss of activity,177 although the hydrolysis of 
the interglycosidic linkage by α-glycosidases can restore the activity. This crucial role 
of the galactose 2-OH group can be due to a mere steric hindrance or to the fact that the 
2-OH is involved in specific interactions at the active site of the receptor. In an attempt 
to clarify these facts compounds 193, 197 and 205, in which the 2-OH of the galactose 
has been replaced by OMe, F, or H, were prepared. All of them showed no significant 
immunostimulatory activity. 
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Scheme 29 
 
The intermediate 192 was synthesised using a modification of the Mukaiyama 
glycosylation procedure,178 which involved the use of the glycosyl acetate 190 instead 
of the glycosyl fluoride, and SnCl4-AgClO4, instead of SnCl2-AgClO4. In addition, the 
alcohol of the sphingosine moiety was activated with a trityl group.179 Coupling 190 and 
191 under these conditions afforded 192 in 69% yield as an essentially pure α-anomer. 
Then, 192 was converted into the 2-methoxy-galactoceramide 193 (Scheme 29). 
                                                 
177
 Barbieri, L.; Constantino, V.; Fattorusso, E.; Mangoni, A.; Aru, E.; Parapini, s.; Tamarelli, D. Eur. J. 
Org. Chem. 2004, 468–473. 178
 (a) Mukaiyama, T.; Murai, Y.; Shoda, S.  Chem. Lett. 1981, 431-432. (b) Akimoto, K.; Natori, T.; 
Morita, M. Tetrahedron Lett. 1993, 34, 5593–5596. (c) Mukaiyama,  T.; Takashima, T.; Katsurada, M., 
Aizawa, H. Chem. Lett. 1991, 533–536. 179
 Houdier, S.; Vottéro, P. J. A. Tetrahedron Lett. 1993, 34, 3283–3284. 
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Scheme 30 
 
A similar procedure was used in the synthesis of the 2-deoxy-2-fluoro-
galactosylsphingosine 196 which was then converted into the 2-deoxy-2-fluoro-
galactosylceramide 197 (Scheme 30).180 2-Deoxy-2-fluorogalactose 194a, which was 
synthesised from tri-O-benzylgalactal, was reacted with the trityl derivative 195 (R=Tr) 
using SnCl4-AgClO4 as promoter affording 196 in 32% yield as 1:1 anomeric mixture. 
When the reaction was carried out under standard Mukaiyama conditions from glycosyl 
fluoride 194b and the non tritrilated azido-sphingosine 195 (R=H) using SnCl2-AgClO4, 
the
 
yield increased slightly but the stereoselectivity was also essentially null. Comparing 
Schemes 28, 29 and 30 it can be concluded that the presence of fluorine at position 2 
has strong influence in the yield and stereoselectivity of glycosylation reaction. 
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Scheme 31 
 
Recently, it has been shown that glycosyl iodides181 are excellent donors for 
glycosylation reactions. A high α-stereoselectivity was achieved by in situ 
anomerization of the α-iodide to the more reactive β-iodide, from which the α-
glycoside was exclusively formed as a consequence of an SN2 displacement. Recently 
this procedure has been used in the synthesis of α-galacto-azido-sphingolipids 200 by 
reacting azidosphingosine 199 with the per-O-benzylated 198a and per-O-silylated 
                                                 
180
 Barbieri, L.; Costantino, V.; Fattorusso, E.; Mangoni, A.; Basilico, N.; Mondani, M.; Tamarelli, D. 
Eur. J. Org. Chem. 2005, 3279–3285. 181
 (a) Schmid, U.; Waldemann, H.; Tetrahedron Lett. 1996, 37, 3837–3840.( b) Gervay, J.; Hadd, M. J. J. 
Org. Chem. 1997, 62, 6961–6967. (c) Gervay, J.; Hadd, M. J. Carbohydr. Res. 1999, 320, 61–69. (d) 
Lam, S. N.; Gervay-Hague, J. Org. Lett. 2002, 4, 2039–2042. 
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iodide 198b donors in the presence of Bu4NI (Scheme 31).182 Compounds 200a,b were 
obtained in remarkable yields, 94% and 84% respectively, exclusively as the α-anomer.  
The 2-deoxy derivative 205 was synthesised by using 3,4,6-tri-O-acetyl-galactal 
2002 as the chiral starting material for synthesising phytosphingosine 203 and as 
starting material for glycosylation (Scheme 32).183 Thus, stereoselective glycosylation 
was accomplished using 202 as glycosyl donor in an iodonium-mediated coupling with 
the azidosphingosine 203 to give 204, which was converted into the 2-deoxy derivative 
205. The stereochemistry of this reaction was determined by the attack of iodine to the 
β-face of the double bond which controls the selective formation of the α glycosidic 
bond.184 
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Scheme 32 
 
3.2.2.2. Glycosylation of ceramides 
 
There are several examples of the use of perbenzyl-glycosyl fluorides in the 
glycosylation of structurally different ceramides in order to obtain α-anomers (Schemes 
33-36). Using SnCl2/AgClO4 as a promoter system, good stereoselectivity and moderate 
to poor yields are usually obtained. A series of α-mannosyl and α-galactosyl ceramide 
analogues 209, incorporating sphinganines 207 in place of sphingosine, were prepared 
from the protected derivative 208 in order to examine their effects on immune responses 
by Vα19 NKT cells (Scheme 33). Compound 208 was synthesized by glycosylation of 
ceramide 207 with β-tetrabenzylgalactosyl fluoride 206 in the presence of 
SnCl2/AgClO4. The α isomer was preferentially obtained (α/β= 9:1).185  
 
 
                                                 
182
 Du W.; Gervay-Hague J. Org. Lett. 2005, 7, 2063–2065. 183
 Constantino, V.; Fattotuddo, E.; Imperatore, C.; Mangoni, A. Tetrahedron 2002, 58, 369–375. 184
 For reviews about synthesis of 2-deoxy-glycosides see: (a) Kirschning, A.; Jesberger, M.; Schöning, 
K-U. Synthesis 2001, 507–540. (b) Veyrières, A. In Carbohydrates in Chemistry and Biology, Ernst, 
B.; Hart, G.W.; Sinaÿ, P. Ed.s, Wiley, Weinheim 2000, Part I, Vol. I, p 367. (c) Marzabadi, H.; Franck, 
R.W. Tetrahedron 2000, 56, 8385–8417. (d) Castro-Palomino, J.C.; Schmidt, R.R. Synlett 1998, 501–
503. (e) Toshima, K.; Tatsuta, K. Chem. Rev. 1993, 93, 1503–1531. 185
 Shimamura, M.; Okamoto, N.; Huang, Y.-Y.; Yasuoka, J.; Morita, K.; Nishiyama, A.; Amano, Y.; 
Mishina, T. Eur. J. Med. Chem. 2006, 41, 569–576. 
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Scheme 33 
 
The α-galactosylceramide has proven to be an invaluable tool for enhancing 
understanding of the role of CD1d antigen presentation and NKT cell function. With the 
aim of elucidate this role sphinganines 211a,b, analogues of α-GalCer, were prepared 
(Scheme 34). Glycosylation of ceramides 210a,b with glycosyl fluoride 206 in the 
presence of SnCl2/AgClO4 afforded 211a,b in low yields but with excellent α 
selectivity.186  
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Scheme 34 
 
Modelling of CD1d-α-GalCer complex suggested that the hydroxyl groups at C4 
and C6 on galactose are not involved in complex formation. In order to quantify the 
association of glycolipids with CD1d and NKT cell receptors, α-galactosylceramides 
215, which have labels (fluorofores and biotin) appended at the C6 position of the 
sugar, were prepared. Glycosylation of ceramide 213 with 6-azido-6-deoxy-α-
tribenzylgalactosyl fluoride 212 promoted by SnCl2/AgClO4 gave exclusively the α-
                                                 
186
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anomer 214 in 44% yield (Scheme 35).187 Compound 215 was prepared from 214 by 
removing the protecting groups and anchoring the label at position 6. 
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Scheme 35 
 
α-Galactosylceramide 218 containing BODIPY, a fluorescent group, was 
prepared with the purpose of visualizing the behaviour of this compound in vivo, and 
how the presence of this group affects the biological activity (Scheme 36).188  Ceramide 
216 was glycosylated with the galactosyl fluoride 206 promoted by SnCl2/AgClO4 
giving the ceramide 217 in 37% yield exclusively as the α-anomer. The lipidic chain in 
217 was further elaborated and the protecting groups removed to give 218.  
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Scheme 36 
  
A series of α-galactosylceramides 222 in which the lipid chain lengths have 
been incrementally varied were prepared in order to study the effects of lipid chain 
lengths on cytokine release by natural killer T cells (NKT cells). They concluded that 
truncation of the phytosphingosine lipid chain increases the IL-4 vs INF-γ bias of 
released cytokines and that the length of the acyl chain in α-galactosylceramides 
influences cytokine release profiles. With this purpose ceramides 220 were glycosylated 
with α-galactosyl bromide 219 in the presence of silver triflate providing the α-
galactosylceramides 221 in good yield (62 %) contaminated with small amounts of the 
                                                 
187
 Zhou, X.-T.; Forestier, C.; Goff, R.D.; Li, C.; Teyton, L.; Bendelac, A.; Savage, P.B. Org. Lett. 2002, 
4, 1267–1270. 
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β-anomers (Scheme 37).189 Donor 219 was used because the selective deprotection of 
the benzyl group allows an easier separation of the β-anomer. It is remarkable that a 
relatively good yield is obtained in this case from the more classical glycosyl donors. 
However, this glycosyl donor differentiates from 206, apart from the halogen at the 
anomeric position, by the presence of the acetyl protecting groups of hydroxyls in the 
carbons 3, 4, and 6.  
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Scheme 37 
 
Agelagalastatin190 226 is a glycolipid isolated from a marine sponge Agelas sp., 
as other relevant glycolipids such as longiside and α-GalCer,191 that has shown 
inmunomodulating activity (Scheme 38). Agelagalastatin is integrated by a trisaccharide 
containing two furanose and one galactose units, which is linked to phytosphingosine. 
In the context of the total synthesis of 226 the stereoselective construction of α-
galactofuranoside and α-galactopyranoside bonds was performed by using 2’-
carboxybenzyl (CB) group as leaving group.192 The synthesis of 225, a precursor of the 
angelagalastatin 226, was carried out by glycosylation of ceramide 224 with the 
trisaccharide 223a, which has a 4,6-benzylidene protecting group. Using triflic 
anhydride as promoter, the yield of glycosylation was good (77%) but the 
stereoselectivity was very low (α/β=1.4:1). When glycosylation was performed using 
the glycosyl fluoride 223b and SnCl2-AgClO4 as promoter, the yield was also good 
(72%) and the α-anomer was exclusively obtained. In this case the glycosylation 
                                                 
189
 Goff, R.D.; Gao, Y.; Mattner, J.; Zhou, D.; Yin, N.; Cantu III, C.; Teyton, L.; Bendelac, A.; Savage, 
P.B. J. Am. Chem. Soc. 2005, 126, 13602–13603. 190
 Lee, Y. J.; Lee, B. Y.; Jeon, H. B.; Kim, K. S. Org. Lett. 2006, 8, 3971–3974. 191
 Kim, S.; Song, S.; Lee, T.; Jung, S.; Kim, D.; Synthesis, 2004, 6, 847–850. 192
 (a) Kim, K.S.; Kim, J.H.; Lee, Y.J.; Park, J. J. Am. Chem. Soc.  2001, 123, 8477–8481. (b) Kim, K.S.; 
Park, J.; Lee, Y.J.; Seo, Y.S. Angew. Chem. Int. Ed.  2003, 42, 459–462. 
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reaction appears to be more dependent on the leaving group in the glycosyl donor and 
on the reaction conditions than on the presence of the 4,6-benzylidene group.  
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Scheme 38 
 
A particular problem in the synthesis of glycans is the synthesis of α-2-deoxy-2-
aminoglycans that usually require starting from 2-azido-derivatives in order to avoid 
participating groups. However, the anomeric selectivity and yield of glycosylation 
varies greatly depending on the structure of donors and acceptors. Alternatives to 
circumvent this problem include the use of 2-nitro-glycals193 as glycosyl donors or 
using (1S)-phenyl-2-phenyl-2-(phenylsulfanyl)ethyl group at the C2- hydroxyl 
position.194 Recently, it has been demonstrated that the presence of a 4,6-O-di-tert-
butylsilylene group (DTBS) in galactosyl donors 227 allows the α-selective 
glycosylation of simple alcohols and carbohydrates to give 228 in excellent yields 
despite the presence of participating groups at the C2 position (Scheme 39).195 
Furthermore, the thio-glycoside 227 can be easily converted into other useful glycosyl 
donors 230, all of them with α-configuration.  
 
                                                 
193
 Winterfed, G.A.; Schmidt, R.R. Angew. Chem. Int. Ed. 2001, 40, 2654–2657. 194
 Kim, J. H.; Yang, H.; Park, J.; Boons, J. Am. Chem. Soc. 2005, 127, 12090–12097. 195
 (a) Imamura, A.; Ando, H.; Korogi, S.; Tanabe, G.; Muraoka, O.; Ishida, H.; Kiso, M. Tetrahedron 
Lett. 2003, 44, 6725–6728. (b) Imamura, A.; Ando, H.; Ishida, H.; Kiso, M.  Org.  Lett. 2005, 7, 4415–
4418. 
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Scheme 39 
 
This discovery has been recently applied to the synthesis of α-GalCer,196 and 
iGb3.197 Remarkably, ceramides 231 and 232 were glycosylated with the glycosyl donor 
230, which have a participating group at position 2 and trichloroacetimidate as a leaving 
group, to give the galactosyl ceramides 233 and 234, respectively, in 60% yield 
exclusively as the α-anomers (Scheme 40). The presence of benzoate groups in the 
carbohydrate and in the lipidic portion facilitates the deprotection process leading to α-
GalCer. 
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Scheme 40 
 
Similarly, the DTBS galactosyl donors 229 (Y=NHTroc, Z=, SPh, TCA) have 
also been successfully used in the synthesis of α-galactosaminyl Ser/Thr sequences, 
obtaining in most cases, yields higher than 88% and almost exclusively the α-isomer.196  
 
 
                                                 
196
 Imamura, A.; Kimura, A.; Ando, H.; Ishida, H.; Kiso, M. Chem. Eur. J. 2006, 12, 8862–8870. 197
 Kimura, A.;, Imamura, A.; Anfo, H.; Ishida, H.; Kiso, M. Synlett 2006, 2379–2382. 
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3.2.3 Recent contributions in the synthesis of β-glycosyl sphingosines and 
ceramides reported in the literature (2000-2007) 
 
3.2.3.1. Glycosylation of azidosphingosine 
 
β-Glucosyl- and β-galactosyl ceramides are frequently obtained by the 
azidosphingosine method, from glucose and galactose trichloroacetimidates protected 
with participating groups, mainly Ac, Bz, Piv (Scheme 41). The glycosyl-azido-
sphingosines obtained are further converted into the amino derivatives, which are 
amidated to afford the final product.  
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Scheme 41 
 
Glucosyl-sphingosine 237a was prepared in 56% yield by reaction of 235a with 
the azidosphingosine 29 in dichloromethane by using BF3·OEt2 as promoter.198 β-
Galactosyl-azidosphingosines 238 were prepared with the final objective of obtaining 
sulfated galactosyl ceramides. Thus, 238a was synthesized in 55% yield by reaction of 
236a (6-OH was protected with CH2COOMe in order to anchor the fluorescent dansyl 
group) with 29 using TESOTf as promoter.199 However, when a similar reaction was 
carried out from the pivaloyl derivative 236b and BF3·OEt2 as promoter 238b was 
obtained in an excellent 88% yield.200 After deprotection of the sugar moiety and 
reduction of the azido group, the saturated fatty acid chains were introduced and the 
                                                 
198
 Duclos, R.I. Chem. Phys. Lipids 2001, 111, 111–138. 199
 Franchini, L.; Compostella, F.; Donda, A.; Mori, L.; Colombo, D.; De Libero, G.; Matto, P.; 
Ronchetti, F.; Panza, L. Eur. J. Org. Chem. 2004, 4755–4761. 200
 Compostella, F.; Franchini, L.; De Libero, G.; Palmisano, G.; Ronchetti, F.; Panza, L. Tetrahedron 
2002, 58, 8703–8708. 
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resulting compound was selectively sulfated176 at position 3 of the sugar moiety to 
afford 241a-c (Figure 21). 
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Figure 21 
 
To assess the role of the position of the sulfate in CD1a-mediated T cell 
activation, the synthesis of three β-D-galactosylceramides, bearing a sulfate at position 
2, 4, or 6 of galactose was carried out. Trichloroacetimidate 242, with all the hydroxyl 
groups differentially protected, was reacted with 29 using TESOTf as activator to give 
the β-galactosyl-azidosphingosine 243 in excellent yield (86%) (Scheme42).201 
Compound 71 was further converted into the ceramides 239, 240 and 241c by selective 
deprotection and sulfation.  
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Scheme 42 
 
Trisaccharides isoglobotrihexose, and globotrihexose, which are very difficult to 
obtain either from natural sources or by chemical synthesis, were synthesized by using 
enzymatic procedures. The suitably protected free trisaccharide was transformed into 
the corresponding trichloroacetimidate 242 and coupled with azido sphingosine 199 in 
the presence of TMSOTf to give the protected ceramides 245 in excellent yield (92%) 
and selectivity (Scheme 43).202 When the trisaccharide was protected with benzoyl or 
acetyl groups yield decreased up to 75% and 48%, respectively.203 Removal of 
protecting groups under typical reaction conditions rendered iGb3 3 and Gb3 246. 
                                                 
201
 Compostella, F.; Ronchi, S.; Panza, L.; Mariotti, S.; Mori, L.; De Libero, G.; Ronchetti, F. Chem. Eur. 
J. 2006, 12, 5587–5595. 202
 Yao, Q.; Song, J.; Xia, C.; Zhang, W.; Wang, P.G. Org. Lett. 2006, 8, 911–914. 203
 Ohtsuka, I.; Hada, N.; Sugita, M.; Takeda, T. Carbohydr. Res. 2002, 337, 2037–2047. 
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Scheme 43 
 
Gangliosides are ubiquitously located in vertebrate cells and are particularly 
abundant in the nervous system. The synthesis of the glycosyl donor 247 started from 
glucosamine which was further transformed into a galactosamine derivative by inverting 
the configuration of 4-OH. Reaction of 29 with the glycosyl donor 247 activated by 
BF3·OEt2 afforded the β-linked glycosyl sphingosine derivative 248 in 36% yield 
(Scheme 44).204 Compound 248 was then converted into GM1a by azide reduction, 
coupling with octadecanoic acid, methanolysis and saponification of the methyl ester. 
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Scheme 44 
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In the synthesis of ganglioside GF3 the coupling between the oligosaccharide 
and azidosphingosine 29 was also carried out by activating with BF3·OEt2 the 
trichloroacetimidate 249, which is protected at positions 3 and 6 with acetate groups and 
at position 2 with a pivaloyl group. In this case the yield of glycosyl-sphingosine 250 
was 82% and only the isomer β was obtained (Scheme 45).205 Compound 250 was then 
transformed into 251 following the standard procedure. 
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Scheme 45 
 
The total synthesis of plakosides A, B, 255 and 258, which are prenylated and 
immunosuppressive marine galactosphingolipids, and their designed analogs was 
accomplished through an efficient and convergent strategy (Schemes 46 and 47). In this 
case the galactosyl fluoride 252 in the presence of SnCl2/AgClO4 was used for the 
glycosylation of sphinganine analogues 253 and 256.206 Yields were practically 
quantitative, showing also the efficiency of galactosyl fluorides for the synthesis of β-
galactosyl ceramides.  
 
                                                 
205
 Castro-Palomino, J.C.; Simon, B.; Speer, O.; Leist, M.; Schmidt, R.R. Chem. Eur. J. 2001, 7, 2178–
2184. 206
 Nicolaou, K.C.; Li, J.; Zenke, G. Helv. Chim. Acta 2000, 83, 1977–2006. 
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It can be concluded that trichloroacetimidates and fluorides are efficient glycosyl 
donors for glycosylation of azidosphingosine, and that better yields are obtained when 
there is a pivaloyl group at 2-OH of the carbohydrate. 
 
3.2.3.2. Glycosylation of ceramides 
 
The total synthesis of plakosides A 255 was also carried out by direct 
glycosylation of ceramide 260 with the galactosyl bromide 259 in the presence of 
Hg(CN)2 and MeNO2 affording the β-galactosyl ceramide 261 in 59% yield.207 2-
ClAcO was used in order to avoid the orthoester formation (Scheme 48). 
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Scheme 48 
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GalCer 264 is a water-soluble analogue of natural GalCer that contains either a 
hexanoic or a decanoic acyl unit and a saturated nine-carbon sphingosine moiety, and 
was prepared from Garner's aldehyde.208 These analogues were used to clearly establish 
the molecular basis for the selective recognition process between HIV-1 surface 
glycoprotein and GSL analogues within a GalCer monolayer. The authors provide 
evidence that this process involves conformations similar to the fundamental conformer 
of GalCer and demonstrate that the alkyl chains of the ceramide moiety are essential to 
the gp120 insertion into the monolayer. Glycosylation of ceramide 263 was carried out 
using penta-O-acetyl-galactose 262 as donor and BF3·OEt2 as promoter affording the 
glycosylated product in 64% yield, similar yields were obtained in other glycosylation 
procedures of ceramides (Scheme 49). The final GalCer 265 was obtained after removal 
of protecting groups. 
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Scheme 49 
 
In the course of studies oriented to the synthesis of α-GalCer, the reaction of the 
glycosyl donor 265 with the differentially protected phytosphingosines 266a,b was 
studied.209,210 It is well known that benzyl group is usually selected to protect the 2-OH 
position of glycosides to give α-glycosylation. However, unexpectedly it was observed 
that the stereoselectivity of the reaction depended on the protecting group at the 
ceramide moiety. Thus, α-anomer 267a was exclusively obtained from ceramide 266a 
with a benzoyl protecting group, while the β-anomer 267b was obtained when ceramide 
266b (R=Bn) was used as starting material (Scheme 50). It was suggested that 266a 
reacts in a SN1 manner (intermediate B), while when 266b is used an SN2 mechanism is 
                                                 
208 Villard, R.; Hammache, D.; Delapierre, G-; Fotiadu, F.; Buono, G.; Fantini, J. ChemBioChem 2002, 3, 
517–525. 209 Xia, C.; Yao, Q.; Schümann, J.; Rossy, E.; Chen, W.; Zhu, L.; Zhang, W.; De Libero, G.; Wang, P.G. 
Biorg. Med. Chem. Lett. 2006, 16, 2195-2199. 210 The use of  similar glycosyl donors for the glycosylation of azido-phytosphingosine has been recently 
reported. Lee, A.; Farrand, K.J.; Dickgreber, N.; Hayman, C.M.; Jürs, S.; Hermans, I.F.; Painter, G.F. 
Carbohydr. Res. 2006, 341, 2785–2798.  
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followed (intermediate A). An armed-disarmed effect in the ceramide moiety is 
suggested for explaining this behaviour. 
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Scheme 50 
 
Unprotected glycosyl-ceramides 274-277 were isolated from the metacestodes of 
Echinococcus multicularis (Scheme 51).211 Coupling between benzoyl protected 
oligosaccharidic thioglycosides 269-272 with ceramide 273 promoted by NIS/TfOH 
afforded the β-glycosides 274-277 in 44%, 33%, 54%, and 27% yield, respectively. The 
fully protected glycosides were deprotected to give the four target glycosphingolipids. 
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Scheme 51 
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3.2.3.3. Enzymatic procedures 
 
In recent years,212 biocatalysis has become an established technology for 
synthetic production of fine chemicals. Enzymes are applied for transformations leading 
to complex target molecules, mainly because of their high selectivity and mild 
operational conditions. Novel enzymes213 with improved properties are now accessible 
as a result of advances in high throughput screening methods, genomics, and rational 
protein design. Recently, GSL syntheses through enzymatic catalysis by glycosynthase, 
generated from endoglycoceramidase II (EGC II), has been described.214 By utilizing 
specific enzymatic catalysis, GSL 280 was obtained from the fluoride 278 and the salt 
279 in a high regio and stereoselective transformation (Scheme 52). 
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Scheme 52 
 
 The ability of glycosidases215 to use unactivated sugars and their broad 
specificity for aglycones, have limited synthetic applications, since, the native enzymes 
perform poorly in organic media, the thermodynamic considerations require the water 
content to be minimized for maximal yields, and are difficult to satisfy the divergent 
solvent requirements of hydrophilic sugar donors and hydrophobic acceptors. However, 
when the reaction is carried out in plasticized glasses, high concentrations of both 
acceptor and sugar donor enable obtainment of glycosides 281 and 282 in good yields 
and high selectivity (Figure 22).216 
 
                                                 
212
 Panke, S.; Held, M.; Wubbolts, M. Curr. Opin. Biotechnol. 2004, 15, 272–279. 213
 Panke, S.; Wubbolts, M. Curr. Opin. Chem. Biol. 2005, 9, 188–194. 214
 Vaughan, M. D.; Johnson, K.; DeFrees, S.; Tang, X.; Warren, R. A. J.; Withers, S. G. J. Am. Chem. 
Soc. 2006, 128, 6300–6301 215
 (a) Kren, V.; Thiem, J. Chem. Soc. Rev. 1997, 26, 463-474. (b) Drauz, K.; Waldmann, H. Enzyme 
Catalysis in Organic Synthesis, VHC, Weindmann, 1995. 216
 Gill, I.; Valivety, R. Angew. Chem. Int. Ed. 2000, 39, 3804–3808. 
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Figure 22 
 
3.2.4. Results 
 
3.2.4.1. Stannyl ceramides as efficient acceptors for synthesising β-
galactosyl ceramides 
 
With this back ground and with the goal to prepare β-glycosphingolipids, we 
glimpse a strategy involving coupling of α-galactosyl iodide and stannyl ether. The last 
one allows increasing the nucleophilicity of the oxygen without significant changes in 
the basicity. Stannyl ethers have been used in the synthesis of β-glycosides from 1,2-
anhydro-glucose (1,2-oxiranes)217 and from selenoglycosides.218 In this contex, we 
selected glycosyl iodides as the glycosyl donors because they can be activated by 
tetrabutylammonium iodide (TBAI), which can also activate the stannyl ether. 
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Scheme 53. Glycosilation-isomerization reation of BnOSnBu3 284 with the iodogalctose 283 
in the presencie of TBAI and TBDMSOTf to give 286 
                                                 
217
 (a) Danishefsky, S. J.; Gervay, J.; Peterson, J. M.; McDonald, F. E.; Koseki, K.; Griffith, D. A.; 
Oriyama, T.; Marsden, S. P. J. Am. Chem. Soc. 1995, 117, 1940–1953. (b) Liu, K. K.-C.; Danishefsky, 
S. J. J. Org. Chem. 1994, 59, 1895–1897. (c) Liu, K. K.-C.; Danishefsky, S. J. J. Am. Chem. Soc. 1993, 
115, 4933–4934. 218
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3867–3870. 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 92
Initially, we studied the reaction of tetra-O-acetyl-α-iodogalactose 283, prepared 
by reaction of penta-O-acetylgalactose 262 with TMSI, with the stannyl ether 284. We 
tried the reaction in toluene at 80 °C using TBAI as the catalyst, and we obtained the 
orthoester 285 (Scheme 53), which is the product usually obtained when the reaction is 
driven in neutral conditions. Treatment of 285 with tert-butyldimethylsilyl triflate 
(TBDMSOTf)219-220 afforded the β-O-glycoside 286 in 90% overall yield (Table 2, entry 
3). In the absence of TBAI, and in similar conditions, the reaction does not evolve 
(Table 2, entry 4). 
 
Table 2. Glycosylation-isomerization reaction of BnOSnBu3 284 with the iodogalactose 283 in the 
presence of TBAI and TBDMSOTf to give 286a 
 
Entry 
 
 
Solvent 
 
Bu4NI 
 
T (oC) 
 
Time 
(h) 
 
Yieldb 
(%) 
 
Ratio (α/β) 
 
1 
 
Toluene 
 
10 % 
 
rt 
 
24  
 
- 
 
- 
     
 
 
2 Toluene - rt 24  - - 
     
 
 
3 Toluene 10 % 80 18  90 0/1 
       
4 Toluene - 80 18  - - 
     
 
 
5 CH2Cl2 10 % reflux 18  95 0/1 
 
6 
 
 
CH2Cl2 
 
10 % 
 
rt 
 
24  
 
96 
 
0/1 
a
 Reaction conditions: 283 (1.2 mmol), 284 (1 mmol), and then TBDMSOTf (0.5 mmol), CH2Cl2 (20 
mL), 0 °C, 30 min. 
b Yields of isolated product after chromatographic purification and for the two steps. 
 
When the reaction was carried out in toluene at room temperature, only the 
starting material was recovered (Table 2, entries 1 and 2) and at 150 °C, decomposition 
products were observed in the crude reaction mixture. The reaction was then tried in 
CH2Cl2 at reflux in the presence of catalytic amounts of TBAI obtaining the orthoester 
285, which after treatment with TBDMSOTf gave 286 in 95% yield (Table 2, entry 5). 
Interestingly, the reaction also evolved at room temperature providing similar yields 
although in a longer reaction time (Table 2, entry 6). In both cases, the presence of 
TBAI was necessary for the reaction takes place. Finally, we tried the reaction with the 
                                                 
219
 (a) Kong, F. Carbohydr. Res. 2006, 342, 345–373. (b) López, J.C.; Agocs, A.; Uriel, C.; Gómez, 
A.M.; Fraser-Reid, B. Chem. Comm. 2005, 5088–5090. (c) Jayaprakash K.N.; Fraser-Reid, B. Org. 
Lett. 2004, 6, 4211–4214. 220
 For a review about the applications of sugar orthoesters in synthesis of oligosaccharies: Kong, F. 
Carbohydr. Res. 2006, 342, 345–373. 
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benzyl alcohol as the glycosyl acceptor in boiling dichloromethane and toluene, and 
neither the glycosylated product nor the orthoester were observed. It can be concluded 
that the use of TBAI and stannylether derivatives allow the efficient activation of 
disarmed glycosyl iodides affording the corresponding orthoester in excellent yields. 
This orthoester can be isomerized to the β-glycoside in excellent yields by using 
TBDMSOTf or BF3·OEt2. 
 
O
AcO
AcO
I
AcO
OAc
α isomer
283
O
AcO
AcO
O
OAc
β isomer
283
O
AcO
AcO O
O
OAc
O
O
AcO
AcO O
O
OAc
O
I
- I
TBDMSOTf
O
AcO
AcO O
O
OAc
O
O
AcO
AcO
AcO
OAc
286
O
285
I
O
Bu3Sn
I I
Bu3Sn
or
I II
 
 
Scheme 54. Proposed reaction mechanism 
 
Scheme 54 shows the proposed mechanism of the reaction, which must start by 
the attack of iodide anion to form the β-iodo-intermediate 283.221 In principle, it would 
be expected, according to the well known mechanism for orthoester formation, that 
intermediate I would be formed by intramolecular attack of the acetate group. But the 
fact that benzyl alcohol does not react in these conditions seems to indicate that the 
attack of iodide is faster, thereby making the reaction reversible. Then, it is reasonable 
to think that iodide, removed from 283 or from TBAI, will attack the tin in I or II to 
form the thermodynamically stable stannyl iodide, driving the reaction to the orthoester 
285 (Scheme 54). Consequently, TBAI should have two functions, to form the reactive 
β-iodo-glycoside and make the reaction irreversible.222 
Next we explored the reaction of the amide 288, a simplified model of 
ceramides, with the glycosyl donor 283 (Table 3). The reaction was carried out in 
                                                 
221
 Gervay, J.; Nguyen, T. N.; Hadd, M. J. Carbohydr. Res. 1997, 300, 119–125. 
222
 (a) Cruzado, C.; Bernabé, M.; Martin-Lomas, M. J. Org. Chem. 1989, 54, 465–469. (b) Harpp, D. N.; 
Gingras, M. J. Am. Chem. Soc. 1988, 110, 7737–7745. 
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dichloromethane and toluene at different temperatures and in the presence or absence of 
TBAI. When the reaction was carried out at room temperature in dichloromethane, the 
orthoester 289 was obtained, and a further treatment with TBDMSOTf or BF3·OEt2 
afforded 291 in 62 % yield for the two steps (Table 3, entry 1). The yield increased to 
88% (entry 2) when the reaction was heated to reflux. The best result, 93% yield, was 
obtained performing the reaction in toluene at 80 °C (entry 3). In this case the presence 
of TBAI was also necessary for the reaction to evolve (entry 4). These results contrast 
with those obtained in the glycosylation of ceramides using other common leaving 
groups such as trichloroacetimidate, iodide or bromide, where yields were lower than 
50%.166 It has been reported that the use of pivaloyl protecting groups avoids the 
formation of the orthoester.223 However, when started from the pivaloyl protected donor 
287, a mixture of orthoester 290 and the β-glycoside 292 was obtained, similar to that 
reported for related glycosyl donors.224 
 
Table 3. Synthesis of compound 291 by glycosylation of the stannyl amide 288 with the iodides 283 
in the presence of TBAI followed by isomerization 
 
 
O
RO
RO
I
O
R
OR
O
RO
RO O
O
OR
H
NO
O289 R=Ac
290 R=Piv
H
NBu3SnO
O
288
291 R=Ac
192 R=Piv
N
H
O
OO
RO
RO
O
R
OR
16
16
16
283 R=Ac
287 R=Piv
 
 
 
 
 
Entry 
 
 
Solvent 
 
Temp. (oC) 
 
Yield (%)b 
 
Ratio (α/β) 
 
1 
 
CH2Cl2 
 
Rt 
 
62 
 
0/1 
   
 
 
2 CH2Cl2 Reflux 88 0/1 
   
 
 
3 Toluene 80 93 0/1 
     
4c 
 
Toluene 80 - - 
a
 Reaction conditions: 283 (1.2 mmol), 288 (1 mmol), Bu4NI (0.10 mmol), 18 h and then BF3·Et2O (3 
mmol), CH2Cl2 (20 mL), rt, 3h. 
b Yields of isolated product after chromatographic purification and for the two steps. 
c In absence of TBAI 
 
                                                 
223
 (a) Pleuss, N.; Kunz, H. Angew. Chem. Int. Ed. 2003, 42, 3174-3176. (b) Herreus, A.; Kunz, H. 
Liebigs Ann. Chem. 1982, 41–48. 
224
 Perrie, J. A.; Harding, J.R.; King, C.; Sinnott, D.; Stachulski, A. V. Org. Lett. 2003, 5, 4545–4548. 
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Table 4. Glycosilation of 284 with the iodide 283 in presence of AgOTF to give 286 
 
 
O
AcO
AcO
I
O
283
Bu3SnO
284Ac
OAc
O
AcO
AcO O
Ac
OAc
O
286
AgOTf
CH2Cl2, 0oC
     30 mi.
 
 
 
 
 
Entry 
 
 
Equi. AgOTf 
 
Time (h) 
 
Yield (%)b 
 
Ratio α/β 
 
1 
 
 
1 
 
0.5 
 
63 
 
0/1 
2 
 
1 2  63 0/1 
3 
 
2 0.5 68 0/1 
4 
 
2 2 69 0/1 
5 
 
3 0.5 89 0/1 
6 
 
3 2  90 0/1 
7 
 
4 0.5 100 0/1 
a Reaction conditions: 283 (1.2 equiv), 284 (1 equiv), CH2Cl2 (15 mL), 0 °C, 30 min. 
b Yields of isolated product alter chromatographic purification. 
 
In this point of our research, we considerate the possibility to use other 
promoters. Therefore, a screen of alternative activator for glycosylation reaction was 
conducted, focusing on replacement of the TBAI with AgOTf. Thus, when the α-iodo-
galactose 263 was reacted with benzyl tributylstannyl ether 284 at 0 °C in the presence 
of AgOTf, the β-glycoside 286 was obtained in 63% yield after 0.5 hours (Table 4, 
entry 1). Longer reaction times did not affect the yield (entry 2). The equivalents of 
AgOTf have a strong influence in the yield and when 3 and 4 equivalents were used 
compound 286 was obtained in quantitative yield in a short time (Table 4, entries 3-5). 
The 1H NMR spectrum of the reaction crude showed exclusively the presence of the β-
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anomer, and the presence of orthoester, or elimination products was not observed. When 
the reaction was carried out with benzyl alcohol as glycosyl acceptor in the optimized 
conditions, only 42 % yield was obtained. These results indicated that stannyl ether is 
necessary to facilitate the reaction. 
Then, we tried to glycosylate the stannyl ether 288 (Scheme 55), using AgOTf as 
promoter. When the glalactosyl iodide 283 was reacted with 288 in the presence only of 
AgOTf a mixture of the orthoester 289 and the corresponding β-O-glycoside 291 (ratio 
1:2) was obtained, which was deduced from the 1H NMR of the reaction crude. The 1H 
NMR spectra show in particular δ 5.79 (1H, d, J=3.6 Hz, 1-H) and 1.6 (3H, s, methyl 
group), that can be attributed to ortoester 289. The mixture of 289 and 291 was treated 
with BF3·OEt2 to effect the rearrangement of 289 to 291 and the β-O-glycoside was 
obtained in 90% of overall yield (Scheme 55). Adding of Cl2Sn not seem to affect the 
ratio between 289 and 291, and the presence of 2,6-di-tert-butyl-4-methylpyridine 
(DTBMP) afforded the orthoester exclusively as a consequence of the decreasing of the 
acidity. It should be noted that pivaloyl-protected glycosyl donor does not prevent the 
formation of orthoester totally.223 
 
 
O
AcO
AcO
I
AcO
OAc
H
NBu3SnO
O
O
AcO
AcO O
O
OAc
H
NO
O
N
H
O
OO
AcO
AcO
AcO
OAc
 BF.EtO2
16
16
16
283
288
289
291
 AgOTf (3.0 equiv.), 
DTBMP (1.2 equiv.),
4-Å MS, CH2Cl2 ,
 
0oC, 3 h, and then rt, 3 h
CH2Cl2, 
0 °C, 3 h,
 90 % two steps
 
 
Scheme 55. Glycosylation of the stannyl ether 288 derived from β-amido alcohol 
 
To test the scope of these glycosylation protocols in the synthesis of biologically 
relevant glycolipids, glycosylation of azidosphingosine, ceramide and analogues was 
tested (Table 5). Thus, when the stannyl ether 293, a ceramide analogue, was reacted 
with 283 following the general protocol of glycosylation employing TBAI as promoter 
the orthoester was exclusively obtained, which was treated with BF3·OEt2 affording the 
glycolipid 294 in 93 % yield. Similar yields were obtained when AgOTf was used as 
promoter (Table 5, entry 1). 
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Table 5. Glycosilation of 293, 295 and 297 using 283 as glycosyl donor and TBAI or AgOTf as 
promoters to afford the orthoester followed by isomerizationo to give the glycolipids 294, 296, 298 
and 299 
 
Entry 
 
 
Stannylated glycosyl acceptor 
 
Glycolipid 
 
Promoter 
 
Yield 
(%)c 
 
 
1 
 
 
 
 
 
 
N
O
Bu3SnO
293
 
 
 
O
O
O
AcO
AcO
OAc
OAc
N
294
 
 
 
TBAIa 
 
 
 
93 
AgOTfb 
 
91 
2 
 
 
 
 
O
N3
O
Sn
Bu Bu
295
 
N3
O
OH
O
AcO
AcO
OAc
OAc
296
 
TBAIa 
 
94 
AgOTfb 
 
93 
3 
 
 
 
 
HN
O
O
Sn
O
Bu Bu
297
 
HN
O
O
OH
O
AcO OAc
AcO
OAc
298
 
TBAIa 
 
90 
AgOTfb 
 
90 
4 
 
 
 
 
 
HN
O
O
Sn
O
Bu Bu
297
 
HN
O C13H27
O
OH
OO
OAc
AcO
OAc
O
AcO OAc
AcO
AcO
16
299
 
TBAIa 
 
90 
AgOTfb 
 
88 
a
 Reaction conditions: 283 (1.2 mmol), 293, 295 or 297 (1 mmol), Bu4NI (0.10 mmol), 18 h and then 
BF3·Et2O (3 mmol), CH2Cl2 (20 mL), rt, 3 h. b Reaction conditions: 283 (1.2 mmol), 293, 295 or 297 
(1mmol), AgOTf (3.0 mmol), DTBMP (1.2 mmol), 4-Å MS, CH2Cl2 (20 mL), 0°C for 3 h, after 3 h, 
and then BF3·Et2O (3 mmol), CH2Cl2 (15 mL), rt, 3 h.  
b Yields of isolated product after chromatographic purification and for the two steps, glycosylation and 
isomerization 
 
The classical protocol for selective glycosylation of diols, require a series of 
programmed protection-deprotection steps to ensure that only one of the hydroxyls 
reacts. Azido-sphingosine has two hydroxyl functions in positions 1,3 that can be 
simultaneously protected as stannyl acetal. When stannyl acetal 295, obtained from 
azidosphingosine by reaction with Bu2SnO with water exclusion, was reacted with 283 
in the standard conditions the β-O-glycoside 296 was obtained in 94 % yield after 
orthoester isomerization. Also in this case, the use of AgOTf as promotor afforded 
similar yields (Table 5, entry 2). The reaction was fully chemo and stereoselective by 
involving exclusively the primary hydroxyl group. Similarly, the stannyl acetal 297, 
obtained by reaction of ceramide and Bu2SnO, was also reacted with the glycosyl iodide 
283 in the presence of TBAI or AgOTf, and then the corresponding reaction products 
were treated with BF3·OEt2 to obtain the galactosyl ceramide 298 in 90 % yield. Also in 
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this case the reaction was fully chemo and stereoselective (Table 5, entry 3). Finally, 
glycosilation of 297 with the corresponding hepta-O-acetyllactosyl iodide in the 
presence of TBAI or AgOTf, also afforded corresponding glycolipid 299 in excellent 
yield (90%) after orthoester isomerization. The overall process takes place with 
complete chemo and stereoselectivity (Table 5, entry 4). Pleasingly, all these results are 
close to the obtained by enzymatic procedures by using glycosyl fluorides as glycosyl 
donors.225. In all cases when the reaction crudes were analyzed by 1H NMR no α 
anomer or the corresponding elimination product (glycal) were observed. 
Alternatively, we also investigated the reactivity of stannyl ethers with various 
leaving groups such as bromide, fluoride, trichloroacetimidate and acetate in the 
appropriate reaction conditions. This study focused in the use of stannyls ethers and 288 
and 297, which were reacted with glycosyl donors 300-302 and 262 (Table 6). It was 
expected that the bromo derivative 300 will behaves similarly to iodo derivative 283 
when AgOTf will be used as promotor. Effectively, when 300 was reacted with the 
stannyl ether 288 a mixture of galactoside 291 and the orthoester 289 was obtained. 
Further isomerization by treatment with BF3·OEt2, exclusively affoded the β-
galactoside 291 in yield similar to the obtained starting from α-iodo-galactose (Table 6, 
entry 1).  
Using the glycosyl fluoride 301 as donor, the stannyl ethers 288 and 297 as 
acceptors and the couple SnCl2/AgOTf as promoter β-glucosides 291 and 298 together 
with the respective orthoesters, were also obtained. In the presence of BF3·OEt2 these 
mixtures evolved to compounds 291 and 298, which were obtained in high yields and 
exclusive as β-anomers (Table 6, entries 3 and 4,). When the trichloroacemidate 302 
was used as donor the glycosylation of 288 and 297 in the presence of BF3·OEt2 
afforded the orthosters as major products, in spite of the presence of subestequiometrics 
amounts of BF3·OEt2. The orthoester was, however, then isomerized in good yields to 
give the β-anomer by adding additional amounts of BF3·OEt2 (Table 6, entries 5 and 6,).  
The reaction of penta-O-acetyl-β-D-galactopyranose 262, a readily accessible 
glycosyl donor, was also probed with with the stannylated acceptors 288 and 297 in the 
presence of large excess of BF3·OEt2 which afforded directly the β-glycoside 291 in 
(76%) and 298 (70%). In this case the O-glycosides were obtained only in moderate 
yields due to the side reactions; the acetates groups are hydrolyzed to give the partially 
                                                 
225
 Vaughan, M.D.; Johnson, K.; DeFrees, S.; Tang, X.; Warren, R.A.J.; Withers, S.G. J. Am. Chen. Soc. 
2006, 128, 6300–6301. 
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deprotected compound (Table 6, entries 7 and 8,). These results reveal that stannyl 
ethers exhibit enhancement of the nucleophilicity of hydroxyl group, properties that 
make them react with unique selectivity with a variety of leaving groups. Despite the 
stannyl ethers are basic molecules with lower reactivity than the common alkoxide, no 
elimination product (glycal) were observed. 
 
Table 6. Examination of various glycosyl donors-promotors pairs in glycosilation of ceramidesa 
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O
AcO
AcO
X
AcO
OAc
298
288 297
1.0 equiv1.0 equiv.
300  X = Br        302  X = TCA
301  X = F         262  X =  AcO
1.2 equiv
N
H
O
OO
AcO
AcO
AcO
OAc
16
291
HN
O C13H27
O
OH
O
AcO OAc
AcO
OAc
16
 
 
 
 
Entry 
 
 
Acceptor 
 
Donor 
(X) 
 
 
Promoter 
 
Time 
(h) 
 
Product  
 
 
Yield (%)a 
 
1 
 
 
288b 
 
300 (Br) 
 
AgOTf  
(3 mmol) 
 
 
5 
 
291 
 
88 
2 
 
2997b 300 (Br) AgOTf  
(3 mmol) 
 
5 298 85 
3 
 
288c 301 (F) SnCl2/AgOTf  
(3 mmol) 
 
3 291 91 
4 
 
297c 301 (F) SnCl2/AgOTf  
(3 mmol) 
 
3 298 90 
5 
 
288d 302 (TCA) BF3·OEt2 
(0.5 mmol) 
 
3 291 85 
6 
 
297d 302 (TCA) BF3·OEt2 
(0.5 mmol) 
 
3 298 82 
7c 
 
288e 262 (OAc) BF3·OEt2 
(6 mmol) 
 
4 291 73 
8c 
 
297e 262 (OAc) BF3·OEt2 
(6 mmol) 
 
4 298 70 
aYields of isolated product after chromatographic purification and for the two steps. For conditions see: 
bRef. 226, cref. 227, dref. 228, and eref. 229. 
 
 
                                                 
226
 Hanessian, S.; Banoub, J. Carbohydr. Res. 1977, 53, C13–C16 
227
 (a) Mukaiyama, T.; Murai Y.; Shoda, S. Chem. Lett. 1981, 431–432. (b) Ogawa T.; Takahashi, Y. 
Carbohydr. Res. 1985, 138, C5–C9. (c) Nicolaou, K. C.; Li J.; Zenke, G. Helv. Chim. Acta 2000, 83, 
1977–2006. (d) Seki, M.; Kayo A.; Mori, K. Tetrahedron Lett. 2001, 42, 2357–2360. 
228
 (a) Schmidt R. R.; Michel, J. Angew. Chem. Int. Ed. Engl. 1980, 19, 731–732. (b) Compostella, F.; 
Franchini, L.; De Libero, G.; Palmisano, G.; Ronchetti F.; Panza, L. Tetrahedron 2002, 58, 8703–8708. 
229
 (a) Dahmen, J.; Frejd, T.; Magnusson G. Noori, G. Carbohydr. Res. 1983, 114, 328–330. (b) Villard, 
R.; Hammache, D.; Delapierre, G.; Fotiadu, F.; Buono G.; Fantini. J. ChemBioChem. 2002, 3, 517–525. 
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Table 7. Synthesis of compound 291 by glycosylation fo stannyl amide 288 with iodide 283 in the 
presence of TBAI and 4Å AW 300 MSa 
 
 
O
AcO
AcO
I
AcO
OAc H
NBu3SnO
O N
H
O
OO
AcO
AcO
AcO
OAc
16
16
288283 291
TBAI (1.0 equiv.)
4Å AW 300 MS
 
 
 
 
 
Entry 
 
 
AW 300MS (g) 
 
Solvent 
 
Temp/°C 
 
Time (h) 
 
Yield (%)b 
 
1 
 
 
0.2 
 
Toluene 
 
80 
 
18 
 
22 
2 
 
0.4 Toluene 80 18 35 
3 
 
0.6 Toluene 80 18 37 
4 
 
0.8 Toluene 80 18 42 
5 
 
1 Toluene 80 18 48 
6 
 
1.2 Toluene 80 18 64 
7 
 
1.2 Toluene rt 18 25 
8 
 
1.2 CH2Cl2 reflux 18 50 
9 
 
1.2 CH2Cl2 rt 18 29 
10 
 
1.2 Et2O reflux 18 35 
11 
 
1.2 Et2O rt 18 15 
a Conditions: 283 (0.366 mmol), ratio 283/288/TBAI=1.2:1:1 
bYields of isolated product after chromatographic purification. 
 
 
 
Traditionally, the rearrangement of ortho ester has been carried out by strong 
and moisture sensitive Lewis acids, including TMSOTf, 219-220 BF3·Et2O, 219-220 
TBSOTf,230 Yb(OTf)3,231  and more recently AuCl3232 under strictly anhydrous 
                                                 
230
 Mathew, F.; Mach, M.; Hazen, K. C.; Fraser-Reid, B. Synlett 2003, 1319–1322. 
231
 Fraser-Reid, B.; Chaudhuri, S. R.; Jayaprakash, K. N.; Lu, J.; Ramamurty, Ch. V. S. J. Org. Chem. 
2008, 73, 9732–9743. 
232
 Sureshkumar, G.; Hotha, S. Chem. Comm. 2008, 4282–4284. 
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conditions. In this context, it was recently observed that activated 4 Å acid washed 
molecular sieves (4Å AW MS or AW 300), also catalyzed this rearrangement.233 Other 
studies indicated that AW 300 can both play the usual role of drying agents and 
promote234 in the synthesis of trisacharides.235 We hence sought to exploit the 
application of heterogeneous solid acid promoter to tackle the direct glycoslylation of 
ceramides. We describe here that β-O-galactosyl ceramides can be obtained in one-pot 
manner from 2,3,4,6-tetra-O-acetylgalactosyl iodide and stannyl ceramides in the 
resence of TBAI and AW300 MS. 
The effectiveness of AW 300 as a glycosylation promoter was first tested by 
triggering the model experiment of donor tetra-O-acetyl-α-iodogalctose 283 with 
stannyl ceramide 288 in the presence of TBAI (1.0 equiv.) to give the glycosphingolipid 
291 (Table 7). Thus, we started the screening with a relation of 0.2, 0.4, 0.6, 0.8 and 1.0 
g of AW 300/1.0 mmol of stannyl ceramide 288 in toluene at 80 °C (Table 7, entries 1-
5). This initial experiment gave only low yield until to our delight; we found that the 
corresponding β-glycoside was obtained in good yield and high stereoslective when 1.2 
g of AW 300 was used (Table 7, entry 6). Encouraged by the success of this reaction, 
we next examined the effects of temperature and solvents. As depicted in Table 7, the 
reaction conducted in CH2Cl2 at reflux gave good yield (50%, entry 8). When the 
reaction was performed in Et2O, the glycolipid 291 was obtained in 35% yield (Entry 
10). The yield was dramatically decreased by lowering the reaction temperature under 
the same reaction conditions in CH2Cl2 and toluene (Table 7, entries 7 and 9). The use 
of AW 300 makes the workup procedure very simple; the solid was easily separated 
from reaction mixture by a simple filtration. 
 
 
With these results in hand, we tried to extend this methodology to other aceptors 
and donors (Table 8). Thus, ceramide 293 could be also glyosilated with donor 283 
under the same reaction conditions used for 288 giving the glycosphingolipid 294 in 
good yield (65 %, Table 7, entry 1). Reactions conducted with ceramide 297 provide the 
β-GalCer 298 in 60% yields (Table 7, entry 2). As illustrated in Table 7, reactions 
performed with hepta-O-acetyllactosyl iodide as donor afforded the corresponding 
                                                 
233
 Rabiad, A.; Liu, X.; Kovacs, L.; Seeberger. P. H. Org. Lett. 2006, 8, 1815–1818. 
234
 Adinolfi, M.; Barone, G.; Iadonisi, A.; Schiattarella, M. Org. Lett. 2003, 5, 987–989. 
235
 Adinolfi, M.; Iadonisi, A.; Ravidà, A.; Schiattarella, M. J. Org. Chem. 2005, 70, 5316–5319. 
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glycosphingolipid 299 in moderate yield with high stereoselectivity (60 %, Table 8, 
entry 3).  
 
 
Table 8. Glycosilation of 293, and 297 using 283 as glycosyl donor in the presence of TBAI and 4Å 
AW 300 MS to give the glycolipids 294, 298 and 299a  
 
Entry 
 
 
Stannylated glycosyl acceptor 
 
Glycolipid 
 
Ratio 
(α/β) 
 
Yieldb 
(%)c 
 
 
1 
 
 
 
 
N
O
Bu3SnO
293
 
 
O
O
O
AcO
AcO
OAc
OAc
N
294
 
 
 
0/1 
 
 
 
65 
 
3 
 
 
 
HN
O
O
Sn
O
Bu Bu
297
 
HN
O
O
OH
O
AcO OAc
AcO
OAc
298
 
 
0/1 
 
60 
 
3 
 
 
 
 
HN
O
O
Sn
O
Bu Bu
297
 
HN
O C13H27
O
OH
OO
OAc
AcO
OAc
O
AcO OAc
AcO
AcO
16
299
 
 
0/1 
 
60 
a
 Reaction conditions: 283 (1.2 mmol), 293, or 297 (1 mmol) and 4-Å AW 300 MS (1200 mg), in toluene 
(10 mL), 80 °C for 18 h. b Yields of isolated product after chromatographic purification. 
 
 
 
In an attempt to promote the rearrangement of ortho ester in situ, various acids 
and conditions were tested: TfOH, TMSOTf, TBSOTf, BF3·Et2O (Table 9). Although 
no glycoside with 0.2-1.0 equiv of these Lewis acids was observed, the use of BF3·Et2O 
was found successful but no equally effective tan AW 300. In this case, two equiv of 
BF3·Et2O was necessary to obtain 20 % yield.  
 
 
Table 9. Synthesis of compound 291 by glycosylation fo stannyl amide 288 with iodide 283 in the 
presence of TBAI and different Lewis acidsa 
 
Entry 
 
 
Acid 
 
Equiv. 
 
Product observed 
 
Yieldb (%) 
 
Ratio (α/β) 
 
1 
 
TfOH 
 
0.2 
 
Orthoester 289 
 
90 
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2 TfOH 0.4 Orthoester 289 90  
3 TfOH 0.8 Orthoester 289 90  
4 TfOH 1 Side products -  
5 TMSOTf 0.2 Orthoester 289 90  
6 TMSOTf 0.4 Orthoester 289 90  
7 TMSOTf 0.8 Orthoester 289 85  
8 TMSOTf 1 Side products -  
9 TBSOTf 0.2 Orthoester 289 90  
10 TBSOTf 0.4 Orthoester 289 80  
11 TBSOTf 0.8 Orthoester 289 75  
12 TBSOTf 1 Glycolipid 291 10 0/1 
13 BF3·Et2O 0.2 Orthoester 289 90  
14 BF3·Et2O 0.4 Orthoester 289 90  
15 BF3·Et2O 0.8 Orthoester 289 90  
16 BF3·Et2O 1 Orthoester 289 and 
glycolipid 291 
85:5  
17 BF3·Et2O 1.5 Glycolipid 291 10 0/1 
18 BF3·Et2O 2 Glycolipid 291 15 0/1 
19 
 
BF3·Et2O 3 Glycolipid 291 20 0/1 
a
 Reaction conditions: 283 (1.2 mmol), 288 (1 mmol) in toluene (10 mL), 80 °C for 18 h. b Yields was 
determinate by 1H NMR. 
 
 
3.2.5. Synthesis of iGb3  
 
The synthetic utility of the new approach was further demonstrated by the rapid 
access to isoglobotrihexosylceramide 3 (iGb3). The donor 305 and stannyl ceramide 
306 would serve as the building blocks for glycosylation. Thus, isoglobotrihexose 303 
was treated with acetic anhydride and pyridine in presence of catalytic DMAP to 
provide the peracetylated trisaccharide 304 in 98% yield. Then, the iodide donor 305 
was generated in situ from 304. Finally, treatment of 307 with 306 in the presence of 
TBAI and AW 300, followed by the elimination of the acetate groups furnished iGb3 3 
in 60 % yield as unique anomer. The spectroscopic data of 1H and 13C NMR for 3 were 
consistent with data reported for the synthetic product236 (Scheme 56). 
 
                                                 
236
 Yao, Q.; Song, J.; Xia, Ch.; Zhang,; W.; Wang, P. G.; Org. Lett. 2006, 8, 911–914. 
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Scheme 56. Synthesis of iGB3
 
 
3.2.6. Synthesis of KRN7000 
 
Since the isolation of a group of marine 
galactosyl ceramides in the 1990s from Agelas 
mauritianus,237 and subsequent synthesis of 
analogues,238 this family has been a subject of 
great interest because of the potent antitumor 
activity found in vivo at the organism level and 
because the galactosyl ceramides contained α-
glycosidic bonds between the sugar and 
ceramide, illustrated by agelasphin-9b 308 and 
KRN700 309 (Figure 23), despite being 
naturally occuring compounds, are in general not found in higher organisms, that is, are 
not natural products of mammalian cells.  
At the molecular level, glycolipid 309 has been shown to act as a connecting 
ligand presented by the CD1d molecule of antigen-presenting cells to the murine Vα14 
                                                 
237
 (a) Natori, T.; Koezuka, Y.; Higa, T. Tetrahedron Lett. 1993, 34, 5591–5592. (b) Akimoto, K.; Natori, 
T.; Morita, M. Tetrahedron Lett. 1993, 34, 5593–5596. (c) Natori, T.; Morita, M.; Akimoto, K.; 
Koezuka, Tetrahedron 1994, 50, 2771–2784. 
238
 Franck, R.W.; Tsuji, M. Acc. Chem. Res. 2006, 39, 692–701. 
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Figure 23. α-Glycosphingolipids 
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receptor and the human Vα24 receptor of natural killer T (NKT) cells. Upon 
recognition of the galactosyl ceramide in the context of CD1d, the NKT cell then is 
stimulated to produce interferon-γ (IFN-γ), interleukin-4 (IL-4), and interleukin-2 (IL-
2).239 Other exploration of the biological effects of KRN7000 has unveiled its 
remarkable activity against a group of disease, such as cancer,240 malaria,241 juvenile 
diabetes,242 hepatititis B,243 and autoimmune encephalomyelitis.244 
Gervay-Hague recently demonstrated the effectiveness of α-glycosyl iodides in 
the synthesis of α-galactosyl 
azidosphingolipids182 and α-
GalCer.245 In the case of α-GalCer, 
per-O-silylated galactosyl iodide 
donor 311 and an unprotected 
ceramide acceptor were used under 
microwave conditions. The reaction 
proceeded with complete 
stereoselectivity and a remarkable 
67% yield for the synthesis of 
KRN7000 309. However, in our 
hands, this procedure (TBAI, DIPEA, 
CH2Cl2, 120 °C, 300 W, 2 h) proved 
ineffective for the preparation of 
simple α-GalCer analogues such as 313 starting from per-O-silylated galactosyl iodide 
311 and acceptor 288 (Scheme 57). Under these conditions, the expected product was 
obtained in only 10% yield (α/β ratio 87:13). 
                                                 
239
 (a) Brigl, M.; Brenner, M. B. Annu. Rev. Immunol. 2004, 23, 817–890. (b) Zhou, D.; Mattner, J.; 
Cantu, C., 3rd; Schrantz, N.; Yin, N.; Gao, Y.; Sagiv, Y.; Hudspeth, K.; Wu, Y. P.; Yamashita, T.; 
Teneberg, S.; Wang, D.; Proia, R. L.; Levery, S. B.; Savage, P. B.; Teyton, L. Science 2004, 306, 
1786–1789. 
240
 (a) Kikuchi, A.; Nieda, M.; Schmidt, C.; Koezuka, Y.; Ishihara, S.; Ishikawa, Y.; Tadokoro, K.; 
Durrant, S.; Boyd, A.; Juji, T.; Nicol, A. Br. J. Cancer 2001, 85, 741–746.  
241
 Gonzalez-Aseguinolaza, G.; de Oliveira, C.; Tomaska, M.; Hong, S.; Bruna-Romero, O.; Nakayama, 
T.; Taniguchi, M.; Bendelac, A.; Van Kaer, L.; Koezuka, Y.; Tsuji, M. Proc. Natl. Acad. Sci. USA 
2000, 97, 8461–8466. 
242
 (a) Hong, S.; Wilson, M. T.; Serizawa, I.; Wu, L.; Singh, N.; Naidenko, O. V.; Miura, T.; Haba, T.; 
Scherer, D. C.; Wei, J.; Kronenberg, M.; Koezuka, Y.; Van Kaer, L. Nat. Med. 2001, 7, 1052–1056. 
243
 Kakimi, K.; Guidotti, L. G.; Koezuka, Y.; Chisari, F. V. J. Exp. Med. 2000, 192, 921–930. 
244
 Miyamoto, K.; Miyake, S.; Yamamura, T. Nature 2001, 413, 531–534. 245
 Du, W.; Kulkarni, S.S.; Gervay.Hague, J. Chem. Commun. 2007, 2336–2338. 
O
O
OHHO
HO
HO
HO
N
H
OTMS
O
OTMSTMSO
TMSO
TMSO
I
O
OTMSTMSO
TMSO
TMSO
O
16
Bu3SnO N
H
O
16
N
H
O
16
      TMSI
     CH2Cl2
 0 OC, 10 min
SnBu3
  TfOH
Toluene
  rt, 2 h
1) TBAI, 4A MS
 
2) MeOH, Dowex 50WX8-200
         Reflux, 45 min.
310
311
312
288
313
 
 
Scheme 57. Glycosylation reaction of 42 with the 
iodogalactose 62 in the presence of TBAI 
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In an effort to improve the yield of the direct glycosylation reaction, we applied 
our experience with stannyl ethers in the glycosylation of ceramides to give β-
glycolipids in the synthesis of α-glycolipids. This procedure involves the reaction of 
tetra-O-acetyl-α-galactosyl iodide with stannyl ceramides in the presence of TBAI as 
activator to give β-GalCer analogues in high yield with complete stereoselectivity. 
TBAI inverts the configuration of the anomeric iodine to afford the highly reactive β-
glycosyl iodide. We show herein a new glycosylation protocol providing α-GalCer 
analogues, and particularly KRN7000 309. This method activates classically reluctant 
acceptors such as amido alcohols and ceramides as stannyl derivatives in the TBAI-
promoted glycosylation with glycosyl iodides 311. 
 
Table 10. Synthesis of compound 313 by glycosylation of stannyl amide 288 with iodides 
a α-Galactosyl iodide: TMSO-Gal (1eq), TMSI (1eq), CH2Cl2, 0 ºC, 10 min; Stannyl ether: amide (1eq), 
Bu3SnCH2CH=CH2 (1.3eq), TfOH (0.3eq), rt, 2 h.  
b
 Determined by integration of the anomeric proton signals in the 1H NMR spectrum of the crude reaction 
mixture.  
c
 Addition of the α-Galactosyl iodide over the stannyl ether for 3 h.  
d
 Addition of the stannyl ether over the α-Galactosyl iodide for 3 h. e Dowex 50WX8-200, MeOH, rt, 4 h. 
 
The glycosylation reaction conditions were optimized by starting from amido 
alcohol 312 (Scheme 57), which was converted into stannyl ether 288 to increase the 
nucleophilicity of the oxygen atom without significantly changing the basicity.218 
Initially, the reaction of 288 with α-iodogalactose 311 in the presence of TBAI was 
carried out in CH2Cl2 at room temperature (Table 10, entry 1). After hydrolysis by using 
Dowex 50WX8–200, isomer 313α was obtained as the major product in a modest 25% 
yield. Next, we tried the reaction in toluene at 110 °C for 5 h in the presence of TBAI, 
but unexpectedly, the yield remained moderate (Table 10, entry 2). To our delight, 
however, we found that the order of addition of the reagents was important; specifically, 
we found that by adding the galactosyl iodide over the stannyl ether in toluene at 110 °C 
afforded the expected glycoside in an excellent overall yield of 95% and 88:12 α/β ratio 
 
Entry 
 
 
Reaction conditionsa (eq) 
 
Yield% 
 
α/βb ratio 
 
1 
 
 
TBAI (2), 4Å MS, CH2Cl2, rt, 48 h 
 
25 
 
92:8 
2c 
 
TBAI (2), 4Å MS, toluene, 110 ºC, 5 h 47 89:11 
3d,e 
 
TBAI (2), 4Å MS, toluene, 110 ºC, 18 h 95 88:12 
4 
 
TBAI (2), 4Å MS, toluene, 80 ºC, 18 h 98 97:3 
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(Table 10, entry 3). Moreover, when the reaction was performed at 80 °C, the glycoside 
was obtained in almost quantitative yield with excellent selectivity (α/β ratio 97:3; 
Table 9, entry 4). 
The highly stereoselective glycosylation method described above offers a very 
efficient and direct synthesis of unprotected α-glycolipids. To further demonstrate its 
synthetic value, we showed that the method can be used to rapidly prepare the 
biologically active compound KRN7000 309 (Scheme 58). The reaction of the stannyl 
derivative of ceramide 314 with donor 311 was performed under optimized reaction 
conditions. After hydrolysis of protecting groups by using acidic resin, final product 
309 was obtained in 90% yield with complete α-selectivity. The overall process takes 
place with complete chemoselectivity (differentiation of the primary and secondary OH 
at the lipid moiety) and stereoselectivity (α-anomer only). 
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O
O
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Scheme 58. Direct glycosylation of phitosphingosine to obtain KRN7000 
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3.2.5. Experimental Part 
 
 
General methods 
 
All reactions were conducted under a dried argon stream. Solvents (CH2Cl2 
99.9%, toluene 99.9%) were purchased in capped Pure Solv System-4® bottles and used 
without further purification and stored under argon. Yields refer to the 
chromatographically and spectroscopically (1H and 13C) homogeneous materials, unless 
otherwise stated. TMSI was stored at –15°C under desiccated atmosphere. All other 
solvents and reagents were used without further purification. All glassware utilized was 
flame-dried before use. Reactions were monitored by TLC carried out on 0.25 mm E. 
Merck silica gel plates. Developed TLC plates were visualized under a short-wave UV 
lamp and by heating plates that were dipped in ethanol/H2SO4 (15:1). Flash column 
chromatography (FCC) was performed using flash silica gel (32–63 µm) and employed 
a solvent polarity correlated with TLC mobility. Melting points, determined with 
Reichert apparatus, are uncorrected. Optical rotations were measured at 598 nm on a 
Jasco DIP-370 digital polarimeter using a 100 mm cell. NMR experiments were 
conducted on a Varian 400 MHz instrument using CDCl3 (99.9% D) as the solvent, with 
chemical shifts (δ) reference to internal standards CDCl3 (7.26 ppm 1H, 77.23 ppm 13C) 
or Me4Si as an internal reference (0.00 ppm) Chemical shifts are relative to the 
deuterated solvent peak and are in parts per million (ppm). 
 
Experimental Procedures 
 
Synthesis of N-(2-hydroxyethyl)stearamide 
 
H
N
HO
OO
Cl
HO NH2
CH2Cl2
R.T., 4 h
95 %
 
A solution of stereoyl chloride (50 g 0.165 mol) in 250 mL of dry CH2Cl2 was 
cooled to 0°C. To this solution 2-amino ethanol (100.78 g, 1.65 mol) was added in a 
slow drop-wise manner over a period of 30 min, resulting in the precipitation of a white 
solid. The reaction was stirred for 4 h at room temperature and then the mixture was 
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filtered. The solid was washed with hexane and diethyl ether and dried in vacuo. The 
resulting crystalline material was recrystallized from CH2Cl2 to give 51.26 g of pure N-
(2-hydroxyethyl)stearamide (95%) as a white solid246 that was homogeneous. TLC 
(Hexane-AcOEt-MeOH 60:30:10) Rf 0.25; m.p. 53–55 °C; 1H NMR (400 MHz, CDCl3): 
δ. 5.94 (1H, br. s), 3.72 (2H, t, J=5.2 Hz), 3.42 (2H, td, J=5.2, 1 Hz), 2.18 (2H, t, J=7.2 
Hz), 1.62 (2H, quint, J=7.2 Hz), 1.28 (28H, m), 0.87 (3H, t, J=6.8 Hz); 13C NMR (100.6 
MHz, CDCl3): δ 172.6, 61.0, 41.6, 36.5, 31.8, 29.5, 28.6, 25.6, 22.7, 14.1. Anal. Calcd. 
for C20H41NO2: C, 73.34; H, 12.62; N, 4.28. Found: C, 73.30; H, 12.69; N, 4.20. 
 
Synthesis of N-(2-hydroxyethyl)-N-octadecylstearamide 
 
H
NHO
H
N
HO
O
LiAlH4, THF
N
O
HO
HO
O
  Reflux, 18 h
HOBt, EDC, CH2Cl2
        R.T. 18 h
     80 % 2 steps
 
 
A 250 mL, three-necked, roundbottomed flask was fitted with a heating bath, 
mechanical stirrer, reflux condenser with drying tube, and a stoppered, pressure-
equalizing dropping funnel, flushed with nitrogen or argon, and charged with 75 mL of 
dry THF, and LiAlH4 (1.45 g, 38.22 mmol). A mixture of 75 mL of THF and N-(2-
hydroxyethyl)stearamide (10 g, 30.58 mmol) was added, with stirring, at a rate 
sufficient to reach and maintain refluxing. After the addition was completed, the 
reaction mixture was kept boiling for 18 h. The flask was immersed in an ice bath, and 
30 mL of water, 15 mL of 10% aqueous potassium hydroxide, and again 30 mL of 
water were added cautiously with very vigorous stirring. The reaction mixture was 
stirred for an additional 1h, filtered with suction, and the solid was washed with several 
100-mL portions of ethyl acetate. The two layers were separated, and the aqueous phase 
was extracted with ethyl acetate (3 x 100 mL). The combined organic layers were dried 
                                                 
246
 Eliash, R.; Weissbuch, I.; Weygand, M.J.; Kjaer, K.; Leiserowitz, L.; Lahav, M. J. Phys. Chem. B, 
2004, 108, 7228–7240. 
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over anhydrous sodium sulphate and concentrated in vacuo to get crude residue of 2-
(ocatadecylamino) ethanol as a white solid (6.7 g, 70%).247 
A solution of 2-(octadecylamino) ethanol (1 g, 3.194 mmol), HOBt (586 mg, 
3.832 mmol), EDC (734 mg, 3.832 mmol) and DIPEA (494 mg, 3.832 mmol) in 30 mL 
of dry CH2Cl2 was cooled to 0 °C. Stearic acid (908 mg, 3.194 mmol) in 20 mL of dry 
CH2Cl2 was added drop wise over 6 h at 0°C, and then the reaction was stirred under 
argon for 18 h at room temperature. The mixture was diluted with ethyl acetate (75 mL) 
and washed successively with HCl (10 % aqueous, 2 x 30 mL), NaHCO3 (7 % aqueous, 
2 x 30 mL), K2CO3 (7% aqueous, 2 x 30 mL), and brine (3 x 30 mL). The organic layer 
was dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
column chromatography on silica gel using hexane/AcOEt/MeOH (85:10:5) as the 
eluent to give 1.67 g of pure N-(2-hydroxyethyl)-N-octadecylstearamide (90 %). TLC 
(Hexane/AcOEt/MeOH 60:30:10) Rf 0.70; m.p. 50–52 °C; 1H NMR (400 MHz, CDCl3): 
δ 3.75 (2H, t, J=5.2 Hz), 3.52 (2H, t, J=5.2 Hz), 3.26 (2H, t, J=7.6 Hz), 2.32 (2H, t, 
J=7.6 Hz), 1.62-1.54 (4H, m), 1.25 (58H, m), 0.87 (6H, t, J=6.5 Hz); 13C NMR (100.6 
MHz, CDCl3): δ 173.0, 58.9, 50.2, 47.3, 34.3, 31.8, 30.4, 29.6, 29.3, 28.9, 28.6, 27.7, 
22.7, 14.1. Anal. Calcd. for C38H77NO2: C, 78.69; H, 13.38; N, 2.41. Found: C, 78.73; 
H, 12.98, N, 2.45. 
 
 
Synthesis of N-((2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl)stearamide 
 
 
HO
O
HOBt, EDC, CH2Cl2
R.T. 18 h
82 %
HO
OH
NH2
O
HO
OH
HN
 
A solution of sphingosine (100 mg, 0.333 mmol), HOBt (61 mg, 0.4 mmol), EDC (76 
mg, 0.4 mmol) and DIPEA (77 mg, 0.6 mmol) in 20 mL of dry CH2Cl2 was cooled to 0 
°C. Under stirring, stearic acid (94 mg, 0.333 mmol in 20 mL of dry CH2Cl2) was added 
drop wise over 6 h at 0°C, and then the reaction was stirred under argon for 18 h at room 
temperature. The mixture was diluted with ethyl acetate (75 mL) and washed 
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 Wilson, C.V.; Stenberg, J.F.Org. Synth. Coll. Vol. 4, 564–565. 
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successively with HCl (10% aqueous, 2 x 30 mL), NaHCO3 (7% aqueous, 2 x 30 mL), 
K2CO3 (7% aqueous, 2 x 30 mL), and brine (3 x 30 mL). The organic layer was dried 
over MgSO4 and concentrated in vacuo. The residue was purified by flash column 
chromatography on silica gel using hexane-AcOEt-MeOH (85:10:5) as the eluent to 
give 154 mg of pure N-((2S,3R,E)-1,3-dihydroxyoctadec-4-en-2-yl)stearamide (82 %). 
TLC (Hexane-AcOEt-MeOH 60:30:10) Rf 0.70; m.p. 104–106 °C; 1H NMR (400 MHz, 
CDCl3): δ 6.23 (1H, d, J=7.3 Hz),  5.77 (1H, dt, J=15.4, 6.7 Hz), 5.51 (1H, dd, J=15.4, 
6.4 Hz), 4.3 (1H, dd, J=6.4, 3.4 Hz), 3.94 (1H, dd, J=11.3, 3.7 Hz), 3.89 (1H, dddd, 
J=7.3, 3.7, 3.4, 3.2 Hz), 3.69 (1H, dd, J=11.3, 3.2 Hz), 2.21 (2H, t, J=7.5 Hz), 2.03 (2H, 
dt, J=7.2, 6.7 Hz), 1.62 (2H, quint, J=7.5 Hz), 1.35 (2H, m), 1.34-1.20 (48H, m), 0.86 
(6H, t, J=6.9 Hz); 13C NMR (100.6 MHz, CDCl3): δ 174.2, 134.6, 129, 74.9, 62.8, 54.7, 
36.92, 32.2, 31.98, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 26, 22.9, 14.3. Anal. Calcd. for 
C36H71NO3: C, 76.40; H, 12.64; N, 2.47. Found: C, 76.59; H, 12.47, N, 2.59. 
 
 
General procedures for the preparation of amide-derivative of stannyl ethers 
 
 
Preparation of 284, 288 and 293: A mixture of alcohol (0.305 mmol) and bis-
(tributyltin) oxide (30 mg, 0.152 mmol) in 15 ml of dry toluene, was heated to reflux 
and was subjected to azeotropic dehydration using a Dean-Stark system or 4 Å 
molecular sieves overnight. Removal of solvent under reduced pressure afforded the 
stannyl ethers 284, 288, and 293 which were used for the glycosylation reaction without 
further purification. 
 
 
Preparation of 295, 297, 306 and 34: A mixture of sphingosine or ceramide (0.176 
mmol) and dibutyltin oxide (0.176 mmol) in dry toluene (15 mL), was heated to reflux 
and was subjected to azeotropic dehydration using a Dean-Stark system or 4 Å 
molecular sieves overnight. Removal of solvent under reduced pressure afforded the 
stannyl acetals 295, 297, 306 and 34, which was used for the glycosylation reaction 
without further purification. 
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General procedure for glycosylation employing TBAI as promoter 
 
The following protocol was followed prior to the glycosylation reaction: 
1,2,3,4,6-penta-O-acetyl-β-D-galactopyranose and donor alcohol were separately dried 
by co-destillation with toluene (3 x 5 mL) in dried flasks and then were placed under 
vacuum for 1 h. TBAI was added to a dried flask with a magnetic stirring bar and was 
co-destilled with dry toluene (2 x 5 mL) in the dark. Activated 4 Å molecular sieves 
were added to the flask, and the mixture was co-destilled with toluene once more (5 
mL) before being placed under vacuum for 1 h. Complete water exclusion is crucial to 
achieve good yields. 
A solution of 1,2,3,4,6-penta-O-acetyl-β-D-galactopyranose previously dried 
(0.366 mmol) in CH2Cl2 (3 mL) was cooled to 0°C under argon atmosphere in the dark 
and TMSI (0.439 mmol) was added to the stirring mixture. The reaction was stirred for 
20 min at 0°C. The reaction was stopped by adding 3 mL of dry toluene and co-
destilling three times with dry toluene to obtain compound 283 as a slightly yellow oil, 
which was then dissolved in anhydrous toluene (5 mL) and kept under argon. 
To a stirred mixture of TBAI (0.030 mmol) and 4Å molecular sieves (300 mg) in 
anhydrous toluene (5 mL) under argon at room temperature was added a solution of 
stannyl derivative (0.305 mmol) in dry toluene (5 mL) and a solution of 283 (0.366 
mmol) in dry toluene (5 mL) via syringe. The reaction mixture was stirred at 80 °C in 
the dark for 18 h and then diluted with AcOEt (15 mL) and cooled to 0 °C. The white 
precipitate was removed by filtration through a pad of Celite. The organic layer was 
concentrated in vacuo to get the orthoester, which was co-destilled with dry toluene (3 x 
5 mL) and placed under vacuum for 1 h before the next reaction. 
A solution containing the orthoester in anhydrous CH2Cl2 (5 mL) was cooled to 
0 °C under argon atmosphere, and freshly distilled BF3·EtO2 (0.915 mmol) was added to 
the stirring mixture. After, the resulting reaction mixture was stirred for 3 h at room 
temperature, it was quenched with saturated aqueous NaHCO3 solution and 25 mL of 
AcOEt was added. The aqueous phase was extracted with AcOEt (2 x 15  mL), and the 
combined organic extract was washed with saturated aqueous Na2S2O3 solution (2 x 10 
mL) and brine (3 x 10 mL), dried with anhydrous Na2SO4, and concentrated in vacuo. 
The resulting residue was purified by flash column chromatography on silica gel using 
hexane/AcOEt/MeOH as eluent to give the product.  
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Synthesis of 291. Following the general procedure, the 
reaction was carried out starting from penta-O-acetyl-
galactopyranose (142 mg, 0.366 mmol), TMSI (88 mg, 
0.839 mmol), TBAI (11 mg, 0.030 mmol) and 288 (188 
mg, 0.305 mmol). When the reaction was finished the reaction crude was purified by 
flash column chromatography on silica gel using hexane-AcOEt-MeOH (85:10:5) as 
eluent to give 186 mg (93%) of 291 as a unique anomer. TLC (hexane/AcOEt/MeOH 
60:30:10) Rf 0.40; m.p. 136–138°C; [α]D25 −5 (c = 1.0, CHCl3). 1H NMR (400 MHz, 
CDCl3): δ 5.85 (1H, t, J=5.2 Hz),  5.34 (1H, d, J=3.2 Hz), 5.13 (1H, dd, J=10.8, 7.6 
Hz), 4.97 (1H, dd, J=10.8, 3.6 Hz), 4.43 (1H, d, J=7.6 Hz), 4.13-4.05 (2H, m), 3.88 (1H, 
t, J=6.4 Hz), 3.82 (1H, ddd, J=10.4, 6.4, 4.0 Hz), 3.63 (1H, ddd, J=10.4, 6.8, 3.6 Hz), 
3.48-3.41 (1H, m) 3.39-3.32 (1H, m), 2.12 (2H, t, J=7.2 Hz), 2.11 (3H, s), 2.02 (3H, s), 
2.01 (3H, s), 1.94 (3H, s), 1.58-1.52 (2H, m), 1.25-1.20 (28H, m), 0.82 (3H, t, J=7.2 
Hz); 13C NMR (100.6 MHz, CDCl3): δ 172.0, 170.2, 170.0, 169.9, 168.8, 100.0, 71.8, 
70.9, 68.2, 67.0, 61.2, 61.0, 41.6, 36.5, 31.8, 29.5, 28.6, 25.6, 22.7, 20.7, 20.5 14.1. 
Anal. Calcd. for C34H59NO11: C, 62.08; H, 9.04; N, 2.11. Found: C, 62.02; H, 9.08; N, 
2.21. 
 
Synthesis of 294. Following the general 
procedure, the reaction was carried out 
starting from penta-O-acetyl-galactopyranose 
(80 mg, 0.206 mmol), TMSI (49 mg, 0.247 
mmol), TBAI (6 mg, 0.017 mmol) and 293 (149 mg, 0.172 mmol). When the reaction 
was finished the reaction crude was purified by flash column chromatography on silica 
gel using hexane-AcOEt-MeOH (85:10:5) as eluent to give 145 mg (93%) of 294 as a 
unique anomer.  TLC (Hexane/AcOEt/MeOH 60:30:10) Rf 0.50; m.p. 136–138 °C; 
[α]D25 −11 (c = 1.0, CHCl3). 1H NMR (400 MHz CDCl3): δ 5.37 (1H, d, J=3.2 Hz), 5.17 
(1H, dd, J=10.4, 8.0 Hz), 5.0 (1H, dd, J=10.4, 3.2 Hz), 4.47 (1H, d, J=8.0 Hz), 4.17-
4.03 (2H, m), 3.88 (1H, t, J=6.4 Hz), 3.83 (1H, ddd, J=10.0, 6.0, 4.0 Hz), 3.64 (1H, ddd, 
J=10.0, 6.4, 3.6 Hz), 3.47-3.41 (1H, m) 3.39-3.33 (1H, m), 2.27 (2H, t, J=7.2 Hz), 2.12 
(2H, t, J=7.2 Hz), 2.11 (3H, s), 2.02 (3H, s), 2.01 (3H, s), 1.94 (3H, s),1.57-1.50 (4H, 
m), 1.25 (58H, m), 0.87 (6H, t, J=7.2 Hz); 13C NMR (100.6 MHz, CDCl3): δ 172.0, 
170.2, 170.0, 169.9, 168.8, 100.0, 71.8, 70.9, 68.2, 67.0, 61.2, 61.0, 41.6, 36.5, 31.8, 
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29.5, 28.6, 25.6, 22.7, 20.7, 20.5 14.1. Anal. Calcd. for C52H95NO11: C, 68.61; H, 10.52; 
N, 1.54. Found: C, 68.59; H, 10.55, N, 1.49. 
 
Synthesis of 296. Following the general 
procedure, the reaction was carried out starting 
from penta-O-acetyl-galactopyranose (143 mg, 
0.368 mmol), TMSI (88 mg, 0.441 mmol), TBAI 
(11 mg, 0.030 mmol) and 295 (171 mg, 0.307 mmol). When the reaction was finished 
the reaction crude was purified by flash column chromatography on silica gel using 
hexane-AcOEt-MeOH (85:10:5) as eluent to give 188 mg (94%) of 296 as a unique 
anomer. TLC (Hexane/AcOEt/MeOH 60:30:10) Rf 0.60; m.p. 50–52 °C; [α]D25 −21 (c = 
1.0, CHCl3).1H NMR (400 MHz, CDCl3): δ 5.8 (1H, dt, J=15.6, 6.4 Hz), 5.48 (1H, dd, 
J=15.6, 7.2 Hz), 5.37 (1H, d, J=3.2 Hz), 5.19 (1H, dd, J=10.5, 7.5 Hz), 5.0 (1H, dd, 
J=10.5, 3.2 Hz), 4.5 (1H, d, J=8.0 Hz), 4.25 (1H, dd, J=6.8, 6.0 Hz), 4.2-4.06 (2H, m), 
3.96 (1H, t, J=6.4 Hz), 3.93 (1H, dd, J=12.8, 6.0 Hz), 3.69 (1H, dd, J=10.4, 4.4 Hz), 
3.45 (1H, m), 2.06 (2H, q, J=7.2 Hz), 2.05 (3H, s), 2.04 (3H, s), 2.03 (3H, s), 1.96 (3H, 
s), 1.36 (2H, m), 1.25 (20H, m), 0.87 (3H, t, J=7.2 Hz); 13C 
NMR (100.6 MHz, CDCl3): δ 170.2, 169.3, 169.2, 165.0, 139.0, 122.7, 100.5, 72.8, 
72.5, 72.0, 71.0, 68.3, 68.1, 63.5, 61.8, 32.4, 31.9, 29.6-28.7, 22.7, 20.6, 20.5, 14.0. 
 Anal. Calcd. for C32H53N3O11: C, 58.61; H, 8.15; N, 6.41. Found: C, 58.80; H, 8.17; N, 
6.28. 
 
Synthesis of 298. Following the general 
procedure, the reaction was carried out starting 
from penta-O-acetyl-galactopyranose (82 mg, 
0.211 mmol), TMSI (50 mg, 0.253 mmol), 
TBAI (6 mg, 0.017 mmol) and 297 (140 mg, 0.176 mmol). When the reaction was 
finished the reaction crude was purified by flash column chromatography on silica gel 
using hexane-AcOEt-MeOH (85:10:5) as eluent to give 139 mg (90%) of 298 as a 
unique anomer. TLC (Hexane/AcOEt/MeOH 60:30:10) Rf 0.60; m.p. 50–52 °C; [α]D25 
−13.5 (c = 1.0, CHCl3). 1H NMR (400, MHz CDCl3): δ 5.94 (1H, t, J=7.0 Hz), 5.75 
(1H, dt, J=15.3, 6.7 Hz), 5.49 (1H, dd, J=15.3, 7.5 Hz), 5.38 (1H, d, J=3.2 Hz), 5.17 
(1H, dd, J=10.6, 8.0 Hz), 5.0 (1H, dd, J=10.6, 3.6 Hz), 4.47 (1H, d, J=8.0 Hz), 4.25 
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(1H, dd, J=7.5, 3.4 Hz), 4.16 (1H, dd, J=10.0, 4.6 Hz), 4.15-3.99 (3H, m), 3.92 (1H, t, 
J=6.4 Hz), 3.65 (1H, dd, J=10.0, 3.2 Hz), 2.20 (2H, t, J=7.5 Hz), 2.05 (3H, s), 2.04 (3H, 
s), 2.03 (2H, dt, J=7.2, 6.7 Hz), 2.03 (3H, s), 1.99 (3H, s), 1.61 (2H, m), 1.35 (2H, m), 
1.34-1.20 (48H, m), 0.87 (6H, t, J=6.9 Hz); 13C NMR (100.6 MHz, CDCl3): δ 174.3, 
170.2, 170.1, 169.9, 168.8, 133.9, 128.8, 101.0, 71.9, 71.7, 71.0, 68.2, 68.1, 67.1, 61.3, 
53.0, 36.0, 31.9, 31.5, 29-28.8, 25.5, 21.2, 20.6, 20.5, 13.4.  Anal. Calcd. for 
C49H87NO12: C, 66.7; H, 9.94; N, 1.59. Found: C, 66.97; H, 9.63, N, 1.38. 
Synthesis of 299. Following the general 
procedure, the reaction was carried out starting 
from octa-O-acetyl-lactose (143 mg, 0.211 
mmol), TMSI (50 mg, 0.253 mmol), TBAI (6 
mg, 0.017 mmol) and 297 (140 mg, 0.176 mmol). When the reaction was finished the 
reaction crude was purified by flash column chromatography on silica gel using hexane-
AcOEt-MeOH (85:10:5) as eluent to give 184 mg (90%) of 299 as a unique anomer. 
TLC (Hexane/AcOEt/MeOH 60:30:10) Rf 0.35; m.p. 50–52 °C; [α]D25 −12.2 (c = 1.0, 
CHCl3). 1H NMR (400 MHz, CDCl3): δ 5.97 (1H, d, J=7.0 Hz), 5.76 (1H, dt, J=15.3, 
6.7 Hz), 5.50 (1H, dd, J=15.3, 7.5 Hz), 5.33 (1H, d, J=2.6 Hz), 5.10 (1H, dd, J=10.4, 
9.2 Hz), 5.08 (1H, dd, J=10.4, 8.0 Hz), 4.94 (1H, dd, J=10.4, 3.4 Hz), 4.87 (1H, dd 
J=9.6, 8.0 Hz), 4.49 (1H, d, J=8.0 Hz), 4.48 (1H, d, J=8.0 Hz), 4.35 (1H, dd, J=9.6, 1.0 
Hz), 4.16-4.01 (2H, m), 4.02-3.93 (3H, m), 3.88 (1H, t, J=6.4 Hz), 3.81 (1H, t, J=9.6 
Hz), 3.62 (1H, dd, J=10.0, 3.2 Hz), 3.55 (1H, m) 2.20 (2H, t, J=7.5 Hz), 2.14 (3H, s), 
2.07 (3H, s), 2.05 (3H, s), 2.03 (2H, dt, J=7.2, 6.7, Hz), 2.02 (3H, s), 2.01 (3H, s), 1.96 
(3H, s), 1.95 (3H, s), 1.61 (2H, m), 1.35 (2H, m), 1.34-1.20 (48H, m), 0.87 (6H, t, J=6.9 
Hz); 13C NMR (100.6 MHz, CDCl3): δ 173.1, 170.7, 170.6, 170.5, 170.2, 170.1, 169.9, 
169.6, 133.5, 128.8, 101.0, 100.7, 76.5, 74.5, 73.1, 73.0, 72.2, 71.4, 71.1, 69.4, 67.9, 
67.0, 62.3, 61.2, 52.2, 36.1, 31.9, 31.6, 21.2-21.0, 14.1. Anal. Calcd. for C61H103NO20: 
C, 62.59; H, 8.87; N, 1.2. Found: C, 62.87; H, 8.29, N, 1.39. 
General procedure for glycosylation employing AgOTf as promoter 
 
The following protocol was followed prior to the glycosylation reaction. The 
acceptor 1,2,3,4,6-penta-O-acetyl-β-D-galactopyranose and donor were azeotroped with 
dry toluene (3 x 5 mL) in a dried flask and placed under vacuum for 1 h before the 
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reaction. The AgOTf was added to a dried flask with a magnetic stirring bar. The flask 
wrapped in Al foil was azeotroped with dry toluene (2 x 5 mL) in the dark. Activated 4 
Å molecular sieves were added to the flask, and the mixture was azeotroped with 
benzene once more (5 mL) before being placed under vacuum for 1 h.  
 A solution of 1,2,3,4,6-penta-O-acetyl-β-D-galactopyranose (286 mg, 0.733 
mmol) in CH2Cl2 (3 mL) was cooled to 0 °C under argon atmosphere in the dark and 
TMSI (176 mg, 0.879 mmol) was added to the stirring mixture. The reaction was stirred 
for 20 min at 0 °C. The reaction was stopped by adding 3 mL of dry toluene and 
azeotroped three times with dry toluene. The slightly yellow oil 283 was dissolved in 
CH2Cl2 (5 mL) and kept under argon. 
To a stirred mixture of AgOTf (1.83 mmol) and 4 Å molecular sieves (600 mg) 
in dry CH2Cl2 (5 mL) under argon at room temperature was added a solution of stannyl 
derivative (0.611 mmol) in dry CH2Cl2 (5 mL) and a solution of 283 (0.733 mmol) in 
dry CH2Cl2 (5 mL) via syringe. The reaction mixture was stirred at 0 °C in the dark for 
3 h before it was allowed to warm to 25 °C and stirred further for 3 h. The mixture was 
diluted with AcOEt (15 mL) and cooled to 0 °C. The white precipitate was removed by 
filtration through a pad of Celite. The organic layer was concentrated in vacuo to get 
crude residue, which mainly consisted of orthoester. This crude product was azeotroped 
with dry toluene (3 x 5 mL) and placed under vacuum for 1 h before the next reaction. 
 A solution containing the orthoester in CH2Cl2 (10 mL) was cooled to 0 
°C under argon atmosphere, and freshly distilled BF3·EtO2 (1.833 mmol) was added to 
the stirring mixture. After, the resulting reaction mixture was stirred for 3 h at room 
temperature, it was quenched with saturated aqueous NaHCO3 solution and 25 mL of 
AcOEt was added. The aqueous phase was extracted with AcOEt (2 X 20 mL), and the 
combined organic extract was washed with saturated aqueous Na2S2O3 solution (2 x 20 
mL) and brine (3 x 20 mL), dried with anhydrous Na2SO4, and concentrated in vacuo. 
The resulting residue was purified by flash column chromatography on silica gel using 
hexane-AcOEt-MeOH (85:10:5) as eluent to give the product. 
 
Activation of MSAW3000. Molecular sieves AW-300 (MSAW300) purchased from 
Aldrich (lot no. 04024CI) were ground and activated by heating over 200 °C under 
reduced pressure 12 h. 
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Synthesis of 304: Isoglobotrihexose 303 (50 mg, 
0.099 mmol) was dissolved in 10 ml of pyridine 
followed by addition of acetic anhydride (0.556 
mg, 5.45 mmol) and DMAP (65 mg, 0.54 mmol). 
The mixture was stirred for 48 h at 70 °C and then 
concentrated in vacuo. The residue was dissolved in EtOAc (15 mL) and washed with 
HCl (10% aqueous, 3 x 10 mL), NaHCO3 (7% aqueous, 3 x 30 mL), and brine (3 x 30 
mL) successively, The organic layer was dried over MgSO4 and concentrated in vacuo. 
The residue was purified by flash column chromatography on silica gel using hexane-
AcOEt (85:15) as the eluent to give 94 mg of 304 as syrup in 98 %. 1H NMR (400 
MHz, CDCl3):5.68 (1H, d, J=8.4 Hz), 5.43-5.37 (2H, m), 5.26-5.21 (3H, m), 5.14 
(1H, m), 5.0 (1H, m), 4.93 (1H, t, J=8.4 Hz), 4.47-4.40 (2H, m), 4.31 (1H, dd, J=12, 4.0 
Hz), 4.14-3.99 (5H, m), 3.91 (1H, m), 3.81 (1H, dd, J=15, 6.4 Hz), 3.77 (1H, m), 3.68 
(1H,m), 2.2 (3H, s), 2.18 (3H, s), 2.16 (3H, s), 2.15 (3H, s), 2.14 (3H, s), 2.13 (3H, s), 
2.12 (3H, s), 2.11 (3H, s), 2.04 (3H, s), 1.99 (3H, s), 1.95 (3H, s); 13C NMR (100.6 
MHz, CDCl3):170.5, 170.4, 170.3, 170.2, 170.0, 169.8, 169.7, 169.5, 169.3, 168.7, 
96.9, 95.0, 91.7, 75, 73.3, 72.8, 72.3, 71.5, 70.8, 70.3, 69.9, 69.2, 68.9, 68.4, 67.7, 62.5, 
62.1, 61.2, 22, 20.9, 20.8, 20.7, 20.5, 20.3. Anal. Calcd. for C40H54O27: C, 49.69; H, 
5.63. Found: C, 49.63; H, 5.65. 
 
Synthesis of iGB3: Following the general 
procedure, the reaction was carried out 
starting from peracetylated trisaccharide 304 
(50 mg, 0.051 mmol), TMSI (12 mg, 0.061 
mmol), TBAI (13 mg, 0.051 mmol), 306 (46 
mg, 0.051 mmol) and 4Å acid washed molecular sieves (200 mg). When the reaction 
was finished the solvent was evaporated and then, MeOH (15 mL) and Dowex 50WX8–
200 ion-exchange resin (1 g) were added and the reaction was stirred at room 
temperature for 4 h. The resin was then removed by filtration. The solvent was removed 
in vacuo, and the resulting residue was purified by flash column chromatography on 
silica gel using CHCl3-MeOH (85:15) as eluent to give 32 mg (60%) of 3 as a unique 
anomer.1H NMR (Py-d5, 400 MHz): δ 8.31 (1H, d, J=8.0 Hz), 7.53 (1H, br s), 7.32 
(1H, br s), 6.98 (1H, br s), 6.66 (1H, br s), 6.58 (1H, br s), 6.52 (1H, br s), 6.42 (1H br 
s), 6.38 (1H, br s), 6.36 (1H, br s), 6.09 (1H, br s), 6.01 (1H dd, J=15.5 Hz, 6.0 Hz), 
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5.91 (1H, dt,  =15.5, 6.5 Hz), 5.76 (1H, br s), 5.64 (1H, d, J=3.8 Hz), 5.05-5.00 (2H, m), 
4.87 (1H, d, J=12.0 Hz), 4.81-4.75 (3H, m), 4.72-4.69 (1H, m), 4.65 (1H, m), 4.56 (1H, 
m), 4.54-4.49 (3H, m), 4.47-4.39 (4H, m), 4.32-4.29 (1H, m), 4.24-4.20 (3H, m), 4.15 
(1H, dd, J=9.5, 2.5 Hz), 4.05-4.00 (2H, m), 3.86-3.84 (1H, m), 2.42 (2H, t, J=7.0 Hz) 
2.06 (2H, q, J=6.5 Hz), 1.82 (2H, m), 1.39-1.21 (66H, m), 0.87 (3H, t, J=6.5 Hz), 0.86 
(3H, t, J=7.0 Hz); 13C NMR (Py-d5, 100.6 MHz): δ 174.2, 133.5, 133.2, 106.4, 98.6, 
83.0, 81.0, 77.6, 77.5, 77.4, 75.7, 73.7, 73.6, 72.5, 71.7, 71.4, 71.3, 66.9, 63.1, 62.9, 
62.7, 55.8, 37.8, 33.6, 33.0, 31.4, 31.0, 30.9, 30.8, 30.7, 30.6, 30.5, 27.3, 23.3, 15.1. 
Anal. Calcd. for C62H117NO18: C, 63.94; H, 10.13; N, 1.20. Found: C, 63.90; H, 10.11; 
N, 1.18. 
 
Synthesis of KRN7000 309: To asolution of 1,2,3,4,6-
penta-O-trimethylsilyl-D-galactopyranose 310 (38 mg, 
0.071 mmol) in CH2Cl2 (5 mL) at 0 °C was added TMSI 
(14 mg, 0.071 mmol). The reaction was stirred under 
argon at 0 °C for 20 min. The reaction was stopped by 
adding 15 mL of anhydrous benzene and solvent was 
evaporated under reduced pressure. The slightly yellow oil 311 was dissolved in toluene 
(3 mL) and kept under argon. In a separate flask, molecular sieves (MS, 4 Å, 50 mg), 
TBAI (53 mg, 0.143 mmol), and 314 (66 mg, 0.071 mmol) were added into toluene (5 
mL). The mixture was stirred under argon and the glycosyl iodide 311 was added 
dropwise. The reaction mixture was stirred at 80 °C for 18 h and then the solvent was 
evaporated. MeOH (15 mL) and Dowex® 50WX8-200 ion exchange resin (0.5 g) were 
added and the reaction was stirred at rt for 4 h. Resin was removed by filtration. The 
solvent was removed in vacuo and the resulting residue was purified by silica gel 
chromatography. The 1H and 13C NMR spectral data of 309 corroborated well with the 
literature report. 1H NMR (400 MHz, pyridine-d5) δ δ 8.43 (1H, d, J=8.6 Hz), 5.55 (1H, 
d, J=3.5 Hz), 5.25–5.21 (1H, m), 4.66–4.61 (2H, m), 4.53 (1H, m), 4.49 (1H, t, J=5.8 
Hz), 4.42–4.36 (4H, m), 4.31–4.29 (1H, m), 2.43 (2H, t, J=7.4 Hz), 2.23 (1H, m), 1.92–
1.86 (2H, m), 1.82- 1.77 (2H, m), 1.63 (1H, m), 1.44–1.18 (66H, m), 0.88–0.83 (6H, 
m); 13C NMR (125 MHz, pyridine-d5) δ 174.6, 102.8, 78.0, 74.3, 72.98, 72.3, 71.6, 
69.90, 63.90, 52.8, 38.1, 35.60, 33.4, 31.6, 31.4, 31.3, 31.3, 31.2, 31.1, 31.1, 30.9, 27.8, 
27.6, 24.2, 15.5. 
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Glycolipid 313. The general procedure as reported for the 
preparation of 309 was followed. 1H NMR (400 MHz, 
CDCl3/CD3OD, 4:1): δ 7.52 (1H, s), 4.87 (1H, d, J=3.2 Hz), 
3.93 (1H, m), 3.80–3.72 (6H, m), 3.49 (1H, m), 3.32 (2H, m) 
2.20 (2H, t, J=8.0 Hz), 1.62 (2H, m), 1.27 (28H, m), 0.89 (3H, t, 
J=7.2 Hz); 13C NMR (100.6 MHz, 4:1 CDCl3/CD3OD): δ 174.9, 98.8, 70.6, 69.9, 69.5, 
68.7, 66.7, 61.4, 41.5, 36.0, 29.3–28.9, 25.6, 22.3, 13.5. 
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3.3. Synthesis of novel glycodendritic polymer of β-
Galcer that bind HIV-1 gp 120 
 
 
 
 
Glycodendrimers have been employed as useful tools to investigate carbohydrate 
recognition processes. Now, we present new water-soluble hyperbranched glycodentritic 
polymers for the study of carbohydrate interactions. These glycoconjugate consists of 
Boltorn H30 hyperbranched polymers, based on the monomer 2,2-
bis(hydroxymethyl)propionic acid, functionalized with naturally occurring β-Galceramide. 
Click chemistry permits functional group tolerance during the derivatization of Boltorn 
H30. Their ability to bind HIV-1 gp 120 was demonstrated using surface plasmon 
resonance (SPR). 
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3.3.1. The HIV process 
 
HIV-1 infects susceptible cells by fusion of viral membrane with the plasma 
membrane. The HIV entry process is understood in some detail at the molecular level,248 it 
is coordinated by the HIV envelope glycoprotein complex, a trimer of gp120 surface 
glycoproteins, each noncovalently attached to three gp41 membrane glycoprotein subunits. 
HIV must first engage CD4, a host cell surface protein, via the CD4 binding site on gp120. 
Interaction between gp120 and CD4 induces a significant conformational change in the 
envelope glycoprotein, exposing a previously hidden site that, together with the V3 region, 
is necessary for coreceptor engagement.249 Binding to the coreceptor induces the insertion 
of gp41 into the host cell membrane, forming a molecular bridge between the virus and the 
host cell leading to the formation of a prefusion complex, which undergoes further 
conformational rearrangement that is sufficient to drive membrane fusion, allowing the 
contents of the virion to be ejected into the host cell.250 Several viral envelope glycoprotein 
oligomers then assemble into a viral fusion machine, forming a molecular scaffold that 
brings the viral and target cell membranes into close apposition and allow the subsequent 
fusion events.251 The fusion pore formation and its sequential expansion are orchestrated by 
viral and cellular lipids and proteins.  
Recently works has shown that changes in GSLs expression in target membranes 
can modulate viral fusion and entry. These studies on structure–function relationship of 
target membrane GSLs, the gp120-gp41 and the viral receptors suggest that plasma 
membrane GSLs support HIV-1 entry by stabilizing the intermediate steps in the fusion 
cascade.252 These observations, led it to hypothesize that upregulation of GSL metabolites 
                                                 
248
 Gallo, S. A.; Finnegan, G. M.; Viard, M.; Raviv, Y.; Dimitrov, A.; Rawat, S. S.; Puri, A.; Durell, S. 
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249
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Krober, B.; Sodroski, J.; Wilson, I. A.; Wyatt, R.; Kwong, P. D. Science 2005, 310, 1025−1028. (b) Chen, 
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(such as ceramide) and/or modulation of GSLs, which preferentially partition in the plasma 
membrane microdomains, could have a significant influence on HIV-1 entry.253 Based on 
these findings, other researchers have attempted to develop strategies to synthesize 
glycoconjugate derivatives, GSL analogs, polymers and/or hybrids as new agents to inhibit 
HIV-1 entry. 
 
3.3.2. Hyperbranched polymers 
 
In the last decade, a new promising class of drug carriers, the dendritic polymers, 
has attracted increasing attention. A large number of interdisciplinary research activities on 
dendritic polymers, i.e., dendrimers and hyperbranched polymers, that explored a wide 
variety of new applications have emerged (Figure 24).254 At the end of the 1990s an 
increasing number of research 
groups focused on the potential of 
dendrimers in the field of life 
science; they were fascinated by 
their unique features such as 
monodispersity, a well-defined 
globular architecture, and the 
possibility of tailoring their 
physical and chemical properties. 
Since several dendrimers exhibit a 
low in vivo toxicity, their 
applications as diagnostic imaging agents, gene-therapy vectors, vaccines, drugs, and boron 
neutron capture therapy agents were examined intensively.255 Dendrimers offer many 
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O. A.; Shipway, A. N.; Stoddart, J. F. Prog. Polym. Sci. 1998, 23, 1−56. 
255
 (a) Malik, N.; Wiwattanapatapee, R.; Klopsch, R.; Lorenz, K.; Frey, H.; Weener, J. W.; Meijer, E. W.; 
Paulus, W.; Duncan, R. J. Control. Release 2000, 68, 299−302. (b) Eichman, J. D.; Bielinska, A. U.; 
Kukowska-Latallo, J. F.; Baker, J. R., Jr. Pharm. Sci. Technol. Today 2000, 3, 232−245. (c) Kawaguchi, H. 
 
 
 
Figure 24. Dendritic polymer chemistry 
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outstanding advantages as a versatile strategy for a more effective delivery of therapeutic 
drugs to disease sites. Their size and structure can be controlled by synthetic means and 
further modifications can ensure biocompatibility and biodegradability. Dendrimers are 
also considered to function as analogs of enzymes, proteins, viruses, and antibodies.255a,b,c 
Thus, it seems certain that dendrimers will play a significant role in the future development 
of new biomedical devices for the treatment of human diseases.256  
Hyperbranched polymers represent an 
important part of the family of dendritic and 
multibranched polymers.257 While dendrimers have 
perfect, monodisperse structures built around a core 
moiety with a branching point in every repeating unit, 
hyperbranched polymers are polydisperse and include 
some linear units in their molecular structure (Figure 
25a). However, these differences are not large enough 
to suppress some of their typical dendritic polymer 
characteristics. Similarly to dendrimers (Figure 25b), 
hyperbranched polymers were shown to exhibit much 
lower solution viscosities than linear polymers due to 
the lack of entanglements and to their very low 
intrinsic viscosities, which result from their packed 
structure.258 The properties of hyperbranched 
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polymers in blends are indeed strongly determined by the nature of their terminal groups.259 
For example, solubility, which mainly depends on the end group structure, may be 
regulated by the partial or total chemical modification of the ‘‘terminal’’ groups. Due to the 
irregularities of hyperbranched polymers in their molecular architecture, these functional 
groups can be located not only in the periphery, as in perfect dendrimers, but also inside the 
globular branched structure; even the terminal functional groups of dendritic 
macromolecules can fold back to the inside.260  
In this context, a promising idea is the replacement of dendrimers by hyperbranched 
polymers.261 The tedious and complex multi step synthesis of dendrimers results in 
expensive products with a limited use for large-scale industrial applications.257d For many 
applications, which do not require structural perfection, hyperbranched polymers can 
circumvent this major drawback of dendrimers.257d,f.256a Unlike dendrimers, randomly 
branched hyperbranched polymers with similar properties can be easily synthesized via 
one-step reactions and, therefore, represent economically promising products for both 
small-scale and large-scale industrial applications. Several hyperbranched polymers have 
been commercialised e.g. by Dendritech®, Inc. (Starburst®), Qiagen (SuperFect®), DSM 
(Astramol, HybraneTM) and Perstorp (Boltorn®). Therefore, during the last years, a wide 
variety of applications, which originally only seemed conceivable for dendrimers, were 
investigated for the statistically branched hyperbranched polymers.257b,261f,262 Among these 
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new potential applications for hyperbranched polymers, the applications in the field of life 
science seem to be one of the most challenging goals. 
The synthesis of multivalent neoglycoconjugates is currently promoted by the 
extensive findings of multiple ligand-receptor interactions that occur in nature and by the 
phenomenon generally referred to as the glycoside cluster effect.263,264 Glycodendritic 
structures are particularly effective due to their propensity to form spherical nano-cellular 
decoys.265 Boltorn H30 hyperbranched dentritic polymer 315 (Figure 26) functionalized 
with mannose has been used to interactions studies with Lens culinaris lectin266 and to 
inhibit DC-SIGN-mediated infection in an Ebola-pseudotyped viral model.267 Thus, to 
study the interaction of HIV-1 rgp 120 with β-GalCer, and to develop potential 
carbohydrate-based inhibitors of this interaction, multivalent scaffolds bearing 
carbohydrates have been prepared. These systems consist of dendritic structures based on 
Boltorn H30 hyperbranched dentritic polymer 315 to which the glycosphingolipids are 
linked through click chemistry. NMR was used to confirm synthesis, and the average 
molecular weights of glycodendrimers were determined by MALDI-TOF MS. Surface 
plasmon resonance (SPR) was used for kinetic analysis of the interaction of HIV-1 rgp 120 
IIIB with the glycodenditric compounds. 
For the preparation of glycodendritic structure three general synthetic approaches were 
considered: 
• Synthesis of β-GalCer containing a hydrophobic chain with azide group. 
• Introduction of acetylene group on the dendritic core surface. 
• Finally, the cycloadition reaction of azide groups with terminal acetylenes. 
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Figure 26. Idealized chemical structure of the commercial hyperbranched polymer Boltorn H30 
 
3.3.3 Results 
 
3.3.3.1. Synthesis of modified β-glycosphingolipid 
 
 The initial efforts were directed toward the synthesis of compound 318 (Scheme 59) 
from the 16-Bromohexadecanoic acid 316 following a standard literature procedure.268 
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Scheme 59. Synthesis of azido ceramide 318 
 
The 16-Bromohexadecanoic acid 316 was transformed into the corresponding azide 
derivative 317 in 90% yield by treatment with NaN3 in DMF at 90 °C. As depicted in 
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Scheme 59, the sphingosine 19, was acylated overnight with the carboxylic acid derivative 
317 in CH2Cl2 to give the ceramide 318 in 88% yield. A mixture of the tetra-O-acetyl-α-
iodogalactose 283 and the stannyl ceramide 319, prepared in situ from 318, in toluene at 80 
°C was treated for 18 h with TBAI in the presence of molecular sieves (MS 300) to afford 
first the orthoester 320, which was further isomerized to the β-anomer 321 with BF3·OEt2. 
Removal of the acetyl protecting groups by treatment with methanolic sodium methoxide, 
followed by chromatography, provided the glycosphingolipid 322 in high yields (88% three 
steps, Scheme 60). 
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Scheme 60. Síntesis of β-glycosphingolipid 322 
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3.3.3.2. A click approach to unprotected glycodendritic structure 
 
The copper(I)-catalyzed regiospecific formation of 1,2,3-triazoles from azides and 
terminal acetylenes (click chemistry), has been used as key step for the efficient 
functionalization of dendrimers.269 Click chemistry serves as a powerful strategy in the 
quest for function, and can be summarised neatly in one sentence: ‘‘all searches must be 
restricted to molecules that are easy to make’’.270 These reactions are governed by kinetic 
control and are highly reliable and selective processes. A set of stringent criteria that a 
process must meet to be useful in the context of click chemistry has been defined by 
Sharpless as reactions that: ‘‘are modular, wide in scope, high yielding, create only 
inoffensive by-products (that can be removed without chromatography), are stereospecific, 
simple to perform and that require benign or easily removed solvent’’. Ideally, starting 
materials and reagents for ‘click’ reactions should be readily available, and it is a 
convenient coincidence that unsaturated-hydrocarbon based organic synthesis is currently 
at the heart of this powerful approach, since these materials are readily available from 
nature or can be obtained by steam cracking of alkanes in the petrochemical industry.270 
This concept and associated set of reactions have garnered a significant amount of 
attention due to its complete specificity, quantitative yields, and almost perfect fidelity in 
the presence of a wide variety of other functional groups.271 This unprecedented degree of 
control is perfectly suited to polymeric materials. In direct contrast with small molecule 
chemistry, one of the greatest challenges in polymer chemistry is the ability to perform 
multiple functionalization reactions without cross-linking (side reactions) or incomplete 
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functionalization occurring.272 The occurrence of even minor amounts of cross-linking can 
lead to gelation due to the numerous functional groups along the backbone, while the 
inability to separate unreacted functional groups is a significant issue. Hyperbranched 
polymers, due to their high functionality, are perfect test vehicles to probe the fidelity of 
click chemistry as a functionalization tool in polymeric systems since crosslinking reactions 
or unreacted starting groups can be detected.  
In this context, click chemistry applications are increasingly found in all aspects of 
drug discovery,273 ranging from lead finding through combinatorial chemistry and target-
templated in situ chemistry, to proteomics and DNA research, using bioconjugation 
reactions. The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal 
acetylenes is a particularly powerful linking reaction, due to its high degree of 
dependability, complete specificity, and the bio-compatibility of the reactants. The triazole 
products are more than just passive linkers; they readily associate with biological targets, 
through hydrogen bonding and dipole interactions.274 
 
3.3.3.3. Functionalization of Boltorn H30 hyperbranched dentritic polymer 
 
With this background and with the goal to prepare the glycocluster of β-Galcer 319 
that bind HIV-1 rgp120 IIIB, it was glimpsed a strategy involving coupling of 
glycosphingolipid 322 and the hyperbranched dentritic polymer 315, based on the monomer 
2,2-bis(hydroxymethyl)propionic acid. The first step of the synthesis was the introduction 
of acetylene groups on the dendritric core surface. This was achieved by mixing Boltorn 
H30 hyperbranched dentritic polymer 315 and 5-hexynoic acid 323 in the presence of EDC 
and TEA (Scheme 61). After, the mixture was stirred for five days at room temperature. 
Thus, the functionalized hyperbranched 324 was obtained, as demonstrated by NMR and 
MALDI-TOF MS analysis. 
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Scheme 61. Functionalization of Boltorn H30 
 
Comercial Boltorn H30 315 from Prestorp have already been used in several studies 
for which that was quite completely characterized, especially recently by Žagar.275 A good 
knowledge of the chemical microstructure of Boltorn H30 315 was indeed particularly 
important in order to understand how it could be influenced by its chemical modification. 
To illustrate the possible defects in the molecular architecture, a typical chemical structure 
of a third-generation is shown in figure 26. To the commercial Boltorn H30 315, Dendritic 
D, Linear L, and terminal T units can be distinguished both by 1H NMR using the methyl 
signal at 1.4-1.0 ppm and 13C NMR using either the carbonyl peaks at 175-171 ppm or that 
of the quaternary carbons at 50.25-46.25 ppm. After modification of part of the OH groups 
by 5-hexynoic acid 323, new pseudo-dendritic and pseudo-linear units are generated and 1H 
NMR and 13C NMR can be as useful in detecting these units as in the case of the 
commercial Boltorn H30. All the units that can be found in a partially modified Boltorn 
H30 are depicted in figure 28. Di, Li and Ti are the initial dendritic, linear and terminal 
units, respectively; whereas Lu is a new linear unit created by the reaction of a Ti unit with 
one hexynoic acid; D1u and D2u arise from the reaction of one hexynoic acid with Li, or of 
two hexynoic acid with Ti, respectively (Figure 27). 
Thus, the 1H NMR spectrum of 324 indicated the presence of methyl groups at 1.26 
ppm, acetylenic protons at 1.99 ppm, and methylene groups at 1.82 ppm, 2.24 ppm, and 
2.48 ppm, which corresponding to protons β, α and γ to acetylene group. The protons of 
Boltorn core appeared at 3.68 ppm to CH2 of alcohol and 4.24 ppm to CH2 of ester (Figure 
28), but from these spectra it is not possible to tell whether hexynoic acid has reacted with 
Boltorn H30. 
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Figure 27. Various D, L, and T units in a partially modified Bolton H30 
 
 
Figure 28. 1H NMR of 324 in CD3Cl 
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Figure 29. 13C NMR of 324 in CD3Cl 
 
The 13C spectrum of the same sample is shown in figure 29. The modified Boltorn 
displays C=O peaks between 175-172 ppm than can be attributed to ester groups. 
Acetylenic carbons appear at 84.6 ppm and 71.3 
ppm, whereas the methylene groups from Boltorn 
core can be found at 66-63 ppm and the methyl 
group can be found at 17 ppm. The signals at 34.9 
ppm, 23.6ppm and 20.7 ppm corresponding to 
methylene γ, β and α to triple bond. The chemical 
modification of Boltorn H30 induces a change in the 
peaks associated with quaternary carbons (Figure 
30), this evolution is visible with a decrease in the 
intensity of T signals at 50.25 ppm, as well as the 
 
 
 
Figure 30. Cq area in the 13C NMR 
spectra 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 135
appearance of news peaks in the L and D areas between 48.5 ppm and 46.2 ppm. A 
quantitative analysis of this resonance allows calculating the total amount of hexynoic acid 
that was initially added to Boltorn H30 from the integration of the quaternary carbons from 
Boltorn H30275 and an acetylenic carbon from modified Boltorn H30 (62%, Equation 1). 
 
[hexynoic acid]0/[OH]0 = (acetylenic carbon)/(LCq+2TCq)HB30                      (1) 
                                                 = (0.716)/(0.570+0.580) 
 
Next a mixture of β-Galceramide 322 and Boltorn hyperbranched polymer 324 was 
treated for 72 h with sodium ascorbate276 and CuSO4 in t-BuOH/H2O (Scheme 62). Dialysis 
purification afforded the corresponding glycodendritic polymer 325 containing β-
Galceramide. The process has allowed to anchor unprotected β-GalCer to the dendritic 
polymer. The efficiency of this coupling reaction was proved by NMR and MALDI-TOF 
MS analysis (see below). 
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Scheme 62. A click approach to unprotected glycodendritic structure 
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The analysis of the 1H NMR spectra of glycodendritic polymer of β-GalCer 325 
revealed the presence of the triazole protons at 7.79 ppm, the presence of vinylic protons at 
5.60 ppm, and complete disappearance of the acetylenic signal at 1.99 ppm. The 1H NMR 
spectroscopic data also showed the presence of aliphatic chains at 1.2 ppm. The protons of 
galactose and Boltorn core showed broad and overlapping peaks between 4.57 ppm and 
3.25 ppm (Figure 31). In 13C NMR spectra carbonyl groups can be seen between 175 and 172 
ppm, methylene groups between 66 and 63 ppm and quaternary carbons between 49 and 46 
ppm. In the same spectra it is possible to find signals of 4- and 5-position of 1,2,3-triazol, these 
signals appeared at 145 ppm and 126.1 ppm. The signals to double bond can be found at 134.6 
ppm and 130.2 ppm, whereas the anomeric carbon from galactose appear at 105 ppm (Figure 
32).  
 
 
 
 
 
Figure 31. 1H NMR of 325 in D2O 
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Figure 32. 13C NMR of 325 in D2O 
 
3.3.3.4. Sulfation of glycodendritic polymer of β-GalCer 
 
The findings of the past decade relating to 
the determination that CD4 alone is not sufficient 
for allowing HIV entry into host cells and that 
coreceptors and heparan sulphate proteoglycans 
(HSPGs) on the host cell are utilized for viral 
fusion, highlights the importance of electrostatic 
interactions between gp120, and the host cell 
surface. Gp120 has several highly basic regions, 
most notably, the V3 loop, while host cell surface 
structures are now known to have polyanionic 
regions that can interact with the basic regions of 
 
 
 
Fig. 33. Structure of an HIV-1 gp120 
 core with V3 
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gp120. It should therefore not be a surprise that there have been a large number of anionic 
polysaccharides of both natural and semisynthetic nature reported to have anti-HIV 
activities relating to early stages of infection, namely viral fusion and entry.277 The figure 
33 shows the structure of an HIV-1 gp120 core with V3. The crystal structure of core 
gp120 (gray) with an intact V3 (red) is shown bound to the membrane-distal two domains 
of the CD4 receptor (yellow) and the portion of the X5 antibody (dark and light blue). In 
this orientation, the viral membrane would be positioned toward the top of the page and the 
target cell toward the bottom.278 
Recently, it was noted that the binding of 
HSPG to recombinant monovalent gp120 
(rgp120) was enhanced if CD4 had bound to 
gp120 prior to HSPG, compared to free gp120 
binding HSPG.279 Further studies highlighted a 
single highly conserved amino acid in the V3 
loop, Arg 298, and its importance in binding to 
both HSPGs and CCR5 (Figure 34). This study 
involved the use of whole virus with trimeric 
gp120, which is important given that carbohydrate interactions within biological systems 
are typically multivalent in nature. The interesting, and perhaps most significant, aspect of 
the findings in this study was that a specific sulfation motif was preferred by the virus, 6-O-
sulfation, indicating that random sulfation or negative charges were not sufficient to yield a 
strong binding event between the virus and the host cell.280 
In this context, recently galactose- and sulphated galactose-derived dendrimers were 
synthesized. By means of surface plasmon resonance studies has been demonstrated that 
the randomly sulphated galactose-derivatized dendrimers are better ligands for rgp120 IIIB 
that nonsulfated glycodendrimers. With this background and the hyperbranched 
glycodentritic polymer to hand, the desired sulfatide were prepared following reported 
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Figure 34. Schematic of HIV-1/syndecan 
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procedures281 as it is shown in Scheme 63. Thus, the glycodendritic compound 325 was 
subjected to sulfation by treatment with an excess of sulphur trioxide/trimethylamine in 
DMF. After the dialysis purification and lyophilization, the sulphated glycodendritic 
compound 326 was obtained. The structure of this compound was confirmed by NMR and 
MALDI-TOF MS analysis. The most relevant data of 1H NMR to 326 indicate the presence 
of aromatic proton at 7.79 ppm, vinylic protons at 5.61 ppm, aliphatic chains at 1.2 ppm 
and protons from galactose and Boltorn core between 4.55 ppm and 3.39 ppm (Figure 35). 
In 13C NMR the modified hyperbranched displays a new peak at 81.6 ppm, which can be 
attributed to sulphated carbon of galactose (Figure 36). 
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Scheme 63. Sulfation of glycodendritic polymer of β-GalCer  
 
                                                 
281
 Gilbert, B.; Davis, N. J.; Pearce, M.; Aplin, R. T.; Flitsch, S. L. Tetrahedron:Asymmetry, 1994, 5, 2163–
2178. 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 140
 
 
Figure 35. 1H NMR of 324 in D2O 
  
Figure 36. 13C NMR of 324 in D2O 
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MALDI-TOF MS analysis of the hyperbranched polymers revealed that 62.84% of 
the Boltorn H30 315 was derivatized with 323 to give 324. To calculate the average number 
of residues incorporated, the theoretical molecular weight of the starting Boltorn H30 315 
was subtracted from the Mw of the functionalized dendrimer and the difference divided by 
the weight of one hexynoic acid 323, minus 18 to account for the loss of a H2O molecule 
during formation of the ester bond. In the case of 325, on average 95.47% of β-GalCer 
residues were incorporated onto the dendritic polymer 324. Finally, these same analyses 
indicated that on average 20.4 sulfate groups were added to the glycodendritic polymer 325 
to afford 326 (Table 11).  
Table 11. MALDI-TOF MS Analysis of the hyperbranched polymers 324, 325 and 326 
Entry Compound Theoretical 
molecular wt 
 
Observed 
molecular wt 
Average of residues 
incorporated 
Theoretical % 
incorporation 
1 324 6392 5275.9 20.11 62.84 
2 325 20064 20033.9 19.92 95.47 
3a 326 21644 21617.1 20.04 100.60 
 
3.3.3.5. Biological Evaluation 
 
To demonstrate the binding ability the hyperbranched glycodentritic polymers 
toward HIV-1 rgp120 IIIB, the kinetic analysis was performed using surface plasmon 
resonance (SPR). The application of surface plasmon resonance (SPR) 282 based on optical 
biosensors have contributed extensively to understanding of the functional aspects of HIV. 
SPR biosensors allow the analysis of real-time interactions of any biomolecule, be it 
protein, nucleic acid, lipid, carbohydrate or small molecule, without the need for intrinsic or 
extrinsic probes. As such, the technology has been used to analyze molecular interactions 
associated with every aspect of the viral life cycle, from basic studies of binding events 
occurring during docking, replication, budding and maturation to applied research related to 
vaccine and inhibitory drug development. Along the way, SPR biosensors have provided a 
unique and detailed view into the inner works of HIV. 
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The ability to measure binding interactions in real time is the hallmark of SPR 
biosensors. Kinetic association and dissociation rates can be extracted from the binding 
responses to provide high-resolution information about complex formation and stability. By 
measuring binding constants over a range of temperatures, it is possible to determine the 
change in enthalpy and entropy associated with complex formation, as well as the 
transition-state energetic. 
When polarized light is shone through a 
prism on a sensor chip with a thin metal film on 
top, the light will be reflected by the metal film 
acting as a mirror. On changing the angle of 
incidence, and monitoring the intensity of the 
reflected light, the intensity of the reflected light 
passes through a minimum (Figure 37, line A). 
At this angle of incidence, the light will excite surface plasmons, inducing surface plasmon 
resonance, causing a dip in the intensity of the reflected light. Photons of p-polarized light 
can interact with the free electrons of the metal layer, inducing a wave-like oscillation of 
the free electrons and thereby reducing the reflected light intensity. The angle at which the 
maximum loss of the reflected light intensity occurs is called resonance angle or SPR angle. 
The SPR angle is dependent on the optical characteristics of the system, e.g. on the 
refractive indices of the media at both sides of the metal, usually gold. While the refractive 
index at the prism side is not changing, the refractive index in the immediate vicinity of the 
metal surface will change when accumulated mass (e.g. proteins) adsorb on it. Hence the 
surface plasmon resonance conditions are changing and the shift of the SPR angle is suited 
to provide information on the kinetics of e.g. protein adsorption on the surface. 
When the refractive index changes, 
the angle at which the intensity minimum 
is observed will shift as indicated in figure 
37, where A depicts the original plot of 
reflected light intensity vs. incident angle 
and B indicates the plot after the change in 
refractive index. Surface plasmon 
 
 
Figure 37. Schematic experimental set-up of 
surface plasmon resonance excitation 
 
 
Figure 38. A sensorgram: the angle at 
 which the dip is observed vs. time 
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resonance is not only suited to measure the difference between these two states, but can 
also monitor the change in time, if one follows in time the shift of the resonance angle at 
which the dip is observed. Figure 38 depicts the shift of the dip in time, a so-called 
sensorgram. If this change is due to a biomolecular interaction, the kinetics of the 
interaction can be studied in real time.  
In the simplest case of an SPR 
measurement, 283 a target component or analyte is 
captured by the capturing element or so-called 
ligand. The ligand is permanently immobilized on 
the sensor surface previous to the measurement. 
The event of capturing the analyte by the ligand 
gives rise to a measurable signal; this is called 
direct detection (Figure 39). Each measurement 
starts with conditioning the sensor surface with a 
suitable buffer solution (Figure 40, base line step). At this point, the sensor surface contains 
the active ligands, ready to capture the target analytes. On injecting the solution containing 
the analytes (Figure 40, association step), they are captured on the surface. At this step, 
adsorption kinetics of the analyte molecule can be determined in a real-time measurement. 
Next, buffer is injected on to the sensor and the non-specifically bound components are 
flushed off (Figure 40, dissociation step). 
As indicated in the figure, the accumulated 
mass can be obtained from the SPR 
response (∆R). Also in this step, 
dissociation of the analyte starts, enabling 
the kinetics of the dissociation process to 
be studied. Finally, a regeneration solution 
is injected, which breaks the specific 
binding between analyte and ligand 
(Figure 40, regeneration step).  
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Figure 39. Schematic representation 
of direct detection 
 
 
 
Figure 40. Sensorgram showing the steps of an 
analysis cycle 
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The most prominent benefit of direct detection using SPR biosensor technology is 
the determination of kinetics of biomolecular interactions. Reaction rate and equilibrium 
constants of interactions can be determined, e.g. the interaction A+B→AB can be followed 
in real time with SPR technology, where A is the analyte (in this work: rgp 120 IIIB 
protein) and B is the ligand immobilized (in this work: polymer dendrimeric 345 and 324) 
on the sensor surface. The association constant (ka) is the reaction rate of complex (AB) 
formation, giving the number of complexes formed per time at unit concentration of A and 
B (Figure 41). As soon as the complex AB is formed, its dissociation can commence. The 
dissociation rate constant (kd) describing this process expresses the number of AB 
complexes dissociating per unit time (Figure 
41). When association of A and B starts, no 
product is yet present at the sensing surface. 
At this point, the rate of the association 
reaction is the highest and that of the 
dissociation reaction is the lowest. As the 
process progresses, more and more of the AB 
complex is produced, enhancing the rate of 
dissociation (Figure 41). Due to decreasing A 
and B concentration, the rate of association 
might decrease. Equilibrium is reached when 
the rates of the association and dissociation reactions are equal. Thus, the equilibrium 
association (KA) and dissociation (KD) constants, which represent the affinity of an 
interaction and stability of AB, are given by the equations 2 and 3: 
 
 KA 
 
  KD 
(2) [AB]/[A][B]=ka/kd and (3) [A][B]/[AB]=kd/ka 
 
Thus, sensorgrams (Figure 42 and 43) were analyzed by fitting the data to a 1:1 
(Langmuir) binding model and kinetic constants determined using the BiaE-valuation 3.2 
 
 
Figure 41. Interpretation of binding 
response curves 
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software. The rate constants and affinity constants for hyperbranched-rgp120 IIIB 
interactions are shown in Table 12. These data suggest that rgp120 IIIB exhibits similar 
binding to hyperbranched glycodentritic polymers 325 and 326, and appreciably lower 
affinity that reported by Schengrund284 to Dextran sulphate 327 (DxS, Figuer 44), which is a 
potent binding antagonist of HIV infection in vitro.285 
 
Table 12. Rate and Equilibrium Constants for the Interaction of Rgp120 IIIB with 
hyperbranched glycodentritic polymers 325 and 326 
Entry Compound ka kd KD (M) 
1 325 6.4 x 105 5.9 x 10-3 9.14 x 10-8 
2 326 3.6 x 104 4.6 x 10-3 1.28 x 10-8 
3a DxS (50 kDa) 327 2.8 x 106 6.4 x 10-5 2.29 x 10-11 
aValue reported by Schengrund and co-wokers.  
 
 
 
Figuere 42. Sensogram to glycodendritic compound 325 
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The response sensograms were obtained with increasing concentration of 
glycodendritic compound 325 and sulphated glycodendritic compound 326: 10, 20, 50, 100, 
250, 500 nM, and 1 µM as show in Figure 43 and 44 respectively. That 325 and 326 bind 
HIV rgp120 IIIB with comparable affinity suggests the importance of multivalent 
presentation of carbohydrates and how this contributes to the binding affinity, which it may 
be possible by cluster effect. 
 
 
Figure 43. Sensogram to sulphated glycodendritic compound 326 
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Figure 44. Structure of DxS 327 
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In the other hand, the efficiency of hyperbranched glycodendritic polymers was 
tested for their ability to inhibit HIV-1 BaL (R5-tropic) infection of U373-MAGI-CCR5 
cells and their effect on cell viability. The observed EC50 for the compound 328 was 80 µM 
(Figure 45). This observed efficiency in the micromolar range is consistent with 
observations recently reported to similar structures, however is lower that EC50 of DxS 
(<1.0 µM).284 In contrast, no inhibition was observed when the glycodendritic polymer 327 
was tested. The fact that 327 and 328 have different behaviour in the inhibition suggests 
that it may be possible by presence of sulphate groups in these compounds. Finally, neither 
hyperbranched glycodentritic polymers 327 nor DxS were cytotoxic to the cultured 
indicator cells at the highest concentrations tested (2.5 mg/mL).  
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Figure 45. Inhibition of HIV-1 BaL (R5-tropic) infection of U373-MAGI-CCR5 cells 
 
UNIVERSITAT ROVIRA I VIRGILI 
SYNTHESIS OF GLYCOLIPIDS AND GLYCODENDRITIC POLYMERS THAT BIND HIV RGP120 
José Antonio Morales Serna
 148
3.3.4. Experimental Part 
 
General methods 
 
All reactions were conducted under a dried argon stream. Solvents (CH2Cl2 99.9%, 
toluene 99.9%) were purchased in capped Pure Solv System-4® bottles and used without 
further purification and stored under argon. Yields refer to the chromatographically and 
spectroscopically (1H and 13C) homogeneous materials, unless otherwise stated. TMSI was 
stored at –15°C under desiccated atmosphere. All other solvents and reagents were used 
without further purification. The sphingosine was purchased from Avanti Polar Lipids Inc 
(Alabaster, AL). All glassware utilized was flame-dried before use. Reactions were 
monitored by TLC carried out on 0.25 mm E. Merck silica gel plates. Developed TLC 
plates were visualized under a short-wave UV lamp and by heating plates that were dipped 
in ethanol/H2SO4 (15:1). Flash column chromatography (FCC) was performed using flash 
silica gel (32–63 µm) and employed a solvent polarity correlated with TLC mobility. 
Melting points, determined with Reichert apparatus, are uncorrected. Optical rotations were 
measured at 598 nm on a Jasco DIP-370 digital polarimeter using a 100 mm cell. NMR 
experiments were conducted on a Varian 400 MHz instrument using CDCl3 and D2O 
(99.9% D) as the solvents. Chemical shift are in ppm with respect to TMS 
(Tetramethylsylane). Integrals in the 13C NMR spectra were obtained from 10% solutions 
using an inverse gated decoupling mode with a suppressed NOE effect, a relaxation delay 
of 20 s, an acq. time of 5 s and up to 20,000 repetitions. 
Mass Spectrometry MALDI-TOF MS was done on a Perseptive Biosystems 
Voyager DE-PRO spectrometer. Spectra of negatively charged sugars were generated in 
linear, negative ion mode using THAP matrix, or in linear, positive ion mode using IAA. 
Glycodendrimer spectra were generated in linear, positive ion mode using an IAA matrix 
(20 mg/mL in DMF, diluted 11:1 with a 1 mM aqueous solution of glycodendrimer to yield 
a matrix-to analyte ratio of 1000:1). 
Surface Plasmon Resonance experiments were done at 25 °C using a Biacore 3000 
system and CM5 sensor chips (Biacore, Uppsala, Sweden). Glycodendrimers were amine-
coupled to the sensor chip according to the manufacturer’s protocol. To obtain a low-
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density surface suitable for affinity analysis, 350-500 RUs of each glycodendrimer were 
immobilized. Varying concentrations of rgp120 were injected simultaneously over a blank 
control surface and the immobilized glycodendrimers at a flow rate of 30 mL/min for 3 min 
in HBS-EP buffer (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.005% P-20 surfactant, 
pH 7.4). Following the injection, the dissociation of the rgp120-glycodendrimer complex 
was measured for 10 min. Any remaining bound rgp120 was removed by 1 min injection of 
4 M KCl. This regeneration step prepared the surface for the next injection of rgp120. Each 
concentration of rgp120 was injected in duplicate over the immobilized glycodendrimer, 
with a representative sensorgram chosen for analysis.  
U373-MAGI-CCR5 cells were obtained from the AIDS Reagent Program. Cells 
were propagated in ‘Selection Media’ consisting of DMEM supplemented with 10% FCS, 
0.4 mg/mL L-glutamine, penicillin and streptomycin (0.08 mg/mL each), 0.05% sodium 
bicarbonate, 0.2 mg/mL G418, 0.1 mg/mL hyrgromycin B, and 1.0 ug/mL puromycin. 
‘Culture Media’ for virus inhibition assays consisted of DMEM with 10% FCS and 0.05% 
sodium bicarbonate. Cells were grown at 37 °C in an atmosphere of 95% air and 5% CO2.  
To viral inhibition assays, cells, were plated in 96-well tissue culture plates at a 
density of 1.0 X 10-4 cells per well. One day later, commercially available (Advanced 
Biotechnologies, Columbia, MD), concentrated cell-free viral preparations of HIV-1 Ba-L 
(R5) were diluted 1:400 in ‘Culture Media’. Glycodendrimers solutions were made up in 
culture media and serially diluted with culture media in separate sterile V-bottom 96-well 
microliter plates, to a final volume of 30 mL per well. This was followed by the addition of 
30 mL of the diluted virus and incubation at 37 °C for 20 min. Selection Media was then 
removed from the plated cells, and 50 mL of virus or virus plus potential inhibitor was 
added to the plated cells. The virus- or virus plus inhibitor-exposed cells were then 
incubated at 37 °C in an atmosphere of 95% air/5% CO2 for 2 h. After the absorption 
period, 200 mL of Culture Media was added to the wells, and the cells were allowed to 
grow for an additional 40-48 h. Cells treated with culture media served as negative controls, 
and cells treated with virus only were positive controls. All measurements were done in 
quadruplicate.  
After the 48 h incubation, culture media was removed from the wells, the cells were 
washed with 200 mL of PBS, and β-galactosidase activity was measured using the Galacto-
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Star β-Galactosidase Reporter Gene Assay System from Applied Biosystems (Foster City, 
CA), according to the manufacturer’s instructions. Briefly, after the cells were washed with 
PBS, 10 mL of lysis solution was added to each well and the plate incubated for 10 min at 
37 °C. The Galacto-Star substrate was diluted 1:50 and 100 mL added to each well 
containing cell lysate. Well contents were mixed and 90 mL were removed and added to a 
96-well opaque luminometer plate. One hour after the Galacto-Star substrate was added, 
luminescence was determined using a luminometer. Percent inhibition was determined as 
[(Lno inhibitor - Linhibitor)/Lno inhibitor] X 100. The effective concentration that inhibited 50% of 
viral infectivity (EC50) was determined by plotting the percent inhibition versus the log of 
the concentration of the potential inhibitor. 
 
Experimental Procedures 
 
16-azidohexadecanoic acid 327. To a solution of 16-
Bromohexadecanoic acid 316 (1 g, 2.99 mmol) in 
freshly distilled DMF (50 mL) was added NaN3 (1.94 g, 
29.9 mmol) and a catalytic amount of 18-crown-6, and 
the mixture was stirred at 90 °C for 72 h. The reaction mixture was poured into 1:1 AcOEt-
water (80 mL) and the aqueous phase was extracted with AcOEt (3 x 20 mL). The organic 
phases were combined, washed with brine (3 x 20 mL), dried over MgSO4 and concentrated 
in vacuo. The residue was purified by flash column chromatography on silica gel using 
hexane/AcOEt (95:5) as the eluent to give 799 mg of 317 (90 %). TLC (Hexane/AcOEt 
90:10) Rf 0.70; 1H NMR (400 MHz, CDCl3): δ 3.27 (t, 2H, J=7.2 Hz), 2.37 (t, 2H, J=7.5 
Hz), 1.62 (m, 4H), 1.40–1.20 (m, 22H); 13C NMR (100.6 MHz, CDCl3): δ 177.0, 51.4, 
34.0, 29.6, 29.5, 29.4, 29.2, 29.1, 29.0, 26.7, 24.6. Anal. Calcd. for C16H31N3O2: C, 64.61; 
H, 10.51; N, 14.13. Found: C, 64.68; H, 10.52, N, 14.10. 
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Synthesis of ceramide 318. A solution of 
sphingosine 19 (100 mg, 0.333 mmol), HOBt (61 
mg, 0.4 mmol), EDC (76 mg, 0.4 mmol) and DIPEA 
(77 mg, 0.6 mmol) in 20 mL of dry CH2Cl2 was 
cooled to 0 °C. Under stirring, stearic acid (98 mg, 
0.333 mmol in 20 mL of dry CH2Cl2) was added drop wise over 6 h at 0°C, and then the 
reaction was stirred under argon for 18 h at room temperature. The mixture was diluted 
with ethyl acetate (75 mL) and washed successively with HCl (10% aqueous, 2 x 30 mL), 
NaHCO3 (7% aqueous, 2 x 30 mL), K2CO3 (7% aqueous, 2 x 30 mL), and brine (3 x 30 
mL). The organic layer was dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash column chromatography on silica gel using hexane-AcOEt-MeOH 
(85:10:5) as the eluent to give 162 mg of pure cearamide 318 (85 %). TLC (Hexane-
AcOEt-MeOH 60:30:10); 1H NMR (400 MHz, CDCl3): δ 6.23 (1H, d, J=7.3 Hz),  5.77 
(1H, dt, J=15.4, 6.7 Hz), 5.51 (1H, dd, J=15.4, 6.4 Hz), 4.3 (1H, dd, J=6.4, 3.4 Hz), 3.94 
(1H, dd, J=11.3, 3.7 Hz), 3.89 (1H, dddd, J=7.3, 3.7, 3.4, 3.2 Hz), 3.69 (1H, dd, J=11.3, 3.2 
Hz), 3.27 (t, 2H, J=7.2 Hz), 2.21 (2H, t, J=7.5 Hz), 2.03 (2H, dt, J=7.2, 6.7 Hz), 1.62 (m, 
4H), 1.40–1.20 (m, 44H), 0.86 (t, 3H, J=7.5 Hz); 13C NMR (100.6 MHz, CDCl3): δ 174.2, 
134.6, 129, 74.9, 62.8, 54.7, 51.4, 36.92, 32.2, 31.98, 29.9, 29.8, 29.7, 29.6, 29.5, 29.4, 26, 
22.9, 14.3. Anal. Calcd. for C34H66N4O3: C, 70.54; H, 11.49; N, 9.68. Found: C, 70.52; H, 
11.47, N, 9.69. 
 
Preparation of stannyl acetal 319: A mixture of 
cearamide (101 mg, 0.176 mmol) and dibutyltin 
oxide (44 mg, 0.176 mmol) in dry toluene (20 mL), 
was heated to reflux and was subjected to azeotropic 
dehydration using a Dean-Stark system or 4 Å 
molecular sieves overnight. Removal of solvent 
under reduced pressure afforded the stannyl ether 319, which was used for the 
glycosyilation without further purification. 
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Synthesis of β-GalCer 322. The following 
protocol was followed prior to the 
glycosylation reaction: 1,2,3,4,6-penta-O-
acetyl-β-D-galactopyranose and stannyl ether 
319 were separately dried by co-destillation with toluene (3 x 5 mL) in dried flasks and 
then were placed under vacuum for 1 h.  
TBAI was added to a dried flask with a magnetic stirring bar and was co-destilled 
with dry toluene (2 x 5 mL) in the dark. Activated 4 Å molecular sieves were added, and 
the mixture was co-destilled with toluene once more (5 mL) before being placed under 
vacuum for 1 h. Complete water exclusion is crucial to achieve good yields. 
A solution of previously dried 1,2,3,4,6-penta-O-acetyl-β-D-galactopyranose 262 
(82 mg, 0.211 mmol) in CH2Cl2 (3 mL) was cooled to 0°C under argon atmosphere in the 
dark and TMSI (50 mg, 0.253 mmol) was added to the stirring mixture. The reaction was 
stirred for 20 min at 0°C. The reaction was stopped by adding 3 mL of dry toluene and co-
destilling three times with dry toluene to obtain compound 283 as a slightly yellow oil, 
which was then dissolved in anhydrous toluene (5 mL) and kept under argon. 
To a stirred mixture of TBAI (6 mg, 0.017 mmol) and 4Å acid washed molecular 
sieves (1.2 g) in anhydrous toluene (5 mL) under argon at room temperature was added a 
solution of stannyl derivative 319 (101 mg, 0.176 mmol) in dry toluene (5 mL) and a 
solution of 283 (0.211 mmol) in dry toluene (5 mL) via syringe. The reaction mixture was 
stirred at 80°C in the dark for 18 h and then diluted with AcOEt (15 mL) and cooled to 0°C. 
The white precipitate was removed by filtration through a pad of Celite. The organic layer 
was concentrated in vacuo to get the orthoester 320, which was co-destilled with dry 
toluene (3 x 5 mL) and placed under vacuum for 1 h before the next reaction. 
A solution containing the orthoester in anhydrous CH2Cl2 (5 mL) was cooled to 0 °C 
under argon atmosphere, and freshly distilled BF3·EtO2 (0.528 mmol) was added to the 
stirring mixture. After, the resulting reaction mixture was stirred for 3 h at room 
temperature, it was quenched with saturated aqueous NaHCO3 solution and 25 mL of 
AcOEt was added. The aqueous phase was extracted with AcOEt (2 x 15 mL), and the 
combined organic extract was washed with saturated aqueous Na2S2O3 solution (2 x 10 
mL) and brine (3 x 10 mL), dried with anhydrous Na2SO4, and concentrated in vacuo. 
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Then, MeOH (15 mL) and Dowex 50WX8–200 ion-exchange resin (1.5 g) were 
added and the reaction was stirred at room temperature for 4 h. The resin was then removed 
by filtration. The solvent was removed in vacuo, and the resulting residue was purified by 
flash column chromatography on silica gel using CHCl3-MeOH (85:15) as eluent to give 
114 mg (88%) of 322 as a unique anomer. [α]D25 −5 (c=1.0, Py). 1H NMR (400 MHz, 
CDCl3/CD3OD, 1:1): δ 7.57 (d, 1H, J=9.0 Hz), 5.66 (dt, 1H, J=15.5, 7.0 Hz), 5.42 (ddt, 1H, 
J=15.5, 7.5, 1.0 Hz), 4.19 (d, 1H, J=7.5 Hz), 4.17 (dd, 1H, J=10.0, 4.3 Hz), 4.08 (dd, 1H, 
J=7.5 Hz), 3.99-3.93 (m, 1H), 3.84 (d, 1H, J=3.0 Hz), 3.78 (dd, 1H, J=11.5, 6.6 Hz), 3.71 
(dd, 1H, J=11.5, 5.0 Hz), 3.56 (dd, 1H, J=10.0, 3.0 Hz), 3.53 (dd, 1H, J=9., 7.5 Hz), 3.50-
3.44 (m, 2H), 3.26 (t, 2H, J=7.2 Hz), 2.14 (t, 2H, J=7.5 Hz), 2.02 (dt, 2H, J=7.2, 6.7 Hz), 
1.62 (m, 4H), 1.40–1.20 (m, 44H), 0.86 (t, 3H, J=7.5 Hz); 13C NMR (100.6 MHz, 
CDCl3/CD3OD, 1:1): δ 176.0, 135.5, 130.8, 105.1, 76.5, 74.8, 73.2, 72.7, 70.3, 70.0, 62.7, 
54.7, 51.3, 37.7, 33.6, 33.2, 30.9-30.6, 27.3, 26.3, 23.9, 15.0. Anal. Calcd. for C40H76N4O8: 
C, 64.83; H, 10.34; N, 7.56. Found: C, 64.80; H, 10.32, N, 7.53. 
 
Synthesis of dendritic polymer 324. To a solution of 5-
hexynoic acid 323 (2.115 g, 18.88 mmol, 2 equiv per OH) and 
Boltorn H30 315 (1 g, 0.295 mmol) in DMF:CH2Cl2 1:1 (100 
mL) were added HOBt (2.879 g, 18.88 mmol), EDC (3.587 g, 
18.88 mmol) and DIPEA (2.422 g, 18.88 mmol). The reaction 
mixture was stirred at room temperature for five days and then concentrated in vacuo. The 
residue was purified by dialysis to obtain compound 324 (1.245 g, 80%) as a slightly 
yellow oil. 1H NMR (400 MHz, CDCl3): δ  4.918 (s, br, 12H) 4.24 (m, 96H), 3.62 (m, 
24H), 2.48 (m, 40H), 2.24 (m, 40H), 1.99 (m, 20H), 1.82 (m, 40H), 1.26 (m, 84H); 13C 
NMR (100.6 MHz, CDCl3): δ 175-172, 84.6, 71.3, 71, 66-63, 51-46, 34.9, 23.6, 20.7, 17. 
MALDI-TOF MS: 5275.9 
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Synthesis of glycodendritic polymer 
of β-GalCer 325. To a solution of 
dendritic polymer 324 (17 mg, 0.0032 
mmol) in a 1:1 mixture of t-BuOH-
H2O, were added β-GalCer 322 (95 mg, 
0.128 mmol), CuSO4.5H2O (0.3 eq. per propargyl) and sodium ascorbate (0.3 eq. per 
propargyl). The reaction mixture was stirred at room temperature for 72 h and then purified 
by dialysis to obtain compound 325 (58 mg, 90%) as a white lyophilizate. 1H NMR (400 
MHz, D2O): δ  7.8 (m, 20H), 5.6 (m, 40H), 4.4-4.1 (m, 136H), 3.88-3.4 (m, 244H), 2.6 (m, 
40H), 2.36-2.05 (m, 160H), 1.42-0.8 (m, 1104H); 13C NMR (100.6 MHz, D2O): δ 175-172, 
145, 134.6, 130.2, 126.1, 105, 76.5, 74.8, 73.3, 72.6, 70.4, 70.1, 65.7-63.1, 54.7, 49-46, 
37.7, 34.9, 33.8, 33.4, 30.8-30.5, 27.4, 26.3, 23.8, 23.6, 20.7, 17, 15. MALDI-TOF MS: 
20033.9 
 
Sulfation of glycodendritic polymer 
of β-GalCer. To a solution of 
glycodendritic polymer of β-GalCer 
325 (25 mg, 0.0012 mmol) was added 
SO3NMe3 (2 equiv per hydroxyl 
group). The reaction mixture was refluxed with stirring at 60 °C for 48 h and then dried by 
rotary evaporation under reduced pressure supplied by an oil vacuum pump and then 
purified by dialysis to obtain compound 326 (23 mg, 88%) as a white solid. 1H NMR (400 
MHz, D2O): δ  7.85 (m, 20H), 5.6 (m, 40H), 4.5-4.1 (m, 156H), 3.9-3.4 (m, 224H), 2.6 (m, 
40H), 2.39-2.1 (m, 160H), 1.58-0.83 (m, 1104H); 13C NMR (100.6 MHz, D2O): δ 175-172, 
145.1, 135.6, 130.7, 126.4, 105.5, 81.6, 76.1, 73.1, 70.9, 70.2, 68.7, 65.7-63.1, 54.7, 52.6, 
51-46, 37.7, 33.8, 33.2, 32.4, 31, 30.8-30.5, 28.5, 27.3, 25.3, 23.8, 23.6, 20.7, 17.1, 15. 
MALDI-TOF MS: 21617.1 
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4. CONCLUSIONS 
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1. D/L-erytro-sphingosine 11 has been synthetised in 8 steps and 33% overall yield 
from alcohol 17 using a tethered aminohydroxylation (TA) as key step, which 
allowed to introduce the 2-amino and 3-hydroxylic groups with complete region- 
and stereoselectivity (Figure 33). 
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Figure 33 
 
2. Also, we have reported a very efficient 5-step synthesis of D-erythro-sphingosine 
11 in 60% overall isolted yield and high enantioselectivity and diasteroselctivity by 
an asymmetric sulfur ylide reaction between the allyl bromide of dodecane 23 and 
the appropriate aldehyde 22 in presencia the EtP2 as base (Figure 34). 
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Figure 34 
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3. It has developed a process for the synthesis of glycosphingolipids based on a 
complete chemo and stereoselective reaction of α-glycosyl iodides with stannyl ceramides 
in the presence of TBAI (Figure 35). The synthetic scope was established by the use of a 
disaccharide and trisaccharide as donors. Moreover, it provides a solution for synthesising 
glycolipids via the direct glycosylation of ceramides. We believe that this methodology will 
find use in the efficient assembly of glycosphingolipids, which should provide avenues for 
the synthesis of these therapeutically valuable compounds. 
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Figure 35 
 
4. The copper(I)-catalyzed azide-acetylene cycloaddition has proven to be a powerful 
tool for the preparation of water-soluble glycoconjugates, which are consists of Boltorn 
H30 hyperbranched polymers and the naturally occurring β-Galceramide. The 
hyperbranched glycodentritic polymers have been used as models to mimic GSLs 
clustering at the cell suface demonstrating an excellent cluster effect. This is in agreement 
with the current hypothesis that the assembly of the HIV-1 fusion complex requires, in 
addition to CD4 and a corecptor, specific glycolipids which are present in restricted areas 
of the plasma membrane. This approach opens the way to the development of novel class of 
HIV-1 binding antagonists employing hyperbranched dentritic polymers (Figure 36). 
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Figure 36 
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4. ANNEX 
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